OA16500A - Pesticidal compositions and processes related thereto. - Google Patents

Pesticidal compositions and processes related thereto. Download PDF

Info

Publication number
OA16500A
OA16500A OA1201300315 OA16500A OA 16500 A OA16500 A OA 16500A OA 1201300315 OA1201300315 OA 1201300315 OA 16500 A OA16500 A OA 16500A
Authority
OA
OAPI
Prior art keywords
alkyl
crc
haloalkyl
cycloalkyl
alkenyl
Prior art date
Application number
OA1201300315
Inventor
Gary D. Crouse
Thomas C. Sparks
William Hunter Dent
Casandra Lee Mcleod
Lawrence C. Creemer
Original Assignee
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc filed Critical Dow Agrosciences Llc
Publication of OA16500A publication Critical patent/OA16500A/en

Links

Abstract

This document discloses molecules having the following formulas ("Formula One" &"Formula Two" and "Formula Three")

Description

The invention disclosed in this document is related to the field of processes to produce moiecules that are useful as pesticides (e.g., acaricides, insecticides, molluscîcides, and nematicides), such moiecules, and processes of using such moiecules to control pests.
BACKGROUND OF THE INVENTION
Pests cause millions of human deaths around the world each year. Furthermore, there are more than ten thousand species of pests that cause losses in agriculture. The world-wide agricultural losses amount to billions of U.S. dollars each year.
Termites cause damage to ali kinds of private and public structures. The world-wide termite damage losses amount to billions of U.S. dollars each year.
Stored food pests eat and adulterate stored food. The world-wide stored food losses amount to billions of U.S. dollars each year, but more importantly, deprive people of needed food.
There is an acute need for new pesticides. Certain pests are developing résistance to pesticides in current use. Hundreds of pest species are résistant to one or more pesticides. The development of résistance to some of the older pesticides, such as DDT, the carbamates, and the organophosphates, is well known, but résistance has even developed to some of the newer pesticides.
Therefore, for many reasons, including the above reasons, a need exists for new pesticides.
DEFINITIONS
The examples given in the définitions are generally non-exhaustive and must not be construed as limiting the invention disclosed in this document. It is understood that a substituent should comply with chemical bonding rules and steric compatibility constraints in relation to the particular moiecule to which it is attached.
“Acaricide Group” is defined under the heading “ACARICIDES”.
“Al Group is defined after the place in this document where the Herbicide Group” is defined.
“Alkenyl means an acyclic, unsaturated (at least one carbon-carbon double bond),
Page 1 of160 branched or unbranched, substituent consisting of carbon and hydrogen, for example, vinyl, allyl, butenyl, pentenyl, and hexenyl.
“Alkenyloxy” means an alkenyl further consisting of a carbon-oxygen single bond, for example, allyloxy, butenyloxy, pentenyloxy, hexenyloxy.
“Alkoxy” means an alkyl further consisting of a carbon-oxygen single bond, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, and tert-butoxy.
“Alkyl means an acyclic, saturated, branched or unbranched, substituent consisting of carbon and hydrogen, for example, methyl, ethyl, propyl, isopropyl, butyl, and tert-butyl.
“Alkynyl means an acyclic, unsaturated (at least one carbon-carbon triple bond), branched or unbranched, substituent consisting of carbon and hydrogen, for example, ethynyl, propargyl, butynyl, and pentynyl.
“Alkynyloxy” means an alkynyl further consisting of a carbon-oxygen single bond, for example, pentynyloxy, hexynyloxy, heptynyloxy, and octynyloxy.
“Aryl” means a cyclic, aromatic substituent consisting of hydrogen and carbon, for example, phenyl, naphthyl, and biphenyl.
“Cycloalkenyl” means a monocyclic or polycyclic, unsaturated (at least one carboncarbon double bond) substituent consisting of carbon and hydrogen, for example, cyclobutenyl, cyclopentenyl, cyclohexenyl, norbornenyl, bicyclo[2.2.2]octenyl, tetrahydronaphthyl, hexahydronaphthyl, and octahydronaphthyl.
Cycloalkenyloxy” means a cycloalkenyl further consisting of a carbon-oxygen single bond, for example, cyclobutenyloxy, cyclopentenyloxy, norbornenyloxy, and bicyclo[2.2.2]octenyloxy.
“Cycloalkyl means a monocyclic or polycyclic, saturated substituent consisting of carbon and hydrogen, for example, cyclopropyl, cyclobutyl, cyclopentyl, norbornyl, bicyclo[2.2.2]octyl, and decahydronaphthyl.
Cycloalkoxy” means a cycloalkyl further consisting of a carbon-oxygen single bond, for example, cyclopropyloxy, cyclobutyloxy, cyclopentyloxy, norbornyloxy, and bicyclo[2.2.2]octyloxy.
“Fungicide Group” is defined under the heading FUNGICIDES.
“Halo” means fluoro, chloro, bromo, and iodo.
“Haloalkoxy means an alkoxy further consisting of, from one to the maximum possible number of identicai or different, halos, for example, fluoromethoxy, trifluoromethoxy, 2,2dîfluoropropoxy, chloromethoxy, trichloromethoxy, 1,1,2,2-tetrafluoroethoxy, and pentafluoroethoxy.
“Haloalkyl means an alkyl further consisting of, from one to the maximum possible number of, identicai or different, halos, for example, fluoromethyl, trifluoromethyl, 2,2difluoropropyl, chloromethyl, trichloromethyl, and 1,1,2,2-tetrafluoroethyl.
“Herbicide Group is defined under the heading “HERBICIDES.
Page 2 of 160 “Heterocyclyl’' means a cyclic substituent that may be fully saturated, partially unsaturated, or fully unsaturated, where the cyclic structure contains at least one carbon and at least one heteroatom, where said heteroatom is nitrogen, sulfur, or oxygen. Examples of aromatic heterocyclyls include, but are not limited to, benzofuranyl, benzoisothiazolyl, benzoisoxazolyl, benzoxazolyl, benzothienyl, benzothiazolyl cinnolinyl, furanyl, indazolyl, indolyl, imidazolyl, isoindolyl, isoquinolinyl, isothiazolyl, isoxazolyl, oxadiazolyl, oxazolinyl, oxazolyl, phthalazinyl, pyrazinyl, pyrazolînyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, quinazolinyl, quinolinyl, quinoxalinyl, tetrazolyl, thiazolinyl, thiazolyl, thienyl, triazinyl, and triazolyl. Examples of fully saturated heterocyclyls include, but are not limited to, piperazinyl, piperidinyl, morpholinyl, pyrrolidinyl, tetrahydrofuranyl, and tetrahydropyranyl. Examples of partially unsaturated heterocyclyls include, but are not limited to, 1,2,3,4-tetrahydro-quinolinyl, 4,5-dihydro-oxazolyl, 4,5-dihydro-1H-pyrazolyl, 4,5-dihydro-isoxazolyl, and 2,3-dihydro-[1,3,4]oxadiazolyl.
“Insecticide Group is defined under the heading “INSECTICIDES.
“Nematicide Group is defined under the heading “NEMATICIDES” “Synergist Group is defined under the heading “SYNERGISTIC MIXTURES AND SYNERGISTS”
DETAILED DESCRIPTION OF THE INVENTION
This document discloses molécules having the following formulas (“Formula One &“Formula Two and “Formula Three): (In the following formulas the nitrogens are numbered 1,2, and 3, solely for the purpose of identifying them and being able to refer to them throughout this document for clarity purposes) wherein:
Ar, is
RI
Het z
Formula 1
Het z
Formula 2
RI ,R5
RI
Het z
N3_
Formula 3
R4
Page 3 of160 (1) furanyl, phenyl, pyridazinyl, pyridyl, pyrimidinyl, thienyl, or (2) substituted furanyl, substituted phenyl, substituted pyridazinyl, substituted pyridyl, substituted pyrimidinyl, or substituted thienyl, wherein said substituted furanyl, substituted phenyl, substituted pyridazinyl, substituted pyridyl, substituted pyrimidinyl, and substituted thienyl, hâve one or more substituents independently selected from H, F, Cl, Br, I, CN, N02, CrCe alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-Ce cycloalkoxy, C3-C6 halocycloalkoxy, C,-C6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)r(CrC6 alkyl), 3(=Ο)Γ(0ι-06 haloalkyl), OSO2(Ci-C6 alkyl), OSC^Cj-Ce haloalkyl), C(=O)NRxRy, (CrC6 alkyl)NRxRy, C(=O)(CrCe alkyl), 0(=0)0(0,-06 alkyl), C(=O)(C,-C6 haloalkyl), C(=O)O(C,-C6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C8 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (CrC6 alkyl)S(Ci-Ce alkyl), C(=0)(Ci-C6 alkyl)C(=0)0(C1-C6 alkyl), phenyl, phenoxy, substituted phenyl, and substituted phenoxy, wherein such substituted phenyl and substituted phenoxy hâve one or more substituents independently selected from H, F, Cl, Br, I, CN, N02, CrC6 alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, Cr C6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(C1-C6 haloalkyl), OSO2(CrC6 alkyl), OSO2(Ci-C6 haloalkyl), C(=O)NRxRy, (CrC6 alkyl)NRxRy, C(=0)(CrCe alkyl), C(=O)O(CrCe alkyl), ¢(=0)(0,-06 haloalkyl), 0(=0)0(0,-06 haloalkyl), C(=0)(C3-Ce cycloalkyl), 0(=0)0(03-06 cycloalkyl), 0(=0)(02-06 alkenyl), C(=O)O(C2-C6 alkenyl), (C,-C6 alkyl)O(C,-C6 alkyl), (C,-C6 alkyl)S(CrC6 alkyl), Ο(=Ο)(Ο,-ΟΘ alkyl)C(=O)O(C,C6 alkyl) phenyl, and phenoxy;
(b) Het is a 5 or 6 membered, saturated or unsaturated, heterocyclic ring, containing one or more heteroatoms independently selected from nitrogen, sulfur, or oxygen, and where Αη and Ar2 are not ortho to each other (but may be meta or para, such as, for a five membered ring they are 1,3 and for a 6 membered ring they are either 1,3 or 1,4), and where said heterocyclic ring may also be substituted with one or more substituents independently selected from H, F, Cl, Br, I, CN, NO2, oxo, Ο,-Οβ alkyl, 0,-06 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, CrC6 alkoxy, Ci-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=0)n(CrC6 alkyl), S(=0)n(CrC6 haloalkyl), OSO2(Ci-C6 alkyl), OSO2(CrC6 haloalkyl), C(=O)NRxRy, (CrC6 alkyl)NRxRy, C(=0)(CrC6 alkyl), C(=0)0(Ci-C6 alkyl), C(=O)(CrCe haloalkyl), C(=0)0(CrC6 haloalkyl), Ο(=Ο)(Ο3-Ο6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=0)0(C2-Ce alkenyl), (Ci-C6 alkyl)O(CrC6 alkyl), (0,-06 alkyl)S(CrC6 alkyl), C(=O)(Ci-Ce alkyl)C(=O)0(Ci-C6 alkyl), phenyl, phenoxy, substituted phenyl and substituted phenoxy, wherein such substituted phenyl and substituted phenoxy hâve one or more substituents independently selected from H, F, Cl, Br, I, CN, NO2, CrC6 alkyl, C-i-Ce haloalkyl,
C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, CrCs alkoxy,
Page 4 of 160
Ci-C6 haloalkoxy, C2-C0 alkenyl, C2-Ce alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(CrCe haloalkyl), OSO2(Ci-C6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)NRxRy, (Ci-C6 alkyl)NRxRy, C(=O)(Cr C6 alkyl), C(=O)O(CrCe alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), Ο(=Ο)Ο(Ο3-Ο6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrCe alkyl), (CrC6 alkyl)S(Ci-CG alkyl), 0(=0)(0,-06 alkyl)C(=O)O(CrC6 alkyl), phenyl, and phenoxy;
(c) Arz is (1) furanyl, phenyl, pyridazinyl, pyridyl, pyrimidinyl, thienyl, or (2) substituted furanyl, substituted phenyl, substituted pyridazinyl, substituted pyridyl, substituted pyrimidinyl, or substituted thienyl, wherein said substituted furanyl, substituted phenyl, substituted pyridazinyl, substituted pyridyl, substituted pyrimidinyl, and substituted thienyl, hâve one or more substituents independently selected from H, F, Cl, Br, I, CN, N02) 0,-06 alkyl, 0,-06 haloalkyl, C3-CB cycloalkyl, C3-Ce halocycloalkyl, C3-C6 cycloalkoxy, C3-Ce halocycloalkoxy, 0,-06 alkoxy, Ci-C6 haloalkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(C1-C6 alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)NRxRy, (Ci-C6 alkyl)NRxRy, C(=O)(Ci-C6 alkyl), 0(=0)0(0,-06 alkyl), C(=0)(CrC6 haloalkyl), 0(=0)0(0,-06 haloalkyl), Ο(=Ο)(Ο3-Ο6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), 0(=0)0(C2-C6 alkenyl), (C,-C6 alkyl)O(Ci-C6 alkyl), (CrC6 alkyl)S(CrC6 alkyl), 0(=0)(Ο,-Ce alkyl)C(=O)O(CrC6 alkyl), phenyl, phenoxy, substituted phenyl and substituted phenoxy, wherein such substituted phenyl and substituted phenoxy hâve one or more substituents independently selected from H, F, Cl, Br, I, CN, N02, 0,-06 alkyl, C,-C6 haloalkyl, Ο3-Ο6 cycloalkyl, Ο3-Ο6 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, 0,Ce alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=0)n(CrCe alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)NRxRy, (CrCe alkyl)NRxRy, C(=0)(0rC6 alkyl), C(=O)O(CrC6 alkyl), C(=0)(CrC6 haloalkyl), C(=0)0(CrC6 haloalkyl), 0(=0)(03-0β cycloalkyl), C(=O)0(C3-Ce cycloalkyl), C(=O)(CrC6 haloalkyl), C(=O)(C2-C6 alkenyl), Ο(=Ο)Ο(Ο2-ΟΘ alkenyl), (CrCe alkyl)O(CrC6 alkyl), (CrCe alkyl)S(CrC6 alkyl), C(=0)(CrC6 alkyl)C(=0)0(CrC6 alkyl), phenyl, and phenoxy;
(d) R1 is selected from H, CN, F, Cl, Br, I, CrC6 alkyl, Ο3-Ο6 cycloalkyl, C3-C6 cycloalkoxy, CrC6 alkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(CrC6 alkyl), OSO2(CrC6 alkyl), C(=O)NRxRy, (CrCe alkyl)NRxRy, C(=0)(CrC6 alkyl), 0(=0)0(0,-06 alkyl), Ο(=Ο)(Ο3-Ο6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-Ce alkenyl), 0(=0)0(02-06 alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=0)(CrC6 alkyl)C(=O)O(CrC6 alkyl), phenyl, or phenoxy, wherein each alkyl, cycloalkyl, cycloalkoxy, alkoxy, alkenyl, alkynyl, phenyl, and
Page 5 of160 phenoxy, are optionally substituted with one or more substituents îndependently selected from F, Cl, Br, I, CN, NO2, oxo, Ci-C6 alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-Ce halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, CrC6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(C1-C6 alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)NRxRy, (CrCe alkyl)NRxRy, C(=O)(C1-C6 alkyl), C(=O)O(Ci-C6 alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-Ce cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (C,-C6 alkyl)S(CrC6 alkyl), C(=O)(CrCe alkyl)C(=O)O(C1-C6 alkyl), phenyl, and phenoxy;
(e) R2 is H, CrC6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C(=O)H, C(=O)(CrC6 alkyl), C(=O)O(CrC6 alkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-CB alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (CrC6 alkyl)S(Ci-C6 alkyl), C(=O)(CrC6 alkyl)C(=O)O(Ci-C6 alkyl), phenyl, CrC6 alkylphenyl, Ci-Ce alkyl-O-phenyl, C(=O)Het-1, Het-1, CrCB alkylHet-1, or CrC6 alkyl-O-Het-1, wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and Het-1 are optionally substituted with one or more substituents îndependently selected from F, Cl, Br, I, CN, NO2, NRxRy, CrCB alkyl, Ci-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-Ce cycloalkoxy, C3-C6 halocycloalkoxy, CrC6 alkoxy, CrCe haloalkoxy, C2-C6 alkenyl, C3-C6 cycloalkenyl, C2-C6 alkynyl, S(=O)n(Ci-CB alkyl), S(-O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)NRxRy, (CrCe alkyl)NRxRy, C(-O)(CrCe alkyl), C(=O)O(CrCB alkyl), C(=O)(C,C6 haloalkyl), C(=O)O(CrCB haloalkyl), C(=O)(C3-Ce cycloalkyl), C(=O)O(C3-CB cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-CB alkenyl). (CrCe alkyl)O(CrC0 alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=O)(CrC6 alkyl)C(=O)O(CrCB alkyl), phenyl, phenoxy, and Het-1;
(f) R3 is CrC6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C(=O)H, C(=O)(CrC6 alkyl), C(=O)O(CrC6 alkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=O)(CrCe alkyl)C(=O)O(CrC6 alkyl), phenyl, CrC6 alkylphenyl, CrC6 alkyl-O-phenyl, C(=O)Het-1, Het-1, CrC6 alkylHet-1, Ci-C6alkyl-O-C(=O)CrC6 alkyl-O-CrCe alkyl, Ci-C6alkylO-C(=O)CrC6 alkyl-O-CrCe alkyl-O- CrC6 alkyl, CrCealkyl-O-C(=O)Ci-C6 alkyl-O-CpCe haloalkyl, CrC6 alkyl-O-C(=O)C1-Ce alkyl-N(Rx)C(=O)-O-phenyl, CrC6 alkyl-O-C(=O)CrC6 alkylN(Rx)C(=O)-O-CrC6 alkylphenyl, C1-C6alkylC(=O)N(Rx)Cl-Ce alkyl, C1-C6alkylC(=O)N(Rx)C1-C6 alkylKet-1C(=O)-O-CrC6 alkyl, CrC6 alkylC(=O)N(Rx)Ci-C6 alkylHet-1, CrC6alkylC(=O)Het-1, CrC6 alkylC(=O)N(Rx)Ci-C6 alkyl(N(Rx)(Ry))(C(=O)OH), CrC6 alkylC(=O)N(Rx)C1-C6 alkylN(Rx)(Ry), C1-C6alkylC(=O)N(Rx)C1-C6 alkylN(Rx)C(=O)-O-CrC6 alkyl, CrCe alkylC(=O)N(Rx)CrCe alkyl(N(Rx)C(=O)-O-CrCe alkyl)(C(=O)OH), CrC6alkylC(=O)Het-1C(=O)O-CrC6 alkyl, CrC6 alkyl-O-C(=O)-O-CrC6 alkyl, C,-Ce alkyl-O-C(=O)CrC6 alkyl, CrC6alkyl-OC(=O)C3-C6 cycloalkyl, CrC6alkyl-O-C(=O)Het-1, Ci-C6alkyl-O-C(=O)Ci-Ce alkyl-N(Rx)C(=O)-
Page 6 of 160
O-CrCe alkyl, CrCe alkyl-NRxRy, or CrC6 alkyl-O-Het-1, wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and Het-1 are optionally substituted with one or more substituents independently selected from F, Cl, Br, I, CN, NO2, NRxRy, CrC6 alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, CrCe alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C3-C6 cycloalkenyl, C2-C6 alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)OH, C(=O)NRKRy, (CrC6 alkyl)NRxRy, C(=O)(CrC6 alkyl), C(=O)O(CrC6 alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (Ci-Ce alkyl)O(CrCe alkyl), (CrC6 alkyl)S(CrCe alkyl), C(=O)(CrC6 alkyl)C(=O)O(CrC6 alkyl), phenyl, phenoxy, Si(CrC6 alkyl)3, S(=O)nNRxRy, and Het-1;
(g) R4 is H, CrC6 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C(=O)H, C(=O)(CrC6 alkyl), C(=O)O(CrC6 alkyl), C(=O)(C3-Ce cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrCe alkyl)O(CrCe alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=O)(CrCe alkyl)C(=O)O(C1-C6 alkyl), phenyl, Ci-C6 alkylphenyl, Ci-C6 alkyl-O-phenyl, C(=0)Het-1, Het-1, CrCe alkylHet-1, or CrC6 alkyl-O-Het-1, wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and Het-1 are optionally substituted with one or more substituents independently selected from F, Cl, Br, I, CN, N02, NRxRy, CrC6 alkyl, CrCe haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-Ce halocycloalkoxy, CrC6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C3-C6 cycloalkenyl, C2-C6 alkynyl, S(=0)n(CrC6 alkyl), S(=O)n(C,-C6 haloalkyl), OSO2(C,-Ce alkyl), 0S02(C,-Ce haloalkyl), C(=O)H, C(=O)NRxRy, (C,-Ce alkyl)NRxRy, C(=O)(C,-C6 alkyl), C(=O)O(C,-C6 alkyl), C(=0)(C,Ce haloalkyl), C(=O)O(C,-C6 haloalkyl), C(=O)(C3-C0 cycloalkyl), C(=O)O(C3-Ce cycloalkyl), C(=0)(C2-Ce alkenyl), C(=O)O(C2-C6 alkenyl), (CrCe alkyl)O(C,-C6 alkyl), (C,-C6 alkyl)S(C,-C6 alkyl), C(=O)(Ci-Ce alkyl)C(=O)O(Ci-C6 alkyl), phenyl, phenoxy, and Het-1;
(h) R5 is a 2 to 4 membered saturated or unsaturated hydrocarbyl linkage where said linkage may also be substituted with F, Cl, Br, I, CN, N02( oxo, NRxRy, Ci-Ce alkyl, CrCe haloalkyl, C3-Ce cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, C;C6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C3-C6 cycloalkenyl, C2-C6 alkynyl, S(=O)n(C1-C6 alkyl), S(=O)n(C,-C6 haloalkyl), OSO2(CrC6 alkyl), OSO2(Ci-C6 haloalkyl), C(=O)H, C(=O)OH, C(=O)NRxRy, (CrCe alkyl)NRxRy, C(=0)(CrC6 alkyl), C(=0)0(Ci-C6 alkyl), C(=O)(CrC6 haloalkyl), C(=0)0(CrCe haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrCe alkyl)O(Ci-C6 alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=0)(CrCe alkyl)C(=O)O(Ci-C6 alkyl), phenyl, phenoxy, and Het-1, wherein each alkyl, cycloalkyl, cycloalkoxy, alkoxy, alkenyl, alkynyl, phenyl, phenoxy, and Het-1, are optionally substituted with one or more substituents independently
Page 7 of 160 selected from F, Cl, Br, I, CN, NO2, oxo, NRxRy, CrC6 alkyl, CrCe haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-Ce cycloalkoxy, C3-C6 halocycloalkoxy, CrCe alkoxy, CrC6 haloalkoxy, C2-Ce alkenyl, C3-C6 cycloalkenyl, C2-Ce alkynyl, S(=O)n(Ci-Ce alkyl), S(=O)n(CrC6 haloalkyl), OSO^CrCe alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)OH, C(=O)NRxRy, (CrCe alkyl)NRxRy, C(=O)(CrC6 alkyl), C(=O)O(CrCe alkyl), C(=O)(CrCe haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-Ce cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrCe alkyl), (Ci-Ce alkyl)S(CrC6 alkyl), C(=O)(C1-C6 alkyl)C(=O)O(Cr C6 alkyl), phenyl, halophenyl, phenoxy, and Het-1 ;
(i) n= 0, 1, or 2;
(j) Rx and Ry are independently selected from H, CrC6 alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(Ci-C6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)(CrCB alkyl), C(=O)O(Cr CB alkyl), C(=0)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=O)(CrC6 alkyl)C(=O)O(Ci-C6 alkyl), and phenyl, wherein each alkyl, cycloalkyl, cycloalkoxy, alkoxy, alkenyl, alkynyl, phenyl, phenoxy, and Het-1, are optionally substituted with one or more substituents independently selected from F, CI, Br, I, CN, NO2, oxo, CrCe alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-Ce cycloalkoxy, C3-C6 halocycloalkoxy, CrC6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C3-C6 cycloalkenyl, C2-CB alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(C1-C6 haloalkyl), OSO2(Ci-Cs alkyl), OS02(CrC8 haloalkyl), C(=O)H, C(=O)OH, C(=O)(CrC6 alkyl), C(=O)O(Cr CB alkyl), C(=O)(Ci-C6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=O)(Ci-C6 alkyl)C(=O)O(Ci-C6 alkyl), phenyl, halophenyl, phenoxy, and Het-1, or Rx and Ry together can optionally form a 5- to 7-membered saturated or unsaturated cyclic group which may contain one or more heteroatoms selected from nitrogen, sulfur, and oxygen, and where said cyclic group can contain >C=O or >C=S, and where said cyclic group may be substituted with F, Cl, Br, I, CN, CrC6 alkyl, Ci-Ce haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-CB halocycloalkoxy, CrC6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C3-Cs cycloalkenyl, C2-C6 alkynyl, S(=O)n(Ci-C6 alkyl), S(=O)n(Ci-C6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)(CrC6 alkyl), C(=O)O(C1-C6 alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(Ci-C6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (Ci-C6 alkyl)O(Ci-C6 alkyl), (CrC6 alkyl)S(C-|-C6 alkyl), C(=O)(C1-C6 alkylJCf^OJOfCrCg alkyl), phenyl, substituted phenyl, phenoxy, and Het-1 ; and
Page 8 of 160 (k) Het-1 is a 5- or 6-membered, saturated or unsaturated, heterocyclic ring, containing one or more heteroatoms independently selected from nitrogen, sulfur or oxygen.
It is understood that in Formula 1, when R2 is H, the compounds may exist in more than one tautomeric or isomeric form, wherein the hydrogen is attached to either of the nitrogen atoms; further, both E and Z isomers may exist. Any and ail isomeric forms of the compounds of this invention are claimed.
In another embodiment Αη is a substituted phenyl, wherein said substituted phenyl has one or more substituents independently selected from CrC6 haloalkyl and CrCe haloalkoxy.
In another embodiment Αη is a substituted phenyl, wherein said substituted phenyl has one or more substituents independently selected from CF3, OCF3, and OCFZCF3.
In another embodiment Het is selected from triazolyl, imidazolyl, or pyrazolyl, which can be substituted or unsubstituted.
In another embodiment Het is a 1,2,4-triazolyl
In another embodiment Het is 1,4-imidazolyl
In another embodiment Het is 1,3-pyrazolyl
In another embodiment Het is a substituted 1,3-pyrazolyl.
Page 9 of 160
In another embodiment Het is 1,4-pyrazolyl
In another embodiment Ar2 is a phenyl.
In another embodiment R1 is H or Ci-C6 alkyl.
In another embodiment R1 is H or CH3.
In another embodiment R2 is H.
In another embodiment R3 is selected from Ο,-Ο6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, Cr Ce alkylphenyl, Ο,-Ο6 alkylHet-1, CrC6alkyl-O-C(=O)CrC6 alkyl-O-CrC6 alkyl, C-i-Cealkyl-OC(=O)Ci-C6 alkyl-O-CrC6 alkyl-O- CrCe alkyl, Ο,-Οθ alkyl-O-C(=O)CrCe alkyl-O-CrCe haloalkyl, CrCealkyl-O-C(=O)CrC6 alkyl-N(Rx)C(=0)-O-phenyl, CrC6alkyl-O-C(=O)CrCe alkylN(Rx)C(=O)-O-C1-C6 alkylphenyl, C1-C6alkylC(=O)N(Rx)C1-C6 alkyl, C1-C6alkylC(=O)N(Rx)C1-C6 alkylHet-1C(=O)-O-CrCe alkyl, C1-C6alkylC(=O)N(Rx)C1-C6 alkylHet-1, C1-C6alkylC(=0)Het-1, Ci-CealkylC(=O)N(Rx)C1-C6 alkyl(N(Rx)(Ry))(C(=O)OH). C,-C6alkylC(=O)N(Rx)CrC6 alkylN(Rx)(Ry), C1-C6alkylC(=O)N(Rx)C1-Ce alkylN(Rx)C(=O)-O-CrC6 alkyl, CrCe alkylC(=O)N(Rx)Ci-C6 alkyl(N(Rx)C(=O)-O-Ci-C6 alkyl)(C(=O)OH), C1-C6alkylC(=0)Het-1C(=0)O-CrCe alkyl, Ο,-Οθ alkyl-O-C(=O)-O-CrC6 alkyl. 0,-0^^1-0-0(=0)0,-06 alkyl, CrC6alkyl-OC(=O)C3-C6 cycloalkyl, Ci-C6alkyl-0-C(=0)Ket-1, or Cl-C6alkyl-O-C(=O)C1-C6 alkylN(RX)C(=O)-O-C1-C6 alkyl, wherein each alkyl, alkenyl, alkynyl, phenyl, and Het-1 are optionally substituted with one or more substituents independently selected from F, Cl, Br, CrCe alkyl, Cr Ce haloalkyl, CrCe haloalkoxy, S(=0)n(CrCe alkyl), C(=O)OH, 0(=0)0(0,-06 alkyl), phenyl, 3ϊ(Οι-Ο6 alkyl)3, and S(=O)nNRxRy.
In another embodiment R4 is phenyl, 0,-06 alkylphenyl, Het-1, or 0,-06 alkyl-O-phenyl, wherein each alkyl, Het-1, and phenyl are optionally substituted with one or more substituents independently selected from F, Cl, NRxRy, Ci-C6 alkyl, C3-C6 cycloalkyl, Ci-O6 haloalkoxy, 0(=0)0 CrC6 alkyl, or 0,-06 alkoxy.
In another embodiment R5 is substituted with oxo, C(=O)OH, phenyl, and Het-1, wherein each phenyl and Het-1, may be optionally substituted with one or more substituents independently selected from oxo, CrC6 haloalkyl, CrC6 haloalkoxy, C(=O)OH, and halophenyl.
Page 10 of160 ln another embodiment Rx and Ry are independently selected from H and phenyl, wherein said phenyl, may be optionally substituted with one or more substituents independently selected from F and Cl.
In another embodiment:
Αη is a substituted phenyl wherein said substituted phenyl, has one or more C-iC6 haloalkoxy;
Het is a triazolyl;
Ar2 is a phenyl;
R1 is H;
R2 is H;
R3 is CrCe alkylHet-1 wherein said alkyl and Het-1 are optionally substituted with one or more substituents independently selected from F, Cl, Br, CrC6 alkyl, CrC6 haloalkyl, CrC6 haloalkoxy, S(=O)n(CrC6 alkyl), C(=O)OH, C(=O)O(CrC6 alkyl), phenyl, Si(Cr C6 alkyl)3, and S(=O)nNRxRy;
R4 is phenyl, wherein said phenyl is optionally substituted with one or more substituents independently selected from F, Cl, NRxRy, CrCe alkyl, or Ci-C6 alkoxy; and n= 0, 1, or 2;
Rx and Ry are independently selected from H and phenyl, wherein said phenyl, may be optionally substituted with one or more substituents independently selected from F and CI; and
Het-1 is a 5- or 6-membered, saturated or unsaturated, heterocyclic ring, containing one or more heteroatoms independently selected from nitrogen, sulfur or oxygen.
ln another embodiment Het-1 is selected from benzofuranyl, benzoisothiazolyl, benzoisoxazolyl, benzoxazolyl, benzothienyl, benzothiazolyl cinnolinyl, furanyl, indazolyl, indolyl, imidazolyl, isoindolyl, isoquinolinyl, isothîazolyl, isoxazolyl, oxadiazolyl, oxazolinyl, oxazolyl, phthalazinyl, pyrazinyl, pyrazolinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, quinazolinyl, quinolinyl, quinoxalinyl, tetrazolyl, thiazolinyl, thiazolyl, thienyl, triazinyl, triazolyl, piperazinyl, piperidinyl, morpholinyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydropyranyl, 1,2,3,4tetrahydro-quinolinyl, 4,5-dihydro-oxazolyl, 4,5-dihydro-1H-pyrazolyl, 4,5-dihydro-isoxazolyl, and 2,3-dihydro-[1,3,4]-oxadiazolyl.
ln another embodiment Het is selected benzofuranyl, benzoisothiazolyl, benzoisoxazolyl, benzoxazolyl, benzothienyl, benzothiazolyl cinnolinyl, furanyl, indazolyl, indolyl, imidazolyl, isoindolyl, isoquinolinyl, isothiazolyl, isoxazolyl, oxadiazolyl, oxazolinyl, oxazolyl, phthalazinyl, pyrazinyl, pyrazolinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, quinazolinyl, quinolinyl,
Page 11 of160 quînoxalinyl, tetrazolyl, thiazolinyl, thiazolyl, thienyl, triazinyl, triazolyl, piperazînyl, piperidinyl, morpholinyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydropyranyl, 1,2,3,4-tetrahydro-quinolinyi, 4,5dihydro-oxazolyl, 4,5-dihydro-IH-pyrazolyl, 4,5-dihydro-isoxazolyl, and 2,3-dihydro-[1,3,4]oxadiazolyl.
In another embodiment Het-1 is selected from benzofuranyl, benzoisothiazolyl, benzoisoxazolyl, benzoxazolyl, benzothienyl, benzothiazolyl, benzothiadizolyl, cinnolinyl, furanyl, indazolyl, indolyl, imidazolyl, isoindolyl, isoquinolinyl, isothiazolyl, isoxazolyl, oxadiazolyl, oxazolinyl, oxazolyl, phthalazinyl, pyrazinyl, pyrazolinyl, pyrazolyl, pyridazinyl, pyridyl, pyrimidinyl, pyrrolyl, quinazolinyl, quinolinyl, quinoxalinyl, tetrazolyl, thiazolinyl, thiazolyl, thienyl, thienylpyrazolyl, triazinyl, triazolyl, piperazînyl, piperidinyl, morpholinyl, pyrrolidinyl, tetrahydrofuranyl, tetrahydropyranyl, 1,2,3,4-tetrahydro-quinolinyi, 4,5-dihydro-oxazolyl, 4,5dihydro-IH-pyrazolyl, 4,5-dihydro-isoxazolyl, and 2,3-dihydro-[1,3,4]-oxadiazolyl.
In another embodiment Het-1 is selected from benzothiadizolyl, furanyl, oxazolyl, and thienylpyrazolyl.
While these embodiments hâve been expressed, other embodiments and combinations of these expressed embodiments and other embodiments are possible.
The Molécules of Formulae One, Two and Three will generally hâve a molecular mass of about 100 Daltons to about 1200 Daltons. However, it is generally preferred if the molecular mass is from about 120 Daltons to about 900 Daltons, and it is even more generally preferred if the molecular mass is from about 400 Daltons to about 800 Daltons.
PREPARATION OF TRIARYL-INTERMEDIATES
Compounds of this invention can be prepared by making a triaryl intermediate, Ar,-HetAr2, and then linking it to the desired intermediate to form the desired compound. A wide variety of triaryl intermediates can be used to préparé compounds of this invention, provided that such triaryl intermediates contain a suitable functional group on Ar2 to which the rest of the desired intermediate can be attached. Suitable functional groups include an oxoalkyl or a formyl group. These triaryl intermediates can be prepared by methods previously described in the chemical literature, including Crouse et al. PCT Int. Appl. Publ. W02009/102736 A1.
PREPARATION OF HYDRAZONE-LINKED COMPOUNDS
Hydrazone-linked compounds can be prepared from the corresponding aryl aldéhydes or ketones by one of three methods: (1 ) by reaction with a hydrazine, followed by reaction with an aryl isothiocyanate in tetrahydrofuran (THF), at températures between 0 and 100 °C (Reaction
Page 12 of 160
A); (2) by reaction with methyl hydrazinecarbodithioate, followed by reaction with an aniline in a polar aprotic solvent such as N,N-dimethylformamide (DMF), at températures between 25 and 150 °C (Reaction B); or (3) by reaction with an aryl thiosemîcarbazide, that is either commercially available or can be prepared by one who is skilled in the art, in a polar protic 5 solvent such as ethyl alcohol (EtOH), at températures between 0 and 100 °C (Reaction C).
1. NH2NH-R2 (A)
(B)
2. R4-NH2, DMF,
- 150 °C
S
H2N.nAn.R4 H R3 (C)
EtOH, 0-100 °C
PREPARATION OF ALKYLATED HYDRAZONE-LINKED COMPOUNDS
Alkylated hydrazone-linked compounds can be prepared from the corresponding hydrazone-linked compounds by one of two methods: (1 ) by reaction with an alkylating agent in EtOH or acetone, at températures between 0 and 100 °C for from 1 to 24 h or (2) by reaction with an alkylating agent in chloroform (CHCI3), dichloromethane (CH2CI2), or other halocarbon solvent, with or without a base such as sodium bicarbonate, at from 20 to 60 °C.
Alkylating agent, EtOH (D)
0- 100 °C,
1-24 h
Alkylating agent, CH2C12 or CHC13
(E)
- 60 °C,
1-24 h
Page 13 of160
Compounds of Formula Two, wherein R5 forms a ring with N3 (see Scheme below) or of Formula Three, wherein R5 forms a ring with N2, can be prepared from a suitable acyclic precursor by using O-halo acids, acid halides, esters, or ketones (F or G or H). For example, treatment of the thiosemicarbazone with a slight excess of an D-halo ester, in a protic solvent such as EtOH or methyl alcohol (CH3OH) results in S-alkylation and subséquent ring closure exclusively onto N3 (Reaction F; see for example, J. Indian Chemical Society 1966, 43, 275276, or J.Heterocycl. Chem. 1978, 15, 335-336). When an aprotic solvent such as CH2CI2 or dichloroethane (ClCH2CH2CI) is used at températures from 30 °C to 80 °C, the orientation of addition of □ halo ketones also favors closure onto N3, with subséquent déhydration to form an imino thiazoline (Reaction G). With C-halo acids or acid halides or esters in a halocarbon solvent such as CH2CI2 or CICH2CH2CI, ring closure onto both N2 (Reaction H) and N3 is observed. Though these reactions often proceed in the absence of added base, a base such as sodium bicarbonate, sodium carbonate or sodium acetate, or an amine base such as pyridine or triethylamine, can be added.
Br^.CO2H R1 R4
Br^.CO2CH3 Arr^-Ar^Ni^’yO (F)
EtOH or MeOH
O RI R4
H- . Hct Arf Ar2 N ,N,.y (G)
Br^CO2CH3
CH2Cl2 or
ClCH2CH2Cl
(H)
Alternative^, 3-arylidineimino-2-aryliminothiazolin-4-ones can be prepared by treating an aldéhyde or ketone, wherein R1 is as previously described, with a 3-amino- 2(arylimino)thiazolidin-4-one in acetic acid at from 30 to 70 °C as shown in the following scheme (I). The intermediate 1-amino-2-aryliminothiazolin-5-one, wherein R4 is phenyl, has been described (see for example, J. Org. Chem. 1962, 27, 2878); it was prepared in 80% yield by treatment of 4-phenyl thiosemicarbazide with ethyl 2-chloroacetate and sodium acetate in hot EtOH.
Page 14 of 160
N N
H2N-NYf%4 S
Alternatively, compounds of Formula 2 and Formula 3 may be formed by heating a thiosemicarbazone precursor with a di-halo group Hal1-R5-Hal2 such as 1-bromo-2-chloro 5 ethane, in acetone or 2-butanone or other suitable solvent, using a base such as potassium carbonate or triethylamine, at températures between ambient and 100 °C for from 1 to 72 hours. The S-alkylated intermediate undergoes cyclization at N2 or N3 to generate compounds of Formula Two or Formula Three (Reaction J). In some cases, addition of Kl may be required to accelerate the cyclization of the intermediate S-alkylated dérivatives to the ring-closed products.
(J)
An alternative method of preparing compounds of this invention is by treatment of a thiosemicarbazone precursor with an unsaturated ester or acid chloride (Reaction L).
Page 15 of 160
R4
EXAMPLES
The examples are for illustration purposes and are not to be construed as iimiting the invention disclosed in this document to only the embodiments disclosed in these examples.
Starting materials, reagents, and solvents that were obtained from commercial sources were used without further purification. Anhydrous solvents were purchased as Sure/Seal™ from Aldrich and were used as received. Melting points were obtained on a Thomas Hoover Unimelt capillary melting point apparatus or an OptiMelt Automated Melting Point System from Stanford Research Systems and are uncorrected. Molécules are given their known names, named according to naming programs within MDL ISIS™/Draw 2.5, ChemBioDraw Ultra 12.0 or ACD Name Pro. If such programs are unable to name a molécule, the molécule is named using conventional naming rules. 1H NMR spectral data are in ppm (δ) and were recorded at 300, 400 or 600 MHz, and 13C NMR spectral data are in ppm (□) and were recorded at 75, 100 or 150 MHz, unless otherwise stated.
Example 1: Préparation of (E)-N-(4-dimethylamino)phenyl)-2-(4-(1-(4(trifluoromethoxyJphenyQ-IH-l^^-triazol-a-yObenzylideneJhydrazine-carbothioamide (Compound 1-1) [Synthesis Method A],
Page 16 of160
Step 1. (E)-3-(4-(Hydrazonomethyl)phenyl)-1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4triazole. To a 250 milliliter (mL) round-bottomed flask containing hydrazine hydrate (64% aqueous (aq) solution; 7.27 mL, 15.0 millimoles (mmol)) in EtOH (100 mL) at 80 °C was added
4-[1-(4-trifluoromethoxyphenyl)-1/-/-[1,2,4]triazol-3-yl]-benzaldehyde (5.00 grams (g), 1.50 mmol) portionwise over 5 minutes (min). The solution was stirred at reflux for an additional 3 hours (h) before being diluted with water (H2O; 300 mL) and cooled to 0 °C. The precipitated product was collected by vacuum filtration as a white solid (4.89 g, 93%); mp 222-226 °C; 1H NMR (400
MHz, DMSO-cfc) □ 8.59 (s, 1H), 8.22 (d, J= 8.2 Hz, 2H), 7.84-7.79 (m, 3H), 7.66 (d, J = 8.3 Hz, 2H), 7.41 (d, J = 8.2 Hz, 2H), 7.29 (s, 1H), 5.63 (br s, 2H); ESIMS m/z 348 (M+H).
Step 2. To a 25 mL round-bottomed flask containing (E)-3-(4-(hydrazonomethyl)phenyl)-1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazole (250 mg, 0.720 mmol) in THF (10 mL) was added 4-isothiocyanato-/V,/V-dirnethylaniline (385 mg, 2.16 mmol). The contents were heated at 65 °C with stirring for 2 h before the solvent was removed under reduced pressure. The residue was sluaied in CH2CI2 (10 mL) resulting in précipitation of product material. The desired product was obtained as a yellow solid via vacuum filtration (350 mg, 93%): mp 205208 °C; 1H NMR (400 MHz, DMSO-cfe) 0 11.78 (s, 1 H), 10.02 (s, 1 H), 9.42 (s, 1 H), 8.19-7.99 (m, 6H), 7.64 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 8.3 Hz, 2H), 7.73 (d, J = 8.3 Hz, 2H), 2.92 (s, 6H); ESIMS m/z 526 (M+H).
Example 2: Préparation of A/-(3-(dimethylamino)phenyl)-2-(4-(1-(4(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazinecarbothioamide (Compound l-2) [Synthesis Method B].
Step 1. (E)-Methyl 2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3yl)benzylidene)hydrazinecarbodithioate. To a 250 mL round-bottom flask containing hydrazinecarbodithioic acid methyl ester (2.38 g, 1.95 mmol) in EtOH (100 mL) was added 4-[1(4-trifluoromethoxyphenyl)-1/-/-[1,2,4]triazol-3-yl]-benzaldehyde (5.00 g, 1.50 mmol). The vessel was heated at 80 °C for 3 h before being diluted with H2O (300 mL) and cooled to 0 °C. The precipitated product was collected by vacuum filtration as an off-white solid (6.13 g, 93%): mp 204—206 °C; 1H NMR (400 MHz, DMSO-d6) □ 13.39 (s, 1H), 9.43 (s, 1H), 8.38 (s, 1H), 8.21 (d, J = 8.3 Hz, 2H), 8.09 (d, J = 8.4 Hz, 2H), 7.88 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.3 Hz, 2H), 2.57 (s, 3H); ESIMS m/z 438 (M+H).
Step 2. To a 50 mL round-bottomed flask containing (E)-methyl 2-(4-(1-(4(trifluoromethoxy)phenyl)-1/-/-1,2,4-triazol-3-yl)benzylidene)hydrazinecarbodithioate (250 mg, 0.571 mmol) in DMF (3 mL) was added /V1,N1-dimethylbenzene-1,3-diamine (195 mg, 1.43 mmol). The contents were heated at 150 °C with stirring for 5 h before the solution was allowed to cool overnight. The mixture was filtered, and the filtrate was purified via RP-HPLC to afford the desired material (235 mg, 78%) as an off-white solid: mp 192-194 °C; 1H NMR (400 MHz, DMSO-de) 0011.82 (s, 1H), 10.04 (s, 1H), 9.41 (s, 1H), 8.19 (s, 1H), 8.16-7.99 (m, 6H), 7.61 (d, J = 8.3 Hz, 2H), 7.16 (t, J = 7.2 Hz, 1H), 7.01 (m, 1H), 6.87 (m, 1H), 6.58 (m, 1H), 2.88 (s, 6H); ESIMS m/z 526 ([M+H]+).
Page 17 of 160
Example 3: Préparation of /V-benzyl-2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3yl)benzylidene)hydrazinecarbothioamide (Compound I-3) [Synthesis Method C],
To a 50 mL round-bottomed flask containing 4-[1-[4-(trifluoromethoxy)phenyl]-1,2,4triazol-3-yl]benzaldehyde (500 mg, 1.5 mmol) in EtOH (3 mL) was added 4benzylthiosemicarbazîde (650 mg, 3.6 mmol). The reaction mixture was heated at 80 °C overnight. H2O was added upon completion of the reaction, and the crude product material was isolated by vacuum filtration. The title compound was isolated via RP-HPLC as a white solid (390 mg, 52%): mp 220-224 °C; 1H NMR (400 MHz, CDCI3) δ 9.29 (s, 1H), 8.59 (s, 1 H), 8.21 (d, J - 8.4 Hz, 2H), 7.85-7.79 (m, 3H), 7.71 (d, J = 8.4 Hz, 2H), 7.46-7.30 (m, 8H). 5.01 (d, J = 5.8 Hz, 2H); ESIMS m/z 497.2 (M+H).
Compounds I-4 through 1-31 in Table 1 were synthesized in accordance with the examples above. Other intermediates used in the préparation of compounds of this invention were prepared in accordance with the procedures described in Brown, et al, WO 2011017504, or by other known routes.
Example 4: Préparation of/V-(4-dimethylaminophenyl)-S-methyl-2-{4-[1-(4trifluoromethoxyphenyl)-1H-[1,2,4]-triazol-3-yl]-benzylidene}-hydrazine-carbothioamide (Compound 1C) (Synthesis Method D)
ΝΑ solution containing (E)-/V-(4-(dimethylamïno)phenyl)-2-(4-( 1-(4-(trifluoromethoxy)-phenyl)-1 H1,2,4-triazol-3-yl)benzylidene)hydrazinecarbothioamide (150 mg, 0.285 mmol) and iodomethane (0.054 mL, 0.856 mmol) in EtOH (5 mL) was heated at 80 °C for 3 h before the solvent was removed under reduced pressure. The residue was purified via normal phase flash chromatography (gradient elution with hexanes/EtOAc) to afford the title compound as an orange foam (93 milligrams (mg), 60%): 1H NMR (400 MHz, DMSO-de) δ 8.61 (s, 1H), 8.48 (s,
Page 18 of 160
H). 8.22 (d, J = 8.24 Hz, 2H), 8.17 (s, 1 H), 7.89 (d, J- 8.24 Hz, 2H), 7.80 (d, J= 8.28 Hz, 2H),
7.41 (d, J = 8.28 Hz, 2H), 7.19 (d, J = 8.24 Hz, 2H), 6.71 (d, J = 8.24 Hz, 2H), 2.99 (s, 6H), 2.42 (s, 3H); EIMS m/z 540 (M+).
Example 5: General procedure for S-alkylation of triaryl thiosemicarbazones (Synthesis Method E)
A stirred solution of the thiosemicarbazone and alkylating reagent in CH2CI2 or chloroform (CHCI3) was heated at from 35 to 50 °C for from 10 to 24 h. The cooled solution was concentrated under reduced pressure. The residue was generally purified via chromatography using a chloroform/methanol (CHCI3/CH3OH) or EtOAc-hexane solution as the eluent to afford the S-alkylated products.
Example 6: Préparation of (S)-fert-butyl 3-((2-((Z)-(2,6-dimethylphenylimino)-((E)-2-(4-(1(4-(trifluoromethoxy)phenyl)1H-1,2,4-triazol-3-yl)benzylîdene)hydrazinyl)methylthio)acetamido)methyl)piperidine-1-carboxylate (Compound 56C) (Synthesis Method E)
To a solution of bromoacetyl bromide (26 microliters (pL), 0.299 mmol) in dichloroethane (3 mL) was added dropwise a solution of (S)-fert-butyl 3-(aminomethyl)piperidine-1-carboxylate (63.9 mg, 0.298 mmol) in dichloromethane (1 mL), followed by A/-ethyl-N-isopropylpropan-2amine (76 mg, 0.588 mmol). This mixture was stirred at room température for 30 min, then (E)N-(2,6-dimethylphenyl)-2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3yl)benzylidene)hydrazine-carbothioamide (100 mg, 0,196 mmol) was added as a solid and the mixture was heated to 40 °C for 90 min. It was then allowed to cool to room température and evaporated under reduced pressure, giving a light yellow glass, which was dissolved in acetonitrile (2 mL) and allowed to stand at room température. The resulting precipitate was isolated by centrifuge and decanting, washing with fresh acetonitrile. The solid was dried under a nitrogen stream and then under high vacuum. The crude product was recrystallized from acetone-isopropyl alcohol. The title compound was isolated as a white solid (36.5 mg, 24%): mp 148-151 °C; 1H NMR (400 MHz, methanol-cf4) δ 9.18 (s, 1 H), 8.59 (s, 1H), 8.30 (d, J= 8.1
Page 19 of160
Hz, 2H), 8.12 (m, 2H), 8.07 - 8.00 (m, 2H), 7.58 - 7.43 (m, 2H), 7.33 (dd, J - 8.6, 6.5 Hz, 1 H),
7.25 (d, J = 7.6 Hz, 2H), 4.02 (m, 2H), 3.97 - 3.75 (m, 2H), 3.21 (d, J = 6.9 Hz, 2H), 2.90 (m,
1H), 2.59 (m, 1H), 2.35 (s, 6H), 1.84 (m, 2H), 1.78-1.63 (m, 2H), 1.44 (s, 9H), 1.29 (m, 3H);
ESIMS m/z 765 (M+H).
Example 7: Préparation of (1Z,2E)-2-oxo-2-(((/?)-piperidin-3-ylmethyl)amino)ethyl W-(2,6dimethyl phe ny 1)-2-(4-( 1-(4-(trifl uoromethoxy)phenyl)-1H-1,2,4-triazol-3yl)benzylidene)hydrazinecarbimidothioate trifluoroacetic acid (Compound 62C) (Synthesis Method K)
A solution of (S)-tert-butyl 3-((2-((Z)-(2,6-dimethylphenylimino)-((E)-2-(4-(1-(4(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazinyl)methylthio)acetamido)methyl)piperidine-1 -carboxylate (32.0 mg, 0.042 mmol) in TFA (250 pL, 3.24 mmol) was stirred at room température for 10 min. Et2O (10 mL) was then added giving a white precipitate, which was isolated by centrifuge and decanting, then rinsing with fresh Et2O (5 mL). The solid was dried under nitrogen stream and then under high vacuum giving the title compound as a white solid (19.8 mg, 60%): mp 110-120 °C;1H NMR (400 MHz, methanol-c/4) δ 9.18 (s, 1H), 8.56 (m, 1H), 8.26 (m, 2H), 8.16-7.84 (m, 4H), 7.52 (m, 2H), 7.27 (m, 1H), 7.22 (m, 2H), 4.00 (s, 2H), 3.28 (m. 3H), 3.06 - 2.83 (m, 1H), 2.75 (t, J= 12.2 Hz, 1H), 2.34 (s, 6H), 2.21 -1.83 (m,4H), 1.72 (m, 1H), 1.47 - 1.19 (m, 2H); ESIMS m/z 665 (M+H).
Example 8: Préparation of 2-(((Z)-((4-methoxy-2,6-dimethylphenyl)imino)((Ê)-2-(4-(1-(4(trifluoromethoxy)phenyl)-1H-1,2l4-triazol-3-yl)benzylidene)hydrazinyl)methyl)-thÎo)acetic acid sodium sait (Compound 68C)
Page 20 of 160
To a solution of 2-((Z)-(4-methoxy-2,6-dimethylphenylimino)((E)-2-(4-(1-(4(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazinyl)methylthio)acetic acid (77.7 mg, 0.130 mmol) in THF (10 mL) was added slowly sodium methanolate (0.5 M in methanol; 260 pL, 0.130 mmol) at room température. The mixture immediately tumed a darker yellow and was then evaporated at room température under vacuum giving a light orange solid. This material was triturated with Et2O (2X) and isolated by decanting using a centrifuge and drying under a nitrogen stream and then under high vacuum. The title compound was isolated as a light orange solid (32 mg, 39%). mp 146-154 °C; 1H NMR (400 MHz, methanol-d4) δ 9.11 (s, 1 H), 8.64 - 7.68 (m, 7H), 7.51 (m, 2H), 6.70 (s, 2H), 3.85 - 3.70 (m, 4H), 3,61 (m, 1 H), 2.29 (s, 6H); ESIMS m/z 599 (M+H).
Example 9: Préparation of (Z)-3-(4-methoxy-2,6dimethylphenyl)-2-((E)-(4-(1-(4(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazono)thiazolidin-4-one (Compound 69C) (Synthesis Method F)
To a solution of (E)-A/-(4-methoxy-2,6-dimethylphenyl)-2-(4-(1-(4(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazine-carbothioamide (250 mg, 0.462 mmol) in EtOH (5 mL) was added methyl bromoacetate (100 mg, 0.65 mmol), and the mixture was heated to 70 °C for 4 h. The mixture was allowed to cool to room température and diluted with water (1 mL). The precipitate was vacuum filtered, giving the title compound as a white solid (204 mg, 76%); mp 188-190 °C; Ή NMR (400 MHz, CDCI3) δ 8.56 (s, 1 H), 8.33 (s, 1H), 8.22 (d, J = 8.1 Hz, 2H), 7.90 - 7.70 (m, 4H), 7.39 (d, J = 8.7 Hz, 2H), 6.72 (s, 2H), 4,01 (s, 2H), 3.87 - 3.73 (s, 3H), 2.18 (s, 6H); ESIMS m/z 581 (M+H).
Example 10: Préparation of 4-((2Z)-3-(2,6-dimethylphenyl)-2-((4-(1-(4Page 21 of 160 (trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazono)-2,3dihydrothiazol-4-yl}-/V,/\/-diethylaniline (Compound 74C) (Synthesis Method G)
To a solution of (E)-N-(2,6-dimethylphenyl)-2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H1,2,4-triazol-3-yl)benzylidene)hydrazine-carbothioamide (74.7 mg, 0.144 mmol) in dîchloroethane (5 mL), was added □-bromo-4-diethylamino)acetophenone (53.9 mg, 0.199 mmol), and the mixture was heated to 40 °C for 4 h. The mixture was then cooled to room température and evaporated under vacuum. The crude material was triturated with acetonitrile and decanted (2X). The resulting solid was dried under a stream of nitrogen, giving the title compound as a pale yellow solid (25 mg, 25%); mp 190-193 °C dec; 1H NMR (400 MHz, methanol-d4) δ 9.20 (s, 1 H), 8.38 (s, 1 H), 8.31 - 8.24 (m, 2H), 8.08 - 8.00 (m, 2H), 7.95 - 7.88 (m, 2H), 7.55 - 7.48 (m, 3H), 7.48 - 7.36 (m, 5H), 7.31 (d, J = 7.7 Hz, 2H), 3.60 (q, J = 7.2 Hz, 4H), 2.20 (s, 6H), 1.07 (t, J = 7.2 Hz, 6H); ESIMS m/z 682 (M+H).
Example 11: Préparation of (Z)-2-(2,6-dimethylphenylimino)-3-((E)-4-(1-(4(trifluoromethoxy)phenyl)-1f/-1,2,4-triazol-3-yl)benzylideneamino)thiazolidin-4-one (Compound 81 C) (Synthesis Method I)
To a solution of 1-(2,6-dimethylphenyl)thiourea (1.0 g, 5.55 mmol) in EtOH (10 mL) was added methyl 2-bromoacetate (1.0 g, 6.5 mmol) and sodium acetate (1.0 g, 12.2 mmol). The solution was stirred and heated to reflux for 1 h, then it was cooled and the liquid was decanted from a small amount of solid material and the liquid was then diluted with water (10 mL). The precipitate was isolated by filtration to give (1.1 g, 83%) of (Z)-3-amîno-2-(2,6dimethylphenylimino)thiazolidin-4-one: mp 149-152 qC; ’H NMR (400 MHz, CDCI3) δ 7.06 (d, J = 7.2 Hz, 2H), 6.98 (m, 1 H), 4.75 (s, 2H), 3.80 (s, 2H), 2.12 (s, 6H); ESIMS m/z 236 (M+H).
Page 22 of 160
A portion of this material (0.07 g, 0.3 mmol) was dissolved in glacial acetic acid (3 mL) and treated with 4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzaldehyde (0.10 g, 0.30 mmol), and the solution was heated to 60 °C for 2 h. The solution was then cooled and diluted with water (1 mL), and the resulting solid was filtered and air-dried to give the title compound (0.12 g, 67%): mp 209-213 °C; 1H NMR (400 MHz, CDCI3) δ 9.42 (s, 1 H), 8.59 (s, 1 H), 8.28 (d, J = 8.4 Hz, 2H), 8.01 (d, J = 8.3 Hz, 2H), 7.80 - 7.77 (m, 2H), 7.43 - 7.34 (m, 2H), 7.07 (d, J= 7.5 Hz, 2H), 6.98 (dd, J= 8.2, 6.7 Hz, 1H), 3.90 (s, 2H), 2.17 (s, 6H); ESIMS m/z 551 (M+H).
Example 12: Préparation of (2Z,A/E)-2-((2-isopropylphenyl)imino)-N-(4-(1-(4(trifluoromethyl)phenyl)-1 H-1,2,4-triazol-3-yl)benzylidene)-1,3-thiazinan-3-amine and (Z)-3-(2isopropylphenyl)-2-((E)-(4-(1-(4-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-3yl)benzylidene)hydrazono)-1,3-thiazinane (Compound 87C and 179C) (Synthesis Method J)
To (£r)-/V-(2-isopropylphenyl)-2-(4-(1-(4-(trifluoromethyl)phenyl)-1H-1,2,4-triazol-3yl)benzylidene)hydrazinecarbothioamide (200 mg, 0.393 mmol) and potassium carbonate (217 mg, 1.57 mmol) in butanone (10 ml) in a 25 mL vial equipped with a stir bar and vigruex column was added 1-bromo-3-chloropropane (0.047 ml, 0.472 mmol). The reaction was heated to 60 °C overnight. The reaction was determined to be complété by LCMS. The reaction mixture was diluted with DCM and washed with water. The aqueous layer was extracted with DCM. The organic layers were poured through a phase separator and concentrated. Purification by flash column chromatography provided two compounds. The minor compound was dried overnight under house vacuum providing the title compound 87C (2Z,/\/E)-2-((2-isopropylphenyl)imino)-N(4-(1-(4-(trifluoromethyl)phenyl)-1/-/-1l2,4-triazol-3-yl)benzylidene)-1l3-thiazinan-3-amine (28.5 mg, 13%) as a yellow solid: mp 187-189 qC; 1H NMR (400 MHz, CDCI3) δ 8.81 (s, 1H), 8.66 (s, 1 H), 8.21 (d, J = 8.3 Hz, 2H), 7.92 (d, J = 8.4 Hz, 2H), 7.81 (t, J = 10.2 Hz, 4H), 7.30 - 7.26 (m, 2H), 7.17 - 7.04 (m, 1H), 6.83 (d, J = 6.4 Hz, 1H), 3.96 (t, J = 6.1 Hz, 2H), 3.13 (heptet, J = 6.9 Hz, 1H), 2.97 - 2.90 (m, 2H), 2.47 - 2.38 (m, 2H), 1.25 (d, J= 7.5 Hz, 6H); ESIMS m/z 550 (M+H). The major compound was recrystallized with MeOH. The solid was filtered, washed with MeOH and dried at 50°C under vacuum. The solid was then azeotroped with acetone (3x) and the résultant solid was dried at 50°C under vacuum providing the title compound 179C (Z)-3-(2isopropylphenyl)-2-((E)-(4-(1 -(4-(trifluoromethyî)phenyl)-1 /7-1,2,4-triazol-3yl)benzylidene)hydrazono)-1,3-thiazinane as a yellow solid (92.3 mg, 0.168 mmol, 43%): mp
Page 23 of 160
212-213 °C; 1H NMR (400 MHz, CDCI3) δ 8.64 (s, 1H), 8.15 (d, J = 8.4 Hz, 2H), 8.06 (s, 1H),
7.91 (d, J = 8.5 Hz, 2H), 7.79 (d, J = 8.6 Hz, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.38 (dd, J = 7.8, 1.6
Hz, 1H), 7.33 (td, J = 7.5, 1.4 Hz, 1H), 7.29 - 7.23 (m, 1 H), 7.18 (dd, J= 7.8, 1.4 Hz, 1H), 3.783.72 (m, 1H), 3.59 - 3.48 (m, 1H), 3.18 - 3.04 (m, 3H), 2.40 - 2.30 (m, 2H), 1.26 - 1.20 (m, 6H);
ESIMS m/z 550 (M+H).
Example 13: Préparation of (Z}-3-(2-cyclopropylphenyl)-5-methyl-2-((E)-(4-(1-(4(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazono)thiazolidin-4-one (Compound 127C) (Synthesis Method F)
To (£)-W-(2-cyclopropylphenyl)-2-(4-(1-(4-(trifluoromethoxy)phenyl)-1 H-1,2,4-triazol-3yl)benzylidene)hydrazinecarbothioamide (100 mg, 0.191 mmol) and sodium acetate (63.0 mg, 0.765 mmol) in EtOH (4 mL) was added methyl 2-bromopropanoate (0.026 mL, 0.230 mmol). The reaction was heated to 60 °C overnight. The reaction was then heated to 85 °C for 72 hours. The reaction mixture was diluted with DCM and washed with water. The aqueous layer was extracted with DCM. The organic layers were poured through a phase separator and concentrated. Purification by flash column chromatography provided the title compound as a white solid (32.5 mg, 0.056 mmol, 30%): mp 112-115 °C; ’H NMR (400 MHz, CDCI3) δ 8.58 (s, 1H), 8.32 (s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.87 - 7.75 (m, 4H), 7.43 - 7.32 (m, 4H), 7.26 - 7.24 (m, 2H), 4.23 (q, J = 7.3 Hz, 1 H), 1.85-1.78 (m, 4H), 0.90 - 0.78 (m, 2H), 0.78 - 0.69 (m, 1 H), 0.65 - 0.55 (m, 1 H); ESIMS m/z 578 (M+H).
Example 14: Préparation of (Z)-3-(2-isopropylphenyl)-2-((£)-(4-(1-(4(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazono)thiazolidine (Compound 132C) (Synthesis Method J)
To (E)-N-(2-isopropylphenyl)-2-(4-(1-(4-(trifluoromethoxy)phenyl)-1 H-1,2,4-triazol-3Page 24 of 160 yl)benzylidene)hydrazinecarbothioamide (214 mg, 0.407 mmol) and potassium carbonate (225 mg, 1.63 mmol) in butanone (4 ml) was added 1 -bromo-2-chloroethane (70.0 mg, 0.489 mmol). The reaction was heated to 90 °C ovemight. The reaction was determined to be complété by LCMS. The reaction mixture was cooled, diluted with DCM and washed with water. The aqueous layer was extracted with DCM. The organic layers were filtered through a phase separator and concentrated. Séparation by flash column chromatography and drying the recovered solid at 55 °C under vacuum provided the title compound as a white solid (137 mg, 0.249 mmol, 61%): mp 193-196 °C; ’H NMR (400 MHz, CDCI3) δ 8.56 (s, 1H), 8.22 (s, 1 H), 8.17 (d, J = 8.4 Hz, 2H), 7.80 (ddd, J = 9.5, 6.9, 4.9 Hz, 4H), 7,43 - 7.33 (m, 4H), 7.31 - 7.21 (m, 2H), 4.05 (td, J =9.4, 7.1 Hz, 1H), 3.97 - 3.87 (m, 1H), 3.42 - 3.33 (m, 1 H), 3.33 - 3.24 (m, 1H), 3.12 (heptet, J = 6.8 Hz, 1H), 1.27 (d, J = 6.8 Hz, 3H), 1.22 (d, J = 6.9 Hz, 3H); ESIMS m/z 552 (M+H).
Example 15: Préparation of (Z)-3-(2-isopropylphenyl)-4-methyl-2-((E)-(4-(1-(4(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazono)thiazolidine (Compound 155C) (Synthesis Method J)
To (E)-/V-(2-isopropylphenyl)-2-(4-(1-(4-(trifiuoromethoxy)phenyl)-1/-/-1,2,4-triazol-3yl)benzylidene)hydrazinecarbothioamide (300 mg, 0.572 mmol) and potassium carbonate (316 mg, 2.29 mmol) in butanone (4 ml) was added 1,2-dibromopropane (0.072 ml, 0.686 mmol). The reaction was heated to 85 °C ovemight. The reaction was determined to be complété by LCMS. The reaction mixture was diluted with DCM and washed with water. The aqueous layer was extracted with DCM. The organic layers were poured through a phase separator and concentrated. Purification by flash column chromatography provided a yellow solid. The solid was recrystallized from MeOH. The solid was filtered, washed with MeOH, and dried to provide the title compound as a yellow solid which was dissolved in acetone and concentrated (3x). The light yellow solid was collected and dried under to provide the title compound as a 1:1 mixture of rotational diastereoisomers (75.1 mg, 0.133 mmol, 23%): mp 201-204 °C; 1H NMR of mixture (400 MHz, CDCI3) δ 8.56 (s, 2H), 8.18 (dd, J = 10.8, 7.4 Hz, 6H), 7.84 - 7.73 (m, 8H), 7.45 7.30 (m, 8H), 7.30 - 7.23 (m, 2H), 7.20 (d, J = 6.7 Hz, 1H), 7.12 (dd, J= 7.8, 1.2 Hz, 1H), 4.43 4.33 (m, 1H), 4.16 (dd, J= 12.6,6.3 Hz, 1H), 3.48 (dt, J = 13.3,6.7 Hz. 1H), 3.37 (dd, J =10.8, 6.2 Hz, 1H), 3.24 (dt, J =13.7, 6.9 Hz, 1H), 3,08-2.92 (m. 3H), 1.33-1.16 (m, 18H); ESIMS
Page 25 of 160 m/z 566 (M+H).
Example 16: Préparation of (Z)-3-(2,6-dimethylphenyl)-4-methyl-2-((E)-(4-(1-(4(trif1uoromethoxy)phenyl)-1H-1,2,4-triazol-3-yl)benzylidene)hydrazono)-2,3dihydrothiazole (Compound 173C) (Synthesis Method G)
To a solution of (E)-A/-(o-tolyl)-2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3yl)benzylidene)hydrazinecarbothioamide (257 mg, 0.520 mmol) in butanone (5 mL) was added triethylamine (0.14 mL, 1.0 mmol) and chloroacetone (0.06 mL, 0.73 mmol) and refluxed at 75 °C for 15 h. The mixture was allowed to cool to room température and then transferred to a separatory funnel containing water (5 mL) and extracted twice with dichloromethane. The organic layers were filtered through a phase separator, adsorbed onto silica gel, and purified by flash column chromatography to afford the title compound as a yellow solid (229 mg, 83%): mp 87 °C (dec); 1H NMR (400 MHz, CDCI3) δ 8.56 (s, 1H), 8.19-8.15 (m, 3H), 7.82 - 7,75 (m, 4H),
7.43 - 7.30 (m, 5H), 7.24 (d, J = 7.3 Hz, 1 H), 5.88 (d, J = 1.3 Hz, 1 H), 2.21 (s, 3H), 1.80 (d, J =
1.2 Hz, 3H); ESIMS m/z 536 (M+H).
Example 17: Préparation of (Z)-3-(2-isopropylphenyl)-5-methyl-2-((E)-(4-(1-(4(trifluoromethoxy)phenyl)-1 H-1,2,4-triazol-3-yl)benzylidene)hydrazono)-1,3-thiazinane (Compound 178C) (Synthesis Method J)
Λ=Ν
V
Page 26 of 160
To (E)-N-(2-isopropylphenyl)-2-(4-(1-(4-(trifluoromethoxy)phenyl)-1 H-1,2,4-triazol-3yl)benzylidene)hydrazinecarbothioamide (100 mg, 0.191 mmol) and potassium carbonate (105 mg, 0.763 mmol) in butanone (4 ml) was added 1-bromo-3-chloro-2-methylpropane (39.0 mg,
0.229 mmol). The reaction was heated to 80 °C overnight. The reaction mixture was then diluted with DCM and washed with water. The aqueous layer was extracted with DCM. The organic layers were poured through a phase separator and concentrated. Purification by flash column chromatography provided the title compound as a Iight yellow solid as a mixture of rotational diastereoisomers: mp 186-190 °C; 1H NMR (400 MHz, CDCI3) δ 8.55 (d, J= 3.6 Hz, 1 H), 8.14 (d, J - 8.4 Hz, 2H), 8.06 (s, 1 H). 7.84 - 7.77 (m, 2H), 7.74 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 9.0 Hz, 3H), 7.32 (td, J= 7.5, 1.4 Hz, 1H), 7.26 (s, 1H), 7.17 (t, J= 7.1 Hz. 1H), 3.69 - 3.26 (m, 1H), 3.55-3.37 (m, 1H), 3.18-2.98 (m, 2H), 2.93-2.80 (m, 1H), 2.47 (d, J = 35.9 Hz, 1H), 1.31 1.12 (m, 9H); ESIMS m/z 580 (M+H).
Example 18: Préparation of (Z)-3-(2,6-dimethylphenyl)-2-((E)-(4-(1-(4(trifluoromethoxy)phenyl)-1 H-1,2,4-triazol-3-yl)benzylidene)hydrazono)-1,3-thiazepane (Compound 211C) (Synthesis Method J)
To (E)-A/-(2l6-dimethylphenyl)-2-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3yl)benzylidene)hydrazinecarbothioamide (500 mg, 0.979 mmol) and potassium carbonate (541 mg, 3.92 mmol) in acetone (4 ml) was added 1-bromo-4-chlorobutane (0.135 ml, 1.18 mmol). The reaction was heated to 60 °C overnight. The alkylation was determined to be complété by ultra performance liquid chromatography (MUPLC). The reaction mixture was diluted with DCM and washed with water. The aqueous layer was extracted with DCM. The organic layers were poured through a phase separator and concentrated. Purification by flash column chromatography provided (1Z,A/'£)-4-chlorobutyl A/-(2,6-dimethylphenyl)-N'-(4-(1-(4(trifluoromethoxy)phenyl)-1 H-1,2t4-triazol-3-yl)benzylidene)carbamohydrazonothioate (427 mg, 0.710 mmol, 73%) as a yellow gum which was used without further purification. To (1Z,N'E)-4chlorobutyl /V-(2,6-dimethylphenyl)-/V-(4-(1-(4-(trifluoromethoxy)phenyl)-1H-1,2,4-triazol-3yl)benzylidene)-carbamohydrazonothioate (427 mg, 0.710 mmol), potassium iodide (236 mg, 1.42 mmol) and potassium carbonate (393 mg, 2.84 mmol) was added acetone (7 ml). The reaction was heated to 65°C for 72 h. The reaction was cooled to room température, diluted with DCM and washed with water. The aqueous layer was extracted with DCM. The organic layers were poured through a phase separator and concentrated. Purification by flash column chromatography provided a yellow oil. The yellow oil was recrystallized from MeOH, filtered, washed with MeOH and dried to provide the title compound as a yellow solid (100 mg, 0.177 mmol, 25%): mp 100-106 °C; 1H NMR (400 MHz, CDCI3) δ 8.55 (s, 1 H), 8.15 (d, J =8.4 Hz,
Page 27 of 160
2H), 8.10 (s, 1H), 7.79 (dt, J = 10.4, 5.8 Hz, 4H). 7.38 (d, J = 8.3 Hz, 2H), 7.11 (s, 3H), 3.85 3.78 (m, 2H), 3.20 - 3.12 (m, 2H), 2.30 (s, 6H), 2.13 - 2.07 (m, 2H), 1.87 - 1.82 (m, 2H); ESIMS m/z 566 (M+H).
Exampie 19: Préparation of (Z)-3-(2-isopropylphenyl)-2-((E)-(4-(1-(4(trifluoromethoxy)phenyl)-1 H-1,2,4-triazol-3-yl)benzylidene)hydrazono)-1,3-thiazinan-4one (Compound 224C) (Synthesis Method L)
To (E)-N-(2-isopropylphenyl)-2-(4-(1-(4-(trifluoromethoxy)phenyl)-1 H-1,2,4-trîazol-3yl)benzylidene)hydrazinecarbothioamide (500 mg, 0.953 mmol) in butanone (9.5 ml) was added acryloyl chloride (0.077 ml, 0.953 mmol). The reaction was stirred at ambient température for 10 min followed by 50 °C for 2 h. The reaction was cooled to 40 °C overnight. The reaction was determined to be complété by LCMS. The reaction mixture was diluted with DCM and washed with saturated sodium bicarbonate. The aqueous layer was extracted with DCM. The organic layers were poured through a phase separator and concentrated. Purification by flash column chromatography provided a yellow oil. The oil was recrystallized with diethyl ether/hexanes to provide the title compound as a light yellow solid (125 mg, 0.217 mmol, 23%): mp 118 °C (dec); 1H NMR (400 MHz, CDCI3) δ 8.57 (s, 1H)t 8.21 (d, J = 8.4 Hz, 2H), 8.16 (s, 1H), 7.85 - 7.75 (m, 4H), 7.46 - 7.36 (m, 4H), 7.33 - 7.26 (m, 1H), 7.10 (d, J = 7.6 Hz, 1 H), 3.26 - 3.14 (m, 4H), 2.81 (heptet, J= 6.9 Hz, 1H), 1.21 (t, J = 7.2 Hz, 6H); ESIMS m/z 580 (M+H).
Example 20: Séparation of rotationally stable atropisomers from racemic mixtures
Séparation of constituent isomers from racemic mixtures can be carried out utilizing one of the following chiral HPLC methods.
Séparation Method A: The column used for séparation was a Chiral Technologies INC Chiral Pak 1A 5 pm, 4.6 X 250 mm column (Part number 80325). The method consists of a 1.0 mL/min flow rate from 0 to 30 min with an isocratic hold at 25% B for the duration of the run. The A eluent is n-hexane, the B eluent is /so-propyl alcohol.
Séparation Method B: The column used for séparation was a Chiral Technologies INC Chiral
Page 28 of 160
Pak 1B 5 pm, 4.6 X 250 mm column (Part number 81325). The method consists of a 1.0 mL/min flow rate from 0 to 30 min with an isocratic hold at 15% B for the duration of the run. The A eluent is n-pentane, the B eluent is n-butyl alcohol.
Example 21: Bioassays on Beet Armyworm (BAW) and Corn Earworm (CEW”)
BAW has few effective parasites, diseases, or predators to lower its population. BAW infests many weeds, trees, grasses, legumes, and field crops. In various places, it is of économie concern upon asparagus, cotton, corn, soybeans, tobacco, alfalfa, sugar beets, peppers, tomatoes, potatoes, onions, peas, sunflowers, and citrus, among other plants. CEW is known to attack corn and tomatoes, but it also attacks artichoke, asparagus, cabbage, cantaloupe, collards, cowpeas, cucumbers, eggplant, lettuce, lima beans, melon, okra, peas, peppers, potatoes, pumpkin, snap beans, spinach, squash, sweet potatoes, and watermelon, among other plants. CEW is also known to be résistant to certain insecticides. Consequently, because ofthe above factors control of these pests is important. Furthermore, molécules that control these pests are useful in controlling other pests.
Certain molécules disclosed in this document were tested against BAW and CEW using procedures described in the following examples. In the reporting of the results, the “BAW & CEW Rating Table was used (See Table Section).
Bioassays on BAW (Spodoptera exigua)
Bioassays on BAW were conducted using a 128-well diet tray assay. One to five second instar BAW larvae were placed in each well (3 mL) of the diet tray that had been previously filled with 1 mL of artificial diet to which 50 pg/cm2 of the test compound (dissolved in 50 pL of 90:10 acetone-water mixture) had been applied (to each of eight wells) and then allowed to dry. Trays were covered with a clear self-adhesive cover and held at 25 °C, 14:10 light-dark for five to seven days. Percent mortality was recorded for the larvae in each well; activity in the eight wells was then averaged. The results are indicated in the table entitled Table 5: Biological Results (See Table Section).
Bioassays on CEW (Helicoverpa zea)
Bioassays on CEW were conducted using a 128-well diet tray assay. One to five second instar CEW larvae were placed in each well (3 mL) of the diet tray that had been previously filled with 1 mL of artificial diet to which 50 pg/cm2 of the test compound (dissolved in 50 pL of 90:10 acetone-water mixture) had been applied (to each of eight wells) and then allowed to dry. Trays were covered with a clear self-adhesive cover and held at 25 °C, 14:10 light-dark for five to seven days. Percent mortality was recorded for the larvae in each well; activity in the eight wells was then averaged. The results are indicated in the table entitled “Table 5: Biological Results (See Table Section).
Page 29 of 160
Example 22: Bioassays on Green Peach Aphid (“GPA’’) (Myzus persicae).
GPA is the most significant aphid pest of peach trees, causing decreased growth, shriveling of the leaves, and the death of various tissues. It is also hazardous because it acts as a vector for the transport of plant viruses, such as potato virus Y and potato leafroll virus to members of the nightshade/potato family Solanaceae, and various mosaic viruses to many other food crops. GPA attacks such plants as broccoli, burdock, cabbage, carrot, cauliflower, daikon, eggplant, green beans, lettuce, macadamia, papaya, peppers, sweet potatoes, tomatoes, watercress, and zucchinî, among other plants. GPA also attacks many ornamental crops such as carnation, chrysanthemum, flowering white cabbage, poinsettia, and roses. GPA has developed résistance to many pesticides.
Certain molécules disclosed in this document were tested against GPA using procedures described in the following example. In the reporting of the results, the GPA Rating Table” was used (See Table Section).
Cabbage seedlings grown in 3-inch pots, with 2-3 small (3-5 cm) true leaves, were used as test substrate. The seedlings were înfested with 20-50 GPA (wingless adult and nymph stages) one day prior to chemical application. Four pots with individual seedlings were used for each treatment. Test compounds (2 mg) were dissolved in 2 mL of acetone/methanol (1:1) solvent, forming stock solutions of 1000 ppm test compound. The stock solutions were diluted 5X with 0.025% Tween 20 in H2O to obtain the solution at 200 ppm test compound. A hand-held aspirator-type sprayer was used for spraying a solution to both sides of cabbage leaves until runoff. Reference plants (solvent check) were sprayed with the diluent only containing 20% by volume of acetone/methanol (1:1) solvent. Treated plants were held in a holding room for three days at approximately 25 °C and ambient relative humidity (RH) prior to gradîng. Evaluation was conducted by counting the number of live aphids per plant under a microscope. Percent Control was measured by using Abbott’s correction formula (W.S. Abbott, “A Method of Computing the Effectiveness of an Insecticide J. Econ. Entomol. 18 (1925), pp.265-267) as follows.
Corrected % Control = 100 * (X - Y) / X where
X = No. of live aphids on solvent check plants and
Y = No. of live aphids on treated plants
Page 30 of 160
The results are indicated in the table entitled “Table 5: Biological Results” (See Table Section).
PESTICIDALLY ACCEPTABLE ACID ADDITION SALTS, SALT DERIVATIVES, SOLVATES,
ESTER DERIVATIVES, POLYMORPHS, ISOTOPES AND RADIONUCLIDES
Molécules of Formulas One, Two and Three may be formulated into pesticidally acceptable acid addition salts. By way of a non-limiting example, an amine function can form salts with hydrochloric, hydrobromic, sulfuric, phosphoric, acetic, benzoic, citric, malonic, salicylic, malic, fumaric, oxalic, succinic, tartane, lactic, gluconic, ascorbic, maleic, aspartic, benzenesulfonic, methanesulfonic, ethanesulfonic, hydroxymethanesulfonic, and hydroxyethanesulfonic acids. Additionally, by way of a non-limiting example, an acid function can form salts including those derived from alkali or alkaline earth metals and those derived from ammonia and amines. Examples of preferred cations include sodium, potassium, and magnésium.
Molécules of Formulas One, Two and Three may be formulated into sait dérivatives. By way of a non-limiting example, a sait dérivative can be prepared by contacting a free base with a sufficient amount of the desired acid to produce a sait. A free base may be regenerated by treating the sait with a suitable dilute aqueous base solution such as dilute aqueous sodium hydroxide (NaOH), potassium carbonate, ammonia, and sodium bicarbonate. As an example, in many cases, a pesticide, such as 2,4-D, is made more water-soluble by converting it to its dimethylamine sait..
Molécules of Formulas One, Two and Three may be formulated into stable complexes with a solvent, such that the complex remains intact after the non-complexed solvent is removed. These complexes are often referred to as solvatés.” However, it is particularly désirable to form stable hydrates with water as the solvent.
Molécules of Formulas One, Two and Three may be made into ester dérivatives. These ester dérivatives can then be applied in the same manner as the invention disclosed in this document is applied.
Molécules of Formulas One, Two and Three may be made as various crystal polymorphs. Polymorphism is important in the development of agrochemicals since different crystal polymorphs or structures of the same molécule can hâve vastly different physical properties and biological performances.
Molécules of Formulas One, Two and Three may be made with different isotopes. Of particular importance are molécules having 2H (also known as deuterium) in place of 1H.
Molécules of Formulas One, Two and Three may be made with different radionuclides. Of particular importance are molécules having 14C.
STEREOISOMERS
Molécules of Formulas One, Two and Three may exist as one or more stereoisomers.
Thus, certain molécules can be produced as racemic mixtures. It will be appreciated by those skilled in the art that one stereoisomer may be more active than the other stereoisomers.
Individual stereoisomers may be obtained by known sélective synthetic procedures, by conventional synthetic procedures using resolved starting materials, or by conventional resolution procedures.
Page 31 of160
INSECTICIDES
Molécules of Formulas One, Two and Three may also be used in combination (such as, in a compositional mixture, or a simultaneous or sequential application) with one or more of the foilowing insecticides -1,2-dichloropropane, abamectin, acephate, acetamiprid, acethion, acetoprole, acrinathrin, acrylonitrile, alanycarb, aldicarb, aldoxycarb, aldrin, allethrin, allosamidin, allyxycarb, a/pha-cypermethrin, a/pha-ecdysone, a/pha-endosulfan, amidithion, aminocarb, amiton, amiton oxalate, amitraz, anabasine, athidathion, azadirachtin, azamethiphos, azinphos-ethyl, azinphos-methyl, azothoate, barium hexafluorosilicate, barthrin, bendiocarb, benfuracarb, bensultap, befa-cyfluthrin, heta-cypermethrin, bifenthrin, bioallethrin, bioethanomethrin, biopermethrin, bistrifluron, borax, boric acid, bromfenvinfos, bromocyclen, bromo-DDT, bromophos, bromophos-ethyl, bufencarb, buprofezin, butacarb, butathiofos, butocarboxim, butonate, butoxycarboxim, cadusafos, calcium arsenate, calcium polysulfide, camphechlor, carbanolate, carbaryl, carbofuran, carbon disulfide, carbon tetrachloride, carbophenothion, carbosulfan, cartap, cartap hydrochloride, chlorantraniliprole, chlorbicyclen, chlordane, chlordecone, chlordimeform, chlordimeform hydrochloride, chlorethoxyfos, chlorfenapyr, chlorfenvinphos, chlorfluazuron, chlormephos, chloroform, chloropicrin, chlorphoxim, chlorprazophos, chlorpyrifos, chlorpyrifos-methyl, chlorthiophos, chromafenozide, cinerin I, cinerin II, cinerins, cismethrin, cloethocarb, closantel, clothianidin, copper acetoarsenite, copper arsenate, copper naphthenate, copper oleate, coumaphos, coumithoate, crotamiton, crotoxyphos, crufomate, cryolite, cyanofenphos, cyanophos, cyanthoate, cyantraniliprole, cyclethrin, cycloprothrin, cyfluthrin, cyhalothrin, cypermethrin, cyphenothrin, cyromazine, cythioate, DDT, decarbofuran, deltamethrin, demephion, demephion-O, demephion-S, demeton, demeton-methyl, demeton-O, demeton-O-methyl, demeton-S, demeton-S-methyl, demeton-S-methylsulphon, diafenthiuron, dialifos, diatomaceous earth, diazinon, dicapthon, dichlofenthion, dichlorvos, dicresyl, dicrotophos, dicyclanil, dieldrin, diflubenzuron, dilor, dimefluthrin, dimefox, dimetan, dimethoate, dimethrin, dimethylvinphos, dimetilan, dinex, dinex-diclexine, dinoprop, dinosam, dinotefuran, diofenolan, dioxabenzofos, dioxacarb, dioxathion, disulfoton, dithicrofos, d-ltmonene, DNOC, DNOC-ammonium, DNOCpotassium, DNOC-sodium, doramectin, ecdysterone, emamectin, emamectin benzoate, EMPC, empenthrin, endosulfan, endothion, endrin, EPN, epofenonane, eprinomectin, esdepalléthrine, esfenvalerate, etaphos, ethiofencarb, ethion, ethiprole, ethoate-methyl, ethoprophos, ethyl formate, ethyl-DDD, ethylene dibromide, ethylene dichloride, ethylene oxide, etofenprox, etrimfos, EXD, famphur, fenamiphos, fenazaflor, fenchlorphos, fenethacarb, fenfluthrin, fenitrothion, fenobucarb, fenoxacrim, fenoxycarb, fenpirithrin, fenpropathrin, fensulfothion, fenthion, fenthion-ethyl, fenvalerate, fipronil, flometoquin, flonicamid, flubendiamide (additionally resolved isomers thereof). flucofuron, flucycloxuron, flucythrînate, flufenerim, flufenoxuron, flufenprox, flufiprole , flupyradifurone, fluvalinate, fonofos, formetanate, formetanate
Page 32of_L60 hydrochloride, formothion, formparanate, formparanate hydrochloride, fosmethilan, fospirate, fosthietan, fufenozide, furathiocarb, furethrin, gamma-cyhalothrin, gamma-HCH, halfenprox, halofenozide, HCH, HEOD, heptachlor, heptenophos, heterophos, hexaflumuron, HHDN, hydramethylnon, hydrogen cyanide, hydroprene, hyquincarb, imidacloprid, imiprothrin, indoxacarb, iodomethane, IPSP, isazofos, isobenzan, isocarbophos, isodrin, isofenphos, isofenphos-methyl, isoprocarb, isoprothiolane, isothioate, isoxathion, ivermectin, jasmolin I, jasmolin II, jodfenphos, juvénile hormone I, juvénile hormone II, juvénile hormone III, kelevan, kinoprene, lambda-cyhalothrin, lead arsenate, lepimectin, leptophos, lindane, lirimfos, lufenuron, lythidathion, malathion, malonoben, mazidox, mecarbam, mecarphon, menazon, meperfluthrin, mephosfolan, mercurous chloride, mesulfenfos, metaflumizone, methacrifos, methamidophos, methidathion, methiocarb, methocrotophos, methomyl, methoprene, methothrin, methoxychlor, methoxyfenozide, methyl bromide, methyl isothiocyanate, methylchloroform, methylene chloride, metofluthrin, metolcarb, metoxadîazone, mevinphos, mexacarbate, milbemectin, milbemycin oxime, mipafox, mirex, molosultap, monocrotophos, monomehypo, monosultap, morphothion, moxidectin, naftalofos, naled, naphthalene, nicotine, nifluridide, nitenpyram, nithiazine, nitrilacarb, novaluron, noviflumuron, omethoate, oxamyl, oxydemeton-methyl, oxydeprofos, oxydisulfoton, para-dichlorobenzene, parathion, parathion-methyl, penfluron, pentachlorophenol, permethrin, phenkapton, phenothrin, phenthoate, phorate, phosalone, phosfolan, phosmet, phosnichlor, phosphamidon, phosphine, phoxim, phoxim-methyl, pirimetaphos, pirimicarb, pirimiphos-ethyl, pirimiphos-methyl, potassium arsenite, potassium thiocyanate, pp'-DDT, prallethrin, precocene I, precocene II, precocene III, primidophos, profenofos, profluralin, profluthrin, promacyl, promecarb, propaphos, propetamphos, propoxur, prothidathion, prothiofos, prothoate, protrifenbute, pymetrozine, pyraclofos, pyrafluprole, pyrazophos, pyresmethrin, pyrethrin I, pyrethrin II, pyrethrins, pyridaben, pyridalyl, pyridaphenthion, pyrifluquinazon, pyrimîdifen, pyrimitate, pyriprole, pyriproxyfen, quassia, quinalphos, quinalphos-methyl, quinothion, rafoxanide, resmethrin, rotenone, ryania, sabadilla, schradan, selamectin, silafluofen, silica gel, sodium arsenite, sodium fluoride, sodium hexafluorosilicate, sodium thiocyanate, sophamide, spinetoram, spinosad, spiromesifen, spirotetramat, sulcofuron, sulcofuron-sodium, sulfluramid, sulfotep, sulfoxaflor, sulfuryl fluoride, sulprofos, tau-fluvalinate, tazimcarb, TDE, tebufenozide, tebufenpyrad, tebupirimfos, teflubenzuron, tefluthrin, temephos, TEPP, terallethrin, terbufos, tetrachloroethane, tetrachlorvinphos, tetramethrin, tetramethylfluthrin, theta-cypermethrin, thiacloprid, thiamethoxam, thicrofos, thiocarboxime, thiocyclam, thiocyclam oxalate, thiodicarb, thiofanox, thiometon, thiosultap, thiosultap-disodium, thiosultap-monosodium, thuringiensin, tolfenpyrad, tralomethrin, transfluthrin, transpermethrin, triarathene, triazamate, triazophos, trichlorfon, trichlormetaphos-3, trichloronat, trifenofos, triflumuron, trimethacarb, triprene, vamidothion, vaniliprole, XMC, xylylcarb, zeta-cypermethrin, and zolaprofos (collectively these commonly named insecticides are defined as the “Insecticide Group).
Page 33 of 160
ACARICIDES
Molécules of Formulas One, Two and Three may also be used in combination (such as, in a compositional mixture, or a simultaneous or sequential application) with one or more of the following acaricides - acequinocyl, amidoflumet, arsenous oxide, azobenzene, azocyclotin, benomyl, benoxafos, benzoximate, benzyl benzoate, bifenazate, binapacryl, bromopropylate, chinomethionat, chlorbenside, chlorfenethol, chlorfenson, chlorfensulphide, chlorobenzilate, chloromebuform, chloromethiuron, chloropropylate, clofentezine, cyenopyrafen, cyflumetofen, cyhexatin, dichlofluanid, dicofol, dienochlor, diflovidazin, dinobuton, dînocap, dinocap-4, dinocap-6, dinocton, dinopenton, dinosulfon, dinoterbon, diphenyl sulfone, disulfiram, dofenapyn, etoxazole, fenazaquin, fenbutatin oxide, fenothiocarb, fenpyroximate, fenson, fentrifanil, fluacrypyrim, fluazuron, flubenzimine, fluenetil, flumethrin, fluorbenside, hexythiazox, mesulfen, MNAF, nikkomycins, procîonol, propargite, quintiofos, spirodiclofen, sulfiram, sulfur, tetradifon, tetranactin, tetrasul, and thioquinox (collectively these commonly named acaricides are defined as the Acaricide Group”).
NEMATICIDES
Molécules of Formulas One, Two and Three may also be used in combination (such as, in a compositional mixture, or a simultaneous or sequential application) with one or more of the following nematicides - 1,3-dichloropropene, benclothiaz, dazomet, dazomet-sodium, DBCP, DCIP, diamidafos, fluensulfone, fosthiazate, furfural, imicyafos, isamidofos, isazofos, metam, metam-ammonium, metam-potassium, metam-sodium, phosphocarb, and thionazin (collectively these commonly named nematicides are defined as the “Nematicide Group”)
FUNGICIDES
Molécules of Formulas One, Two and Three may also be used in combination (such as, in a compositional mixture, or a simultaneous or sequential application) with one or more of the following fungicides - (3-ethoxypropyl)mercury bromide, 2-methoxyethyimercury chloride, 2phenylphenol, 8-hydroxyquinoline sulfate, 8-phenylmercurioxyquinoline, acibenzolar, acibenzolar-S-methyl, acypetacs, acypetacs-copper, acypetacs-zinc, aldimorph, allyl alcohol, ametoctradin, amisulbrom, ampropylfos, anilazine, aureofungin, azaconazole, azithiram, azoxystrobin, barium polysulfide, benalaxyl, benalaxyl-M, benodanil, benomyl, benquinox, bentaluron, benthiavalicarb, benthiavalicarb-isopropyl, benzalkonium chloride, benzamacril, benzamacril-isobutyl, benzamorf, benzohydroxamic acid, bethoxazin, binapacryl, biphenyl, bitertanol, bithionol, bixafen, blasticidin-S, Bordeaux mixture, boscalid, bromuconazole, bupirimate, Burgundy mixture, buthiobate, butylamine, calcium polysulfide, captafol, captan, carbamorph, carbendazim, carboxin, carpropamid, carvone, Cheshunt mixture, chinomethionat, chlobenthiazone, chloraniformethan, chloranil, chlorfenazole, chlorodinitronaphthalene,
Page 34 of!60 chloroneb, chloropicrin, chlorothalonil, chlorquinox, chlozolinate, climbazole, clotrimazole, copper acetate, copper carbonate, basic, copper hydroxide, copper naphthenate, copper oleate, copper oxychloride, copper silicate, copper sulfate, copper zinc chromate, cresol, cufraneb, cuprobam, cuprous oxide, cyazofamid, cyclafuramid, cycloheximide, cyflufenamid, cymoxanil, cypendazole, cyproconazole, cyprodinil, dazomet, dazomet-sodium, DBCP, debacarb, decafentin, dehydroacetic acid, dichlofluanid, dichlone, dichlorophen, dichlozoline, diclobutrazol, diclocymet, diclomezine, diclomezine-sodium, dicloran, diethofencarb, diethyl pyrocarbonate, difenoconazole, diflumetorim, dimethirimol, dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dinobuton, dinocap, dinocap-4, dinocap-6, dinocton, dinopenton, dinosulfon, dinoterbon, diphenylamine, dipyrithione, disulfiram, ditalimfos, dithianon, DNOC, DNOCammonium, DNOC-potassium, DNOC-sodium, dodemorph, dodemorph acetate, dodemorph benzoate, dodicin, dodicin-sodium, dodine, drazoxolon, edifenphos, epoxiconazole, etaconazole, etem, ethaboxam, ethirimol, ethoxyquin, ethylmercury 2,3-dihydroxypropyl mercaptide, ethylmercury acetate, ethylmercury bromide, ethylmercury chloride, ethylmercury phosphate, etridiazole, famoxadone, fenamidone, fenaminosulf, fenapanil, fenarimol, fenbuconazole, fenfuram, fenhexamid, fenitropan, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, fentin, fentin chloride, fentin hydroxide, ferbam, ferimzone, fluazinam, fludioxonil, flumetover, flumorph, fluopicolide, fluopyram, fluoroimide, fluotrimazole, fluoxastrobin, fluquinconazole, flusilazole, flusulfamide, flutianil, flutolanil, flutriafol, fluxapyroxad, folpet, formaldéhyde, fosetyl, fosetyl-aluminium, fuberidazole, furalaxyl, furametpyr, furcarbanil, furconazole, furconazole-cis, furfural, furmecyclox, furophanate, glyodin, griseofulvin, guazatine, halacrinate, hexachlorobenzene, hexachlorobutadiene, hexaconazole, hexylthiofos, hydrargaphen, hymexazol, imazalii, imazalii nitrate, imazalii sulfate, imibenconazole, iminoctadine, iminoctadine triacetate, iminoctadine trialbesilate, iodomethane, ipconazole, iprobenfos, iprodione, iprovalicarb, isoprothiolane, isopyrazam, isotianil, isovaledione, kasugamycin, kresoxim-methyl, mancopper, mancozeb, mandipropamid, maneb, mebenil, mecarbinzid, mepanipyrim, mepronil, meptyldinocap, mercuric chloride, mercuric oxide, mercurous chloride, metalaxyl, metalaxyl-M, metam, metam-ammonium, metam-potassium, metam-sodium, metazoxolon, metconazole, methasulfocarb, methfuroxam, methyl bromide, methyl isothiocyanate, methylmercury benzoate, methylmercury dicyandiamide, methylmercury pentachlorophenoxide, metiram, metominostrobin, metrafenone, metsulfovax, milneb, myclobutanil, myclozolin, N-(ethylmercury)-p-toluenesulphonanilide, nabam, natamycin, nitrostyrene, nitrothal-isopropyl, nuarimol, OCH, octhilinone, ofurace, orysastrobin, oxadixyl, oxine-copper, oxpoconazole, oxpoconazole fumarate, oxycarboxin, pefurazoate, penconazole, pencycuron, penflufen, pentachlorophenol, penthiopyrad, phenylmercuriurea, phenylmercury acetate, phenylmercury chloride, phenylmercury dérivative of pyrocatechol, phenylmercury nitrate, phenylmercury salicylate, phosdiphen, phthalide, picoxystrobin, piperalin, polycarbamate, polyoxins, polyoxorim, polyoxorim-zinc, potassium azide, potassium polysulfide,
Page 35 of 160 potassium thiocyanate, probenazole, prochloraz, procymidone, propamocarb, propamocarb hydrochloride, propiconazole, propineb, proquinazid, prothiocarb, prothiocarb hydrochloride, prothioconazole, pyracarbolid, pyraclostrobin, pyraclostrobîn, pyrametostrobin, pyraoxystrobin, pyrazophos, pyribencarb, pyridinitril, pyrifenox, pyrimethanil, pyriofenone, pyroquilon, pyroxychlor, pyroxyfur, quinacetol, quinacetol sulfate, quinazamid, quinconazole, quinoxyfen, quintozene, rabenzazole, salicylanilide, sedaxane, silthiofam, simeconazole, sodium azide, sodium orthophenylphenoxide, sodium pentachlorophenoxide, sodium polysulfide, spiroxamine, streptomycin, sulfur, sultropen, TCMTB, tebuconazole, tebufloquin, tecloftalam, tecnazene, tecoram, tetraconazole, thiabendazole, thiadifluor, thicyofen, thifluzamide, thiochlorfenphim, thiomersal, thiophanate, thiophanate-methyl, thîoquinox, thiram, tiadinil, tioxymid, tolclofosmethyl, tolylfluanid, tolylmercury acetate, triadimefon, triadimenol, triamiphos, triarimol, triazbutil, triazoxide, tributyltin oxide, trichlamide, tricyclazole, tridemorph, trifloxystrobin, triflumizole, triforine, triticonazole, uniconazole, uniconazole-P, validamycin, valifenalate, vinclozolin, zarilamid, zinc naphthenate, zineb, ziram, zoxamide (collectively these commonly named fungicides are defined as the Fungicide Group),
HERBICIDES
Molécules of Formulas One, Two and Three may also be used in combination (such as, in a compositional mixture, or a simultaneous or sequential application) with one or more of the following herbicides - 2,3,6-TBA, 2,3,6-TBA-dimethylammonium, 2,3,6-TBA-sodium, 2,4,5-T,
2.4.5- T-2-butoxypropyl, 2,4,5-T-2-ethylhexyl, 2,4,5-T-3-butoxypropyl, 2,4,5-TB, 2,4,5-Tbutometyl, 2,4,5-T-butotyl, 2,4,5-T-butyl, 2,4,5-T-isobutyl, 2,4,5-T-isoctyl, 2,4,5-T-isopropyl,
2.4.5- T-methyl, 2,4,5-T-pentyl, 2,4,5-T-sodium, 2,4,5-T-triethylammonium, 2,4,5-T-trolamine,
2.4- D, 2,4-D-2-butoxypropyl, 2,4-D-2-ethylhexyl, 2,4-D-3-butoxypropyl, 2,4-D-ammonium, 2,4DB, 2,4-DB-butyl, 2,4-DB-dimethylammonium, 2,4-DB-îsoctyl, 2,4-DB-potassium, 2,4-DBsodium, 2,4-D-butotyl, 2,4-D-butyl, 2,4-D-diethylammonium, 2,4-D-dimethylammonium, 2,4-Ddiolamine, 2,4-D-dodecylammonium, 2,4-DEB, 2,4-DEP, 2,4-D-ethyl, 2,4-D-heptylammonium,
2.4- D-isobutyl, 2,4-D-isoctyl, 2,4-D-isopropyl, 2,4-D-isopropylammonium, 2,4-D-lithium, 2,4-Dmeptyl, 2,4-D-methyl, 2,4-D-octyl, 2,4-D-pentyl, 2,4-D-potassium, 2,4-D-propyl, 2,4-D-sodium,
2.4- D-tefuryl, 2,4-D-tetradecylammonium, 2,4-D-triethylammonium, 2,4-D-tris(2hydroxypropyl)ammonium, 2,4-D-trolamine, 3,4-DA, 3,4-DB, 3,4-DP, 4-CPA, 4-CPB, 4-CPP, acetochlor, acifluorfen, acifluorfen-methyl, acifluorfen-sodium, aclonifen, acrolein, alachlor, allidochlor, alloxydim, alloxydim-sodium, allyl alcohol, alorac, ametridione, ametryn, amibuzin, amicarbazone, amidosulfuron, aminocyclopyrachlor, aminocyclopyrachlor-methyl, aminocyclopyrachlor-potassium, aminopyralid, aminopyralid-potassium, aminopyralid-tris(2hydroxypropyl)ammonium, amiprofos-methyl, amitrole, ammonium sulfamate, anilofos, anisuron, asulam, asulam-potassium, asulam-sodium, atraton, atrazine, azafenidin, azimsulfuron, aziprotryne, barban, BCPC, beflubutamid, benazolin, benazolîn-
Page 36 of 160 dimethylammonium, benazolin-ethyl, benazolin-potassium, bencarbazone, benfluralin, benfuresate, bensulfuron, bensulfuron-methyl, bensulide, bentazone, bentazone-sodium, benzadox, benzadox-ammonium, benzfendizone, benzipram, benzobicyclon, benzofenap, benzofluor, benzoylprop, benzoylprop-ethyl, benzthiazuron, bicyclopyrone, bifenox, bilanafos, bilanafos-sodium, bispyribac, bispyribac-sodium, borax, bromacil, bromacil-lithium, bromacilsodium, bromobonil, bromobutide, bromofenoxim, bromoxynil, bromoxynil butyrate, bromoxynil heptanoate, bromoxynil octanoate, bromoxynil-potassium, brompyrazon, butachlor, butafenacil, butamifos, butenachlor, buthidazole, buthiuron, butralin, butroxydim, buturon, butylate, cacodylic acid, cafenstrole, calcium chlorate, calcium cyanamide, cambendichlor, carbasulam, carbetamide, carboxazole, carfentrazone, carfentrazone-ethyl, CDEA, CEPC, chlomethoxyfen, chloramben, chloramben-ammonium, chloramben-diolamine, chloramben-methyl, chlorambenmethylammonium, chloramben-sodium, chloranocryl, chlorazifop, chlorazifop-propargyl, chlorazine, chlorbromuron, chlorbufam, chloreturon, chlorfenac, chlorfenac-sodium, chlorfenprop, chlorfenprop-methyl, chlorflurazole, chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron, chlorimuron-ethyl, chlornitrofen, chloropon, chlorotoluron, chloroxuron, chloroxynil, chlorprocarb, chlorpropham, chlorsulfuron, chlorthal, chlorthal-dimethyl, chlorthalmonomethyl, chlorthiamid, cinidon-ethyl, cinmethylin, cinosulfuron, cisanilide, clethodim, clïodinate, clodinafop, clodinafop-propargyl, clofop, clofop-isobutyl, clomazone, clomeprop, cloprop, cloproxydim, clopyralid, clopyralid-methyl, clopyralid-olamine, clopyralid-potassium, clopyralid-tris(2-hydroxypropyl)ammonium, cloransulam, cloransulam-methyl, CMA, copper sulfate, CPMF, CPPC, credazine, cresol, cumyluron, cyanamide, cyanatryn, cyanazine, cycloate, cyclosulfamuron, cycloxydim, cycluron, cyhalofop, cyhalofop-butyl, cyperquat, cyperquat chloride, cyprazine, cyprazole, cypromid, daimuron, dalapon, dalapon-calcium, dalapon-magnesium, dalapon-sodium, dazomet, dazomet-sodium, delachlor, desmedipham, desmetryn, di-allate, dicamba, dicamba-dimethylammonium, dicamba-diolamine, dicambaisopropylammonium, dicamba-methyl, dicamba-olamine, dicamba-potassium, dicamba-sodium, dicamba-trolamine, dichlobenil, dichloralurea, dichlormate, dichlorprop, dichlorprop-2-ethylhexyl, dichlorprop-butotyl, dichlorprop-dimethylammonium, dichlorprop-ethylammonium, dichlorpropisoctyl, dichlorprop-methyl, dichlorprop-P, dichlorprop-P-dimethylammonium, dichlorproppotassium, dichlorprop-sodium, diclofop, diclofop-methyl, diclosulam, diethamquat, diethamquat dichloride, diethatyl, diethatyl-ethyl, difenopenten, difenopenten-ethyl, difenoxuron, difenzoquat, difenzoquat metilsulfate, diflufenican, diflufenzopyr, diflufenzopyr-sodium, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dîmethenamid-P, dimexano, dimidazon, dinitramine, dinofenate, dinoprop, dinosam, dinoseb, dinoseb acetate, dinosebammonium, dinoseb-dîolamine, dinoseb-sodium, dinoseb-trolamine, dinoterb, dinoterb acetate, diphacinone-sodium, diphenamid, dipropetryn, diquat, diquat dibromide, disul, disul-sodium, dithiopyr, diuron, DMPA, DNOC, DNOC-ammonîum, DNOC-potassium, DNOC-sodium, DSMA, EBEP, eglinazine, eglinazine-ethyl, endothal, endothal-diammonium, endothal-dipotassium,
Page 37 of 160
endothal-disodium, epronaz, EPTC, erbon, esprocarb, ethalfluralin, ethametsulfuron, ethametsulfuron-methyl, ethidimuron, ethiolate, ethofumesate, ethoxyfen, ethoxyfen-ethyl, ethoxysulfuron, etinofen, etnipromid, etobenzanid, EXD, fenasulam, fenoprop, fenoprop-3butoxypropyl, fenoprop-butometyl, fenoprop-butotyl, fenoprop-butyl, fenoprop-isoctyl, fenopropmethyl, fenoprop-potassium, fenoxaprop, fenoxaprop-ethyl, fenoxaprop-P, fenoxaprop-P-ethyl, fenoxasulfone, fenteracol, fenthiaprop, fenthiaprop-ethyl, fentrazamide, fenuron, fenuron TCA, ferrous sulfate, flamprop, flamprop-isopropyl, flamprop-M, flamprop-methyl, flamprop-Misopropyl, flamprop-M-methyl, flazasulfuron, florasulam, fluazifop, fluazifop-butyl, fluazifopmethyl, fluazifop-P, fluazifop-P-butyl, fluazolate, flucarbazone, flucarbazone-sodium, fiucetosulfuron, fluchloralin, flufenacet, flufenican, flufenpyr, flufenpyr-ethyl, flumetsulam, flumezin, flumiclorac, flumiclorac-pentyl, flumioxazin, flumipropyn, fluometuron, fluorodifen, fluoroglycofen, fluoroglycofen-ethyl, fluoromidine, fluoronitrofen, fluothiuron, flupoxam, flupropacil, flupropanate, flupropanate-sodium, flupyrsulfuron, flupyrsulfuron-methyl-sodium, fluridone, flurochloridone, fluroxypyr, fluroxypyr-butometyl, fluroxypyr-meptyl, flurtamone, fluthiacet, fluthiacet-methyl, fomesafen, fomesafen-sodium, foramsulfuron, fosamine, fosamineammonium, furyloxyfen, glufosinate, glufosinate-ammonium, glufosinate-P, glufosinate-Pammonium, glufosînate-P-sodium, glyphosate, glyphosate-diammonium, glyphosatedimethylammonium, glyphosate-isopropylammonium, glyphosate-monoammonium, glyphosatepotassium, glyphosate-sesquisodîum, glyphosate-trimesium, halosafen, halosulfuron, halosulfuron-methyl, haloxydine, haloxyfop, haloxyfop-etotyl, haloxyfop-methyl, haloxyfop-P, haloxyfop-P-etotyl, haloxyfop-P-methyl, haloxyfop-sodium, hexachloroacetone, hexaflurate, hexazinone, imazamethabenz, imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin-ammonium, imazaquin-methyl, imazaquin-sodium, imazethapyr, imazethapyrammonium, imazosulfuron, indanofan, indaziflam, iodobonil, iodomethane, iodosulfuron, iodosulfuron-methyl-sodium, ioxynil, ioxynil octanoate, ioxynil-lithium, ioxynil-sodium, ipazine, îpfencarbazone, iprymidam, isocarbamid, isocil, isomethiozin, isonoruron, isopolinate, isopropalin, isoproturon, isouron, isoxaben, isoxachlortole, isoxaflutole, isoxapyrifop, karbutilate, ketospiradox, lactofen, lenacil, linuron, MAA, ΜΑΜΑ, ΜΟΡΑ, MCPA-2-ethylhexyl, MCPA-butotyl, MCPA-butyl, MCPA-dimethylammonium, MCPA-diolamine, MCPA-ethyl, MCPA-isobutyl, MCPA-isoctyl, MCPA-isopropyl, MCPA-methyl, MCPA-olamine, MCPA-potassium, MCPAsodium, MCPA-thioethyl, MCPA-trolamine, MCPB, MCPB-ethyl, MCPB-methyl, MCPB-sodium, mecoprop, mecoprop-2-ethylhexyl, mecoprop-dimethylammonium, mecoprop-diolamine, mecoprop-ethadyl, mecoprop-isoctyl, mecoprop-methyl, mecoprop-P, mecoprop-Pdimethylammonium, mecoprop-P-isobutyl, mecoprop-potassium, mecoprop-P-potassium, mecoprop-sodium, mecoprop-trolamine, medinoterb, medinoterb acetate, mefenacet, mefluidide, mefluidide-diolamine, mefluidide-potassium, mesoprazine, mesosulfuron, mesosulfuron-methyl, mesotrione, metam, metam-ammonium, metamifop, metamîtron, metamPage38of 160 potassium, metam-sodium, metazachlor, metazosulfuron, metflurazon, methabenzthiazuron, methalpropalin, methazole, methiobencarb, methiozolin, methiuron, methometon, methoprotryne, methyl bromide, methyl isothiocyanate, methyldymron, metobenzuron, metolachlor, metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinate, monalide, monisouron, monochloroacetic acid, monolinuron, monuron, monuron TCA, morfamquat, morfamquat dichloride, MSMA, naproanilide, napropamide, naptalam, naptalamsodium, neburon, nicosulfuron, nipyraclofen, nitralin, nitrofen, nitrofluorfen, norflurazon, noruron, OCH, orbencarb, ortho-dichlorobenzene, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxapyrazon, oxapyrazon-dimolamine, oxapyrazon-sodium, oxasulfuron, oxaziclomefone, oxyfluorfen, parafluron, paraquat, paraquat dichloride, paraquat dimetilsulfate, pebulate, pelargonic acid, pendimethalin, penoxsulam, pentachlorophenol, pentanochlor, pentoxazone, perfluidone, pethoxamid, phenisopham, phenmedipham, phenmedipham-ethyl, phenobenzuron, phenylmercury acetate, picloram, picloram-2-ethylhexyl, picloram-isoctyl, picloram-methyl, picloram-olamine, picloram-potassium, picloram-triethylammonium, pic!oram-tris(2hydroxypropyl)ammonium, picolinafen, pinoxaden, piperophos, potassium arsenite, potassium azide, potassium cyanate, pretilachlor, primisulfuron, primisulfuron-methyl, procyazine, prodiamine, profluazol, profluralin, profoxydim, proglinazine, proglinazine-ethyl, prometon, prometryn, propachlor, propanil, propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisulfuron, propyzamide, prosulfalin, prosulfocarb, prosulfuron, proxan, proxan-sodium, prynachlor, pydanon, pyraclonil, pyraflufen, pyraflufen-ethyl, pyrasulfotole, pyrazolynate, pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxyfen, pyribenzoxim, pyributicarb, pyriclor, pyridafol, pyridate, pyriftalid, pyriminobac, pyriminobacmethyl, pyrimisulfan, pyrithiobac, pyrithiobac-sodium, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quinonamid, quizalofop, quizalofop-ethyl, quizalofop-P, quizalofop-Pethyl, quizalofop-P-tefuryl, rhodethanil, rimsulfuron, saflufenacil, sebuthylazine, secbumeton, sethoxydim, siduron, simazine, simeton, simetryn, SMA, S-metolachlor, sodium arsenite, sodium azide, sodium chlorate, sulcotrione, sulfallate, sulfentrazone, sulfometuron, sulfometuron-methyl, sulfosulfuron, sulfuric acid, sulglycapin, swep, TCA, TCA-ammonium, TCA-calcium, TCA-ethadyl, TCA-magnesium, TCA-sodium, tebutam, tebuthiuron, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbuchior, terbumeton, terbuthylazine, terbutryn, tetrafluron, thenylchlor, thiazafluron, thiazopyr, thidiazimin, thidiazuron, thiencarbazone, thiencarbazone-methyl, thifensulfuron, thifensulfuron-methyl, thiobencarb, tiocarbazil, tioclorim, topramezone, tralkoxydim, tri-allate, triasulfuron, triaziflam, tribenuron, tribenuron-methyl, tricamba, triclopyr, triclopyr-butotyl, triclopyr-ethyl, triclopyr-triethylammonium, tridiphane, trietazine, trifloxysulfuron, trifloxysulfuron-sodium, trifluralin, triflusulfuron, triflusulfuron-methyl, trifop, trifop-methyl, trifopsime, trihydroxytriazine, trimeturon, tripropindan, tritac, tritosulfuron, vernolate, xylachlor, (collectively these commonly named herbicides are defined as the “Herbicide Group).
Page 39 of 160
BIOPESTICIDES
Molécules of Formulas One, Two and Three may also be used in combination (such as in a compositional mixture, or a simultaneous or sequential application) with one or more biopesticides. The term “biopesticide” is used for microbial biological pest control agents that are applied in a similar manner to chemical pesticides. Commonly these are bacterial, but there are also examples of fungal control agents, including Trichoderma spp. and Ampelomyces quisqualis (a control agent for grape powdery mildew). Bacillus subtilis are used to control plant pathogens. Weeds and rodents hâve also been controlled with microbial agents. One wellknown insecticide example is Bacillus thuringiensis, a bacterial disease of Lepidoptera, Coleoptera, and Diptera. Because it has little effect on other organisms, it is considered more environmentally friendly than synthetic pesticides. Biological insecticides include products based on:
1. entomopathogenic fungi (e.g. Metarhizium anisopliae)·,
2. entomopathogenic nematodes (e.g. Steinernema feltiae): and
3. entomopathogenic viruses (e.g. Cydia pomonella granulovirus).
Other examples of entomopathogenic organisms include, but are not limited to, baculoviruses, bacteria and other prokaryotic organisms, fungi, protozoa and Microsproridia. Biologically derived insecticides include, but not limited to, rotenone, veratridine, as well as microbial toxins; insect tolérant or résistant plant varieties; and organisms modified by recombinant DNA technology to either produce insecticides or to convey an insect résistant property to the genetically modified organism. In one embodiment, the Molécules of Formula One, Two or Three may be used with one or more biopesticides in the area of seed treatments and soil amendments. The Manual ofBiocontrol Agents gives a review of the available biological insecticide (and other biology-based control) products. Copping L.G. (ed.) (2004). The Manual of Biocontrol Agents (formerly the Biopesticide Manual) 3rd Edition. British Crop Production Council (BCPC), Farnham, Surrey UK.
OTHER ACTIVE COMPOUNDS
Molécules of Formulas One, Two and Three may also be used in combination (such as in a compositional mixture, or a simultaneous or sequential application) with one or more of the following:
1. 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-oxa-1 -azaspiro[4,5]dec-3-en-2-one;
2. 3-(4’-chloro-2,4-dimethyl[1,T-biphenyl]-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4,5]dec-3-en-2one;
3. 4-[[(6-chloro-3-pyridinyl)methyl]methylamino]-2(5/-/)-furanone;
4. 4-[[(6-chloro-3-pyridinyl)methyl]cyclopropylamino]-2(5/-/)-furanone;
5. 3-chloro-A/2-[(1S)-1-methyl-2-(methylsulfonyl)ethyl]-A/1-[2-methyl-4-[1,2,2,2-tetrafluoro-1-
Page 40 of 160 (trjfluoromethy1)ethyl]phenyl]-1,2-benzenedicarboxamide;
6. 2-cyano-A/-ethyl-4-fluoro-3-methoxy-benenesulfonamide;
7. 2-cyano-N-ethyl-3-methoxy-benzenesulfonamide;
8. 2-cyano-3-difluoromethoxy-N-ethyl-4-fluoro-benzenesulfonamide;
9. 2-cyano-3-fluoromethoxy-N-ethyl-benzenesulfonamide;
10. 2-cyano-6-fluoro-3-methoxy-A/,N-dimethyl-benzenesulfonamide;
11. 2-cyano-/V-ethyl-6-fluoro-3-methoxy-/V-methyl-benzenesulfonamide;
12. 2-cyano-3-difluoromethoxy-A/,/V-dimethylbenzenesulfon-amide;
13. 3-(difluoromethyl)-/V-[2-(3,3-dimethylbutyl)phenyl]-1-methyl-1 H-pyrazole-4-carboxamide;
14. /V-ethyl-2,2-dimethylpropionamide-2-(2,6-dichloro-a,a,a-trifluoro-p-tolyl) hydrazone;
15. A/-ethyl-2,2-dichloro-1 -methylcyclopropane-carboxamide-2-(2,6-dichloro-a,a,a-trifluoro-ptolyl) hydrazone nicotine;
16. 0-{(E-)-[2-(4-chloro-phenyl)-2-cyano-1 -(2-trifluoromethylphenyI)-vinyl]} S-methyl thiocarbonate;
17. (E)-N1-[(2-chloro-1,3-thiazol-5-ylmethyl)]-N2-cyano-N1-methylacetamidine;
18. 1 -(6-chloropyridin-3-ylmethyl)-7-methyl-8-nitro-1,2,3,5,6,7-hexahydro-imidazo[1,2a]pyridin-5-ol;
19. 4-[4-chlorophenyl-(2-butylidine-hydrazono)methyl)]phenyl mesylate; and
20. N-Ethyl-2,2-dichloro-1-methylcyclopropanecarboxamide-2-(2,6-dichloroa/pba,a/pfïa,a/p/ja-trifluoro-p-tolyl)hydrazone.
Molécules of Formulas One, Two and Three may also be used in combination (such as in a compositional mixture, or a simultaneous or sequential application) with one or more compounds in the following groups: algicides, antifeedants, avicides, bactéricides, bird repellents, chemosterilants, herbicide safeners, insect attractants, insect repellents, mammal repellents, mating disrupters, molluscicides, plant activators, plant growth regulators, rodenticides, and/or virucides (collectively these commonly named groups are defined as the “AI Group”). It should be noted that compounds falling within the Al Group, Insecticide Group, Fungicide Group, Herbicide Group, Acaricide Group, or Nematicide Group might be in more than one group, because of multiple activities the compound has. For more information consult the Compendium of Pesticide Common Names located at http://www.alanwood.net/pesticides/index.html. Also consult “The Pesticide Manual” 14th Edition, edited by C D S Tomlin, copyright 2006 by British Crop Production Council, or its prior or more recent éditions.
SYNERGISTIC MIXTURES AND SYNERGISTS
Molécules of Formulas One, Two and Three may be used with the compounds in the
Insecticide Group to form synergistic mixtures where the mode of action of such compounds compared to the mode of action of the Molécules of Formula One and Two are the same,
Page 41 of 160 similar, or different. Examples of modes of action include, but are not limited to: acetylcholinesterase inhibitor; sodium channel modulator; chitin biosynthesis inhibitor; GABAgated chloride channel antagonist; GABA and glutamate-gated chloride channel agonist; acétylcholine receptor agonist; MET I inhibitor; Mg-stimulated ATPase inhibitor; nicotinic acétylcholine receptor; Midgut membrane disrupter; oxidative phosphorylation disrupter, and ryanodine receptor (RyRs). Additionally, Molécules of Formula One and Two may be used with compounds in the Fungicide Group, Acaricide Group, Herbicide Group, or Nematicide Group to form synergistic mixtures. Furthermore, Molécules of Formulas One, Two and Three may be used with other active compounds, such as the compounds under the heading “OTHER ACTIVE COMPOUNDS, algicides, avicides, bactéricides, molluscicides, rodenticides, virucides, herbicide safeners, adjuvants, and/or surfactants to form synergistic mixtures. Generally, weight ratios ofthe Molécules of Formulas One, Two and Three in a synergistic mixture with another compound are from about 10:1 to about 1:10, preferably from about 5:1 to about 1:5, and more preferably from about 3:1, and even more preferably about 1:1. Additionally, the following compounds are known as synergists and may be used with the molécules disclosed in Formula One: piperonyl butoxide, piprotal, propyl isome, sesamex, sesamolin, sulfoxide, and tribufos (collectively these synergists are defined as the “Synergists Group”).
FORMULATIONS
A pesticide is rarely suitable for application in its pure form. It is usually necessary to add other substances so that the pesticide can be used at the required concentration and in an appropriate form, permitting ease of application, handling, transportation, storage, and maximum pesticide activity. Thus, pesticides are formulated into, for example, baits, concentrated émulsions, dusts, emulsifiable concentrâtes, fumigants, gels, granules, microencapsulations, seed treatments, suspension concentrâtes, suspoemulsions, tablets, water soluble liquids, water dispersible granules or dry flowables, wettable powders, and ultra low volume solutions. For further information on formulation types see “Catalogue of Pesticide Formulation Types and International Coding System Technical Monograph n°2, 5th Edition by CropLife International (2002).
Pesticides are applied most often as aqueous suspensions or émulsions prepared from concentrated formulations of such pesticides. Such water-soluble, water-suspendable, or emulsifiable formulations are either solids, usually known as wettable powders, or water dispersible granules, or liquids usually known as emulsifiable concentrâtes, or aqueous suspensions. Wettable powders, which may be compacted to form water dispersible granules, comprise an intimate mixture of the pesticide, a carrier, and surfactants. The concentration of the pesticide is usually from about 10% to about 90% by weight. The carrier is usually chosen from among the attapulgite clays, the montmorillonite clays, the diatomaceous earths, or the
Page 42 of 160 purified silicates. Effective surfactants, comprising from about 0.5% to about 10% of the wettable powder, are found among sulfonated lignins, condensed naphthalenesulfonates, naphthalenesulfonates, alkylbenzenesulfonates, alkyl sulfates, and non-ionic surfactants such as ethylene oxide adducts of alkyl phénols.
Emulsifiable concentrâtes of pesticides comprise a convenient concentration of a pesticide, such as from about 50 to about 500 grams per liter of liquid dissolved in a carrier that is either a water miscible solvent or a mixture of water-immiscible organic solvent and emulsifiers. Useful organic solvents include aromatics, especially xylenes and petroleum fractions, especially the high-boiling naphthalenic and olefinic portions of petroleum such as heavy aromatîc naphtha. Other organic solvents may also be used, such as the terpenic solvents including rosin dérivatives, aliphatic ketones such as cyclohexanone, and complex alcohols such as 2-ethoxyethanol. Suitable emulsifiers for emulsifiable concentrâtes are chosen from conventional anionic and non-ionic surfactants.
Aqueous suspensions comprise suspensions of water-insoluble pesticides dispersed in an aqueous carrier at a concentration in the range from about 5% to about 50% by weight. Suspensions are prepared by fînely grinding the pesticide and vigorously mixing it into a carrier comprised of water and surfactants. Ingrédients, such as inorganic salts and synthetic or natural gums may also be added, to increase the density and viscosity of the aqueous carrier. It is often most effective to grind and mix the pesticide at the same time by preparing the aqueous mixture and homogenizing it in an implement such as a sand mill, bail mill, or piston-type homogenizer.
Pesticides may also be applied as granular compositions that are particularly useful for applications to the soil. Granular compositions usually contain from about 0.5% to about 10% by weight of the pesticide, dispersed in a carrier that comprises clay or a similar substance. Such compositions are usually prepared by dissolving the pesticide in a suitable solvent and applying it to a granular carrier which has been pre-formed to the appropriate particle size, in the range of from about 0.5 to about 3 mm. Such compositions may also be formulated by making a dough or paste of the carrier and compound and crushîng and drying to obtain the desired granular particle size.
Dusts containing a pesticide are prepared by intimately mixing the pesticide in powdered form with a suitable dusty agricultural carrier, such as kaolin clay, ground volcanic rock, and the like. Dusts can suitably contain from about 1% to about 10% of the pesticide. They can be applied as a seed dressing or as a foliage application with a dust blower machine.
It is equally practical to apply a pesticide in the form of a solution in an appropriate organic solvent, usually petroleum oil, such as the spray oils, which are widely used in agricultural chemistry.
Pesticides can also be applied in the form of an aérosol composition. In such compositions the pesticide is dissolved or dispersed in a carrier, which is a pressure-generating propellant mixture. The aérosol composition is packaged in a container from which the mixture
Page 43 of 160 is dispensed through an atomizing valve.
Pesticide baits are formed when the pesticide is mixed with food or an attractant or both.
When the pests eat the bait they also consume the pesticide. Baits may take the form of granules, gels, flowable powders, liquids, or solids. They can be used in pest harborages.
Fumîgants are pesticides that hâve a relatively high vapor pressure and hence can exist as a gas in sufficient concentrations to kill pests in soil or enclosed spaces. The toxicity of the fumigant is proportional to its concentration and the exposure time. They are characterized by a good capacity for diffusion and act by penetrating the pest's respiratory system or being absorbed through the pest's cuticle. Fumîgants are applied to control stored product pests under gas proof sheets, in gas sealed rooms or buildings or in spécial chambers.
Pesticides can be microencapsulated by suspending the pesticide particles or droplets in plastic polymers of various types. By altering the chemistry of the polymer or by changing factors in the processing, microcapsules can be formed of various sizes, solubility, wall thicknesses, and degrees of penetrability. These factors govern the speed with which the active ingrédient within is released, which in turn, affects the residual performance, speed of action, and odor of the product.
Oil solution concentrâtes are made by dissolving pesticide in a solvent that will hold the pesticide in solution. Oil solutions of a pesticide usually provide faster knockdown and kill of pests than other formulations due to the solvents themselves having pesticidal action and the dissolution of the waxy covering of the integument increasing the speed of uptake of the pesticide. Other advantages of oil solutions include better storage stability, better pénétration of crevices, and better adhesion to greasy surfaces.
Another embodiment is an oil-in-water émulsion, wherein the émulsion comprises oily globules which are each provided with a lamellar liquid crystal coating and are dispersed in an aqueous phase, wherein each oily globule comprises at least one compound which is agriculturally active, and is individually coated with a monolamellar or oligolamellar layer comprising: (1) at least one non-ionic lipophilie surface-active agent, (2) at least one non-ionic hydrophilic surface-active agent and (3) at least one ionic surface-active agent, wherein the globules having a mean particle diameter of less than 800 nanometers. Further information on the embodiment is disclosed in U.S. patent publication 20070027034 published February 1, 2007, having Patent Application serial number 11/495,228. For ease of use, this embodiment will be referred to as “OIWE.
For further information consult Insect Pest Management 2nd Edition by D. Dent, copyright CAB International (2000). Additionally, for more detailed information consult “Handbook of Pest Control - The Behavior, Life History, and Control of Household Pests by Arnold Mallis, 9th Edition, copyright 2004 by GIE Media Inc.
OTHER FORMULATION COMPONENTS
Page 44 of 160
Generally, when the molécules disclosed in Formulas One, Two and Three are used in a formulation, such formulation can also contain other components. These components include, but are not limited to, (this is a non-exhaustive and non-mutually exclusive list) wetters, spreaders, stickers, pénétrants, buffers, sequestering agents, drift réduction agents, compatibility agents, anti-foam agents, cleaning agents, and emulsifiers. A few components are described forthwith.
A wetting agent is a substance that when added to a liquid increases the spreading or pénétration power of the liquid by reducing the interfacial tension between the liquid and the surface on which it is spreading. Wetting agents are used for two main functions in agrochemical formulations: during processing and manufacture to increase the rate of wetting of powders in water to make concentrâtes for soluble liquids or suspension concentrâtes; and during mixing of a product with water in a spray tank to reduce the wetting time of wettable powders and to improve the pénétration of water into water-dispersible granules. Examples of wetting agents used in wettable powder, suspension concentrate, and water-dispersible granule formulations are: sodium lauryl sulfate; sodium dioctyl sulfosuccinate; alkyl phénol ethoxylates; and aliphatic alcohol ethoxylates.
A dispersing agent is a substance which adsorbs onto the surface of particles and helps to preserve the state of dispersion of the particles and prevents them from reaggregating. Dispersing agents are added to agrochemical formulations to facilitate dispersion and suspension during manufacture, and to ensure the particles redisperse into water in a spray tank. They are widely used in wettable powders, suspension concentrâtes and water-dispersible granules. Surfactants that are used as dispersing agents hâve the ability to adsorb strongly onto a particle surface and provide a charged or steric barrier to reaggregation of particles. The most commonly used surfactants are anionic, non-ionic, or mixtures of the two types. For wettable powder formulations, the most common dispersing agents are sodium lignosulfonates. For suspension concentrâtes, very good adsorption and stabilization are obtained using polyelectrolytes, such as sodium naphthalene sulfonate formaldéhyde condensâtes. Tristyrylphenol ethoxylate phosphate esters are also used. Non-ionics such as alkylarylethylene oxide condensâtes and EO-PO block copolymers are sometimes combined with anionics as dispersing agents for suspension concentrâtes. In recent years, new types of very high molecular weight polymeric surfactants hâve been developed as dispersing agents. These hâve very long hydrophobie ‘backbones’ and a large number of ethylene oxide chains forming the 'teetlï of a ‘comb’ surfactant. These high molecular weight polymers can give very good longterm stability to suspension concentrâtes because the hydrophobie backbones hâve many anchoring points onto the particle surfaces. Examples of dispersing agents used in agrochemical formulations are: sodium lignosulfonates; sodium naphthalene sulfonate formaldéhyde condensâtes; tristyrylphenol ethoxylate phosphate esters; aliphatic alcohol ethoxylates; alkyl ethoxylates; EO-PO block copolymers; and graft copolymers.
Page 45 of 160
An emulsifying agent is a substance which stabilizes a suspension of dropiets of one liquid phase in another liquid phase. Without the emulsifying agent the two liquids would separate into two immiscible liquid phases. The most commonly used emulsifier blends contain alkylphenol or aliphatic alcohol with twelve or more ethylene oxide units and the oil-soluble calcium sait of dodecylbenzenesulfonic acid. A range of hydrophile-lipophile balance (“HLB) values from 8 to 18 will normally provide good stable émulsions. Emulsion stability can sometimes be improved by the addition of a small amount of an EO-PO block copolymer surfactant.
A solubilizing agent is a surfactant which will form micelles in water at concentrations above the critical micelle concentration. The micelles are then able to dissolve or solubilize water-insoluble materiais inside the hydrophobie part of the micelle. The types of surfactants usually used for solubilization are non-ïonics, sorbitan monooleates, sorbitan monooleate ethoxylates, and methyl oleate esters.
Surfactants are sometimes used, either alone or with other additives such as minerai or vegetable oils as adjuvants to spray-tank mixes to improve the biological performance of the pesticide on the target. The types of surfactants used for bioenhancement dépend generally on the nature and mode of action of the pesticide. However, they are often non-ionics such as: alkyl ethoxylates; linear aliphatic alcohol ethoxylates; aliphatic amine ethoxylates.
A carrier or diluent in an agriculture! formulation is a material added to the pesticide to give a product of the requîred strength. Carriers are usually materiais with high absorptive capacities, while diluents are usually materiais with low absorptive capacities. Carriers and diluents are used in the formulation of dusts, wettable powders, granules and water-dispersible granules.
Organic solvents are used mainly in the formulation of emulsifiable concentrâtes, oil-inwater émulsions, suspoemulsions, and ultra low volume formulations, and to a lesser extent, granular formulations. Sometimes mixtures of solvents are used. The first main groups of solvents are aliphatic paraffinic oils such as kerosene or refined paraffins. The second main group (and the most common) comprises the aromatic solvents such as xylene and higher molecular weight fractions of C9 and C10 aromatic solvents. Chlorînated hydrocarbons are useful as cosolvents to prevent crystallization of pesticides when the formulation is emulsified into water. Alcohols are sometimes used as cosolvents to increase solvent power. Other solvents may include vegetable oils, seed oils, and esters of vegetable and seed oils.
Thickeners or gelling agents are used mainly in the formulation of suspension concentrâtes, émulsions and suspoemulsions to modify the rheology or flow properties of the liquid and to prevent séparation and settling of the dispersed particles or dropiets. Thickening, gelling, and anti-settling agents generally fall into two categories, namely water-insoluble particulates and water-soluble polymers. It is possible to produce suspension concentrate formulations using clays and silicas. Examples of these types of materiais, include, but are not
Page 46 of 160 limited to, montmorillonite, bentonite, magnésium aluminum silicate, and attapulgite. Watersoluble polysaccharides hâve been used as thickening-gelling agents for many years. The types of polysaccharides most commonly used are natural extracts of seeds and seaweeds or are synthetic dérivatives of cellulose. Examples of these types of materials include, but are not limited to, guar gum; locust bean gum; carrageenam; alginates; methyl cellulose; sodium carboxymethyl cellulose (SCMC); hydroxyethyl cellulose (HEC). Other types of anti-settling agents are based on modified starches, polyacrylates, polyvinyl alcohol and polyethylene oxide. Another good anti-settling agent is xanthan gum.
Microorganisms can cause spoilage of formulated products. Therefore préservation agents are used to eliminate or reduce their effect. Examples of such agents include, but are not limited to: propionic acid and its sodium sait; sorbic acid and its sodium or potassium salts; benzoic acid and its sodium sait; p-hydroxybenzoic acid sodium sait; methyl p-hydroxybenzoate; and 1,2-benzisothiazolin-3-one (BIT).
The presence of surfactants often causes water-based formulations to foam during mixing operations in production and in application through a spray tank. In order to reduce the tendency to foam, anti-foam agents are often added either during the production stage or before filling into bottles. Generally, there are two types of anti-foam agents, namely silicones and nonsillcones. Silicones are usually aqueous émulsions of dimethyl polysiloxane, while the nonsilicone anti-foam agents are water-insoluble oils, such as octanol and nonanol, or silica. In both cases, the function of the anti-foam agent is to displace the surfactant from the air-water interface.
Green agents (e.g., adjuvants, surfactants, solvents) can reduce the overall environmental footprint of crop protection formulations. Green agents are biodégradable and generally derived from natural and/or sustainable sources, e.g. plant and animal sources. Spécifie examples are: vegetable oils, seed oils, and esters thereof, also alkoxylated alkyl polyglucosides.
For further information, see “Chemistry and Technology of Agrochemical Formulations edited by D.A. Knowles, copyright 1998 by Kluwer Academie Publishers. Also see “Insecticides în Agriculture and Environment - Retrospects and Prospects” by A.S. Perry, I. Yamamoto, I. Ishaaya, and R. Perry, copyright 1998 by Springer-Verlag.
PESTS
In general, the Molécules of Formula Formulas One, Two and Three may be used to control pests e.g. beetles, earwigs, cockroaches, flies. aphids, scales, whiteflies, leafhoppers, ants, wasps, termites, moths, butterflies, lice, grasshoppers, locusts, crickets, fleas, thrips, bristîetails, mites, ticks, nematodes, and symphylans.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests in the Phyla Nematoda and/or Arthropoda.
Page 47 of 160
In another embodiment, the Moiecules of Formulas One, Two and Three may be used to control pests in the Subphyla Chelicerata, Myriapoda, and/or Hexapoda.
In another embodiment, the Moiecules of Formulas One, Two and Three may be used to control pests in the Classes of Arachnida, Symphyla, and/or Insecta.
In another embodiment, the Moiecules of Formulas One, Two and Three may be used to control pests of the Order Anopiura. A non-exhaustive list of particular généra includes, but is not limited to, Haematopinus spp., Hoplopleura spp., Linognathus spp., Pediculus spp., and Polyplax spp. A non-exhaustive list of particular species includes, but is not limited to, Haematopinus asini, Haematopinus suis, Linognathus setosus, Linognathus ovillus, Pediculus humanus capitis, Pediculus humanus humanus, and Pthirus pubis.
In another embodiment, the Moiecules of Formulas One, Two and Three may be used to control pests in the Order Coleoptera. A non-exhaustive list of particular généra includes, but is not limited to, Acanthoscelides spp., Agriotes spp., Anthonomus spp., Apion spp., Apogonia spp., Aulacophora spp., Bruchus spp., Cerosterna spp., Cerotoma spp., Ceutorhynchus spp., Chaetocnema spp., Colaspis spp., Ctenicera spp., Curculio spp., Cyclocephala spp., Diabrotica spp., Hypera spp., Ips spp., Lyctus spp., Megascelis spp., Meligethes spp., Otiorhynchus spp., Pantomorus spp., Phyllophaga spp., Phyllotreta spp., Rhizotrogus spp., Rhynchites spp., Rhynchophorus spp., Scolytus spp., Sphenophorus spp., Sitophilus spp., and Tribolium spp. A non-exhaustive list of particular species includes, but is not limited to, Acanthoscelides obtectus, Agrilus planipennis, Anoplophora glabripennis, Anthonomus grandis, Ataenius spretulus, Atomaria linearis, Bothynoderes punctiventris, Bruchus pisorum, Callosobruchus maculatus, Carpophilus hemipterus, Cassida vittata, Cerotoma trifurcata, Ceutorhynchus assimilis, Ceutorhynchus napi, Conoderus scalaris, Conoderus stigmosus, Conotrachelus nénuphar, Cotinis nitida, Crioceris asparagi, Cryptolestes ferrugineus, Cryptolestes pusillus, Cryptolestes turcicus, Cylindrocopturus adspersus, Deporaus marginatus, Dermestes lardarius, Dermestes maculatus, Epilachna varivestis, Faustinus cubae, Hylobius pales, Hypera postica, Hypothenemus hampei, Lasioderma serrîcorne, Leptinotarsa decemlineata, Liogenys fuscus, Liogenys suturalis, Lissorhoptrus oryzophilus, Maecolaspis joliveti, Melanotus commuais, Meligethes aeneus, Melolontha melolontha, Oberea brevis, Oberea linearis, Oryctes rhinocéros, Oryzaephilus mercator, Oryzaephilus surinamensis, Ouléma melanopus, Ouléma oryzae, Phyllophaga cuyabana, Popillia japonica, Prostephanus truncatus, Rhyzopertha dominica,, Sitona lineatus, Sitophilus granarius, Sitophilus oryzae, Sitophilus zeamais, Stegobium paniceum, Tribolium castaneum, Tribolium confusum, Trogoderma variabile, and Zabrus tenebrioides.
In another embodiment, the Moiecules of Formulas One, Two and Three may be used to control pests of the Order Dermaptera.
In another embodiment, the Moiecules of Formulas One, Two and Three may be used to control pests of the Order Blattaria. A non-exhaustive list of particular species includes, but is
Page 48 of 160 not limited to, Blattella germanica, Blatta orientalis, Parcoblatta pennsylvanica, Periplaneta americana, Periplaneta australasiae, Periplaneta brunnea, Periplaneta fuliginosa, Pycnoscelus surinamensis, and Supella longipalpa.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Diptera. A non-exhaustive list of particular généra includes, but is not limited to, Aedes spp., Agromyza spp., Anastrepha spp., Anopheles spp., Bactrocera spp., Ceratitis spp., Chrysops spp., Cochliomyia spp., Contarinia spp., Culex spp., Dasineura spp., Délia spp., Drosophila spp., Fannia spp., Hylemyia spp., Liriomyza spp., Musca spp., Phorbia spp., Tabanus spp., and Tipula spp. A non-exhaustive list of particular species includes, but is not limited to, Agromyza frontella, Anastrepha suspensa, Anastrepha ludens, Anastrepha obliqa, Bactrocera cucurbitae, Bactrocera dorsalis, Bactrocera invadens, Bactrocera zonata, Ceratitis capitata, Dasineura brassicae, Délia platura, Fannia canicularis, Fannia scalaris, Gasterophilus intestinalis, Gracillia perseae, Haematobia irritans, Hypoderma lineatum, Liriomyza brassicae, Melophagus ovinus, Musca autumnalis, Musca domestica, Oestrus ovis, Oscinella frit, Pegomya betae, Psila rosae, Rhagoletis cerasi, Rhagoletis pomonella, Rhagoletis mendax, Sitodiplosis mosellana, and Stomoxys calcitrans.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Hemiptera. A non-exhaustive list of particular généra includes, but is not limited to, Adelges spp., Aulacaspis spp., Aphrophora spp., Aphis spp., Bemisia spp., Ceroplastes spp., Chionaspis spp., Chrysomphalus spp., Coccusspp., Empoasca spp., Lepidosaphes spp., Lagynotomus spp., Lygus spp., Macrosiphum spp., Nephotettix spp., Nezara spp., Philaenus spp., Phytocoris spp., Piezodorus spp., Planococcus spp., Pseudococcus spp., Rhopalosiphum spp., Saissetia spp., Therioaphis spp., Toumeyella spp., Toxoptera spp., Trialeurodes spp., Triatoma spp. and Unaspis spp. A non-exhaustive list of particular species includes, but is not limited to, Acrosternum hilare, Acyrthosiphon pisum, Aleyrodes proletella, Aleurodicus dispersus, Aleurothrixus floccosus, Amrasca biguttula biguttula, Aonidiella aurantii, Aphis gossypii, Aphis glycines, Aphis pomi, Aulacorthum solani, Bemisia argentifolii, Bemisia tabaci, Blissus leucopterus, Brachycorynella asparagi, Brevennia rehi, Brevicoryne brassicae, Calocoris norvegicus, Ceroplastes rubens, Cimex hemipterus, Cimex lectularius, Dagbertus fasciatus, Dichelops furcatus, Diuraphis noxia, Diaphorina citri, Dysaphis plantaginea, Dysdercus suturellus, Edessa meditabunda, Eriosoma lanigerum, Eurygaster maura, Euschistus héros, Euschistus servus, Helopeltis antonii, Helopeltis theivora, Icerya purchasi, Idioscopus nitidulus, Laodelphax striatellus, Leptocorisa oratorius, Leptocorisa varicornis, Lygus hesperus, Maconellicoccus hirsutus, Macrosiphum euphorbiae, Macrosiphum granarium, Macrosiphum rosae, Macrosteles quadrilineatus, Mahanarva frimbiolata, Metopolophium dirhodum, Midis longicornis, Myzus persicae, Nephotettix cindipes, Neurocolpus longirostris, Nezara viridula, Nilaparvata lugens, Parlatoria pergandii, Parlatoria ziziphi, Peregrinus maidis, Phylloxéra vitifoliae, Physokermes piceae,, Phytocoris californicus,
Page 49 of 160
Phytocoris relativus, Piezodorus guildinii, Poecilocapsus lineatus, Psallus vaccinicola,
Pseudacysta perseae, Pseudococcus brevipes, Quadraspidiotus perniciosus, Rhopalosiphum maidis, Rhopalosiphum padi, Saissetia oleae, Scaptocoris castanea, Schizaphis graminum,
Sitobion avenae, Sogatella furcifera, Trialeurodes vaporariorum, Trialeurodes abutiloneus,
Unaspis yanonensis, and Zulia entrerriana.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Hymenoptera. A non-exhaustive list of particular généra includes, but is not limited to, Acromyrmex spp., Atta spp., Camponotus spp., Diprion spp., Formica spp,, Monomorium spp., Neodiprion spp., Pogonomyrmex spp., Po/istes spp., Solenopsis spp., Vespula spp., and Xylocopa spp. A non-exhaustive list of particular species includes, but is not limited to, Athalia rosae, Atta texana, Iridomyrmex humilis, Monomorium minimum, Monomorium pharaonis, Solenopsis invicta, Solenopsis geminata, Solenopsis molesta, Solenopsis richtery, Solenopsis xyloni, and Tapinoma sessi/e.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Isoptera. A non-exhaustive list of particular généra includes, but Is not limited to, Coptotermes spp., Cornitermes spp., Cryptotermes spp., Heterotermes spp., Kalotermes spp., Incisitermes spp., Macrotermes spp., Marginitermes spp., Microcerotermes spp., Procornitermes spp., Reticulitermes spp., Schedorhinotermes spp., and Zootermopsis spp. A non-exhaustive list of particular species includes, but is not limited to, Coptotermes curvignathus, Coptotermes frenchi, Coptotermes formosanus, Heterotermes aureus, Microtermes obesi, Reticulitermes banyulensis, Reticulitermes grassei, Reticulitermes flavipes, Reticulitermes hageni, Reticulitermes hesperus, Reticulitermes santonensis, Reticulitermes speratus, Reticulitermes tibialis, and Reticulitermes virginicus.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Lepidoptera. A non-exhaustive list of particular généra includes, but is not limited to, Adoxophyes spp., Agrotis spp., Argyrotaenia spp., Cacoecia spp., Caloptilia spp., Chilo spp., Chrysodeixis spp., Colias spp., Crambus spp., Diaphania spp., Diatraea spp., Earias spp., Ephestia spp., Epimecis spp., Feltia spp., Gortyna spp., Helicoverpa spp., Heliothis spp., Indarbela spp., Lithocolletis spp., Loxagrotis spp., Malacosoma spp., Peridroma spp., Phyllonorycter spp., Pseudaletia spp., Sesamia spp., Spodoptera spp., Synanthedon spp., and Yponomeuta spp. A non-exhaustive list of particular species includes, but is not limited to, Achaea janata, Adoxophyes orana, Agrotis ipsilon, Alabama argillacea, Amorbia cuneana, Amyelois transitella, Anacamptodes defectaria, Anarsia lineatella, Anomis sabulifera, Anticarsia gemmatalis, Archips argyrospila, Archips rosana, Argyrotaenia citrana, Autographe gamma, Bonagota cranaodes, Borbo cinnara, Bucculatrix thurberiella, Capua reticulana, Carposina niponensis, Chlumetia transversa, Choristoneura rosaceana, Cnaphalocrocis medinalis, Conopomorpha cramerella, Cossus cossus, Cydia caryana, Cydia funebrana, Cydia molesta, Cydia nigricana, Cydia pomonella, Darna diducta, Diatraea saccharalis, Diatraea grandiosella,
Page50ofl60
Earias insulana, Earias vittella, Ecdytolopha aurantianum, Elasmopalpus lignosellus, Ephestia cautella, Ephestia elutella, Ephestia kuehniella, Epinotla aporema, Epiphyas postvittana, Erionota thrax, Eupoecilia ambiguella, Euxoa auxiliaris, Grapholita molesta, Hedylepta indicata, Helîcoverpa armigera, Helicoverpa zea, Heliothis virescens, Hellula undalis, Keiferia lycopersicella, Leucinodes orbonalis, Leucoptera coffeella, Leucoptera malifoliella, Lobesia botrana, Loxagrotis albicosta, Lymantria dispar, Lyonetia clerkella, Mahasena corbetti, Mamestra brassicae, Maruca testulalis, Metisa plana, Mythimna unipuncta, Neoleucinodes elegantalis, Nymphula depunctalis, Operophtera brumata, Ostrinia nubilalis, Oxydia vesulia, Pandemîs cerasana, Pandemis heparana, Papilio demodocus, Pectinophora gossypiella, Peridroma saucia, Perileucoptera coffeella, Phthorimaea operculella, Phyllocnistis citrella, Pieds rapae, Plathypena scabra, Plodia interpunctella, Plutella xylostella, Polychrosis viteana, Prays endocarpa, Prays oleae, Pseudaletia unipuncta, Pseudoplusia includens, Rachiplusia nu, Scirpophaga incertulas, Sesamia inferens, Sesamia nonagrioides, Setora nitens, Sitotroga cerealella, Sparganothis pilleriana, Spodoptera exigua, Spodoptera frugiperda, Spodoptera endania, Thecla basilides, Tineola bisse/lie/la, Trichoplusia ni, Tuta absoluta, Zeuzera coffeae, and Zeuzera pyrina.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Mallophaga. A non-exhaustive list of particular généra includes, but is not limited to, Anaticola spp., Bovicola spp., Chelopistes spp., Goniodes spp., Menacanthus spp,, and Trichodectes spp. A non-exhaustive list of particular species includes, but is not limited to, Bovicola bovis, Bovicola caprae, Bovicola ovis, Chelopistes meleagridis, Goniodes dissimilis, Goniodes gigas, Menacanthus stramineus, Menopon gallinae, and Trichodectes canis.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Orthoptera. A non-exhaustive list of particular généra includes, but is not limited to, Melanoplus spp., and Pterophylla spp. A non-exhaustive list of particular species includes, but is not limited to, Anabrus simplex, Gryllotalpa africana, Gryllotalpa australis, Gryllotalpa brachyptera, Gryllotalpa hexadactyla, Locusta migratoria, Microcentrum retinerve, Schistocerca gregaria, and Scudderia furcata.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Siphonaptera. A non-exhaustive list of particular species includes, but is not limited to, Ceratophyllus gallinae, Ceratophyllus niger, Ctenocephalides canis, Ctenocephalides felis, and Pulex irritans.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Thysanoptera. A non-exhaustive list of particular généra includes, but is not limited to, Caliothrips spp., Frankliniella spp., Scirtothrips spp., and Thrips spp. A nonexhaustive list of particular sp. includes, but is not limited to, Frankliniella fusca, Frankliniella occidentalis, Frankliniella schultzei, Frankliniella williamsi, Heliothrips haemorrhoidalis,
Page 51 of 160
Rhipiphorothrips cruentatus, Scirtothrips citri, Scirtothrips dorsalis, and Taeniothrips rhopalantennalis, Thrips hawaiiensis, Thrips nigropilosus, Thrips orientalis, Thrips tabaci.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Thysanura. A non-exhaustive list of particular généra includes, but is not limited to, Lepisma spp. and Thermobia spp.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Order Acarina. A non-exhaustive list of particular généra includes, but is not limited to, Acarus spp., Aculops spp., Boophilus spp., Demodex spp., Dermacentor spp., Epitrimerus spp., Eriophyes spp., Ixodes spp., Oligonychus spp., Panonychus spp., Rhizoglyphus spp., and Tetranychus spp. A non-exhaustive list of particular species includes, but is not limited to, Acarapis woodi, Acarus siro, Aceria mangiferae, Aculops lycopersici, Aculus pelekassi, Aculus schlechtendali, Amblyomma americanum, Brevipalpus obovatus, Brevipalpus phoenicis, Dermacentor variabilis, Dermatophagoides pteronyssinus, Eotetranychus carpini, Notoedres cati, Oligonychus coffeae, Oligonychus ilicis, Panonychus citri, Panonychus ulmi, Phyllocoptruta oleivora, Polyphagotarsonemus latus, Rhipicephalus sanguineus. Sarcoptes scabiei, Tegolophus perseaflorae, Tetranychus urticae, and Varroa destructor.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pest of the Order Symphyla. A non-exhaustive list of particular sp. includes, but is not limited to, Scutigerella immaculata.
In another embodiment, the Molécules of Formulas One, Two and Three may be used to control pests of the Phylum Nematoda. A non-exhaustive list of particular généra includes, but is not limited to, Aphelenchoides spp., Belonolaimus spp., Criconemella spp., Ditylenchus spp., Heterodera spp., Hirschmanniella spp., Hoplolaimus spp., Meloidogyne spp., Pratylenchus spp., and Radopholus spp. A non-exhaustive list of particular sp. includes, but is not limited to, Dirofilaria immitis, Heterodera zeae, Meloidogyne incognita, Meloidogyne javanica, Onchocerca volvulus, Radopholus similis, and Rotylenchulus reniformis.
For additional information consult “Handbookof Pest Control - The Behavior, Life History, and Control of Household Pests” by Arnold Mallis, 9th Edition, copyright 2004 by GIE Media Inc.
APPLICATIONS
Molécules of Formulas One, Two and Three are generally used in amounts from about
0.01 grams per hectare to about 5000 grams per hectare to provide control. Amounts from about 0.1 grams per hectare to about 500 grams per hectare are generally preferred, and amounts from about 1 gram per hectare to about 50 grams per hectare are generally more preferred.
The area to which a molécule of Formulas One, Two and Three is applied can be any area inhabited (or maybe inhabited, or traversed by) a pest, for example: where crops, trees,
Page 52 of 160 fruits, cereals, fodder species, vines, turf and ornamental plants, are growing; where domesticated animais are residing; the interior or exterior surfaces of buildings (such as places where grains are stored), the materials of construction used in building (such as impregnated wood), and the soil around buildings. Particular crop areas to use a molécule of Formula One include areas where apples, corn, sunflowers, cotton, soybeans, canola, wheat, rice, sorghum, barley, oats, potatoes, oranges, alfalfa, lettuce, strawberries, tomatoes, peppers, crucifers, pears, tobacco, almonds, sugar beets, beans and other valuable crops are growing or the seeds thereof are going to be planted. It is also advantageous to use aluminum sulfate with a molécule of Formula One when growing various plants.
Controlling pests generally means that pest populations, pest activity, or both, are reduced in an area. This can corne about when: pest populations are repulsed from an area; when pests are incapacitated in or around an area; or pests are exterminated, in whole, or in part, in or around an area. Of course, a combination of these results can occur. Generally, pest populations, activity, or both are desirably reduced more than fifty percent, preferably more than 90 percent. Generally, the area is not in or on a human; consequently, the locus is generally a non-human area.
The Molécules of Formulas One, Two and Three may be used in mixtures, applied sîmultaneously or sequentially, alone or with other compounds to enhance plant vigor (e.g. to grow a better root system, to better withstand stressful growing conditions). Such other compounds are, for example, compounds that modulate plant ethylene receptors, most notably 1-methylcyclopropene (also known as 1-MCP).
The Molécules of Formulas One, Two and Three can be applied to the foliar and fruiting portions of plants to control pests. The molécules will either corne in direct contact with the pest, or the pest will consume the pesticide when eating leaf, fruit mass, or extracting sap, that eontains the pesticide. The Molécules of Formulas One, Two and Three can also be applied to the soil, and when applied in this manner, root and stem feeding pests can be controlled. The roots can absorb a molécule taking it up into the foliar portions of the plant to control above ground chewing and sap feeding pests.
Generally, with baits, the baits are placed in the ground where, for example, termites can corne into contact with, and/or be attracted to, the bait. Baits can also be applied to a surface of a building, (horizontal, vertical, or slant surface) where, for example, ants, termites, cockroaches, and flies, can corne into contact with, and/or be attracted to, the bait. Baits can comprise a molécule of Formula One, Two or Three.
The Molécules of Formulas One, Two and Three can be encapsulated inside, or placed on the surface of a capsule. The size of the capsules can range from nanometer size (about
100-900 nanometers in diameter) to micrometer size (about 10-900 microns in diameter).
Because of the unique ability of the eggs of some pests to resist certain pesticides, repeated applications of the Formula One, Two or Three may be désirable to control newly
Page 53 of 160 emerged larvae.
Systemic movement of pesticides in plants may be utilized to control pests on one portion of the plant by applying (for example by spraying an area) the Molécules of Formula One, Two or Three to a different portion of the plant. For example, control of foliar-feeding insects can be achieved by drip irrigation or furrow application, by treating the soil with for example pre- or post-planting soil drench, or by treating the seeds of a plant before planting.
Seed treatment can be applied to ail types of seeds, including those from which plants genetically modified to express specialized traits will germinate. Représentative examples include those expressing proteins toxic to invertebrate pests, such as Bacillus thuringiensis or other insecticidal toxins, those expressing herbicide résistance, such as “Roundup Ready seed, or those with “stacked” foreign genes expressing insecticidal toxins, herbicide résistance, nutrition-enhancement, drought résistance, or any other bénéficiai traits. Furthermore, such seed treatments with the Molécules of Formula One, Two or Three may further enhance the ability of a plant to better withstand stressful growing conditions. This results in a healthier, more vigorous plant, which can lead to higher yields at harvest time. Generally, about 1 gram of the Molécules of Formula One, Two or Three to about 500 grams per 100,000 seeds is expected to provide good benefits, amounts from about 10 grams to about 100 grams per 100,000 seeds îs expected to provide better benefits, and amounts from about 25 grams to about 75 grams per 100,000 seeds is expected to provide even better benefits.
It should be readily apparent that the Molécules of Formulas One, Two and Three may be used on, in, or around plants genetically modified to express specialized traits, such as Bacillus thuringiensis or other insecticidal toxins, or those expressing herbicide résistance, or those with “stacked” foreign genes expressing insecticidal toxins, herbicide résistance, nutritionenhancement, or any other bénéficiai traits.
The Molécules of Formulas One, Two and Three may be used for controliing endoparasites and ectoparasites in the veterinary medicine sector or in the field of non-human animal keeping. The Molécules of Formulas One, Two and Three are applied, such as by oral administration in the form of, for example, tablets, capsules, drinks, granules, by dermal application in the form of, for example, dipping, spraying, pouring on, spotting on, and dusting, and by parentéral administration in the form of, for example, an injection.
The Molécules of Formulas One, Two and Three may also be employed advantageously in livestock keeping, for example, cattle, sheep, pigs, chickens, and geese. They may also be employed advantageously in pets such as, horses, dogs, and cats. Particular pests to control would be fleas and ticks that are bothersome to such animais. Suitable formulations are administered orally to the animais with the drinking water or feed. The dosages and formulations that are suitable dépend on the species.
The Molécules of Formulas One, Two and Three may also be used for controliing parasitic worms, especially of the intestine, in the animais listed above.
Page 54 of 160
The Molécules of Formula One, Two, and Three may also be employed in therapeutic methods for human health care. Such methods include, but are limited to, oral administration in the form of, for example, tablets, capsules, drinks, granules, and by dermal application.
Pests around the world hâve been migrating to new environments (for such pest) and thereafter becoming a new invasive species in such new environment. The Molécules of Formula One and Two may also be used on such new invasive species to control them in such new environment.
The Molécules of Formula One, Two, and Three may also be used in an area where plants, such as crops, are growing (e.g. pre-planting, planting, pre-harvesting) and where there are low levels (even no actual presence) of pests that can commercially damage such plants. The use of such molécules in such area is to benefit the plants being grown in the area. Such benefits, may include, but are not limited to, improving the health of a plant, improving the yield of a plant (e.g. increased biomass and/or increased content of valuable ingrédients), improving the vigor of a plant (e.g. improved plant growth and/or greener leaves), improving the quality of a plant (e.g. improved content or composition of certain ingrédients), and improving the tolérance to abiotic and/or biotic stress of the plant.
Before a pesticide can be used or sold commercially, such pesticide undergoes lengthy évaluation processes by various governmental authorities (local, régional, state, national, and international). Voluminous data requirements are specified by regulatory authorities and must be addressed through data génération and submission by the product registrant or by a third party on the product registrant's behalf, often using a computer with a connection to the World Wide Web. These governmental authorities then review such data and if a détermination of safety is concluded, provide the potential user or seller with product registration approval. Thereafter, in that locality where the product registration is granted and supported, such user or seller may use or sell such pesticide.
A molécule according to Formula One, Two, and Three can be tested to détermine its efficacy against pests. Furthermore, mode of action studies can be conducted to détermine if said molécule has a different mode of action than other pesticides. Thereafter, such acquired data can be disseminated, such as by the internet, to third parties.
The headings in this document are for convenience only and must not be used to interpret any portion hereof.
TABLE SECTION
BAW & CEW Rating Table
% Control (or Mortality) Rating
Page 55 of 160
50-100 A
More than 0 - Less than 50 B
Not Tested C
No activity noticed in this bioassay D
GPA Rating Table
% Control (or Mortality) Rating
80-100 A
More than 0 - Less than 80 B
Not Tested C
No activity noticed in this bioassay D
Page 56 of 160
Table 1: Structures for Compounds
Page 57 of 160
Page 58 of 160
ID Structure
1-19 H e rpx
I-20 F rxT^8
1-21
I-22 h q
I-23 H Q rf y A«<y<TT yJ
I-24 FF il UN^^. F-X T B 'TTJ
I-25 F ' ’ γλ<~Ρ η °<Hi <AJ fA
I-26 zv^nV i HNA °O'U ^^Br
Page 59 of 160
ID Structure
I-27 H e ”x\»· O
I-28 A ΛΛ_ Νγθ^ °OnJi —oAJ
I-29 H e OO
I-30 V XX~N Ό
1-31 γ·-Λ'5 V LJ ™ N OO
Page 60 of 160
Table 2: Analytical Data for Compounds in Table 1.
ID Synthesis Method MS mp (°C) 1H NMR(D)1
1-4 A 551 (M+1) 209-211 (DMSO-d6) 12.06 (s, 1H), 10.19 (s, 1H), 9.42 (s. 1H), 8.22 (s, 1H), 8.17-8.03 (m, 5H), 7.66-7.57 (m, 4H), 7.42-7.38 (m, 2H)
1-5 C 511 (M+1) 220-225 (CDCI3) 9.30 (s, 1H), 8.69 (s, 1H), 8.60 (s, 1 H), 8.26 (d, J = 8.4 Hz, 2H), 7.89 (s, 1 H), 7.81 (m, 4H), 7.41 (d, J = 8.4 Hz, 2H), 7.19 (m, 3H), 2.35 (s, 6H)
1-6 C 555 (M+H) 206-209 (CDCI3) 8.90 (s, 1 H), 8.80 (s, 1 H), 8.6 (s, 1 H), 8.28 (d, J = 8.4 Hz, 2H), 8.9-8.7 (m, 4H), 7.4 (d, J = 8.6 Hz, 2H), 6.7 (s, 2H), 3.80 (s, 3H), 2.39 (s, 3H), 2.32 (s, 6H)
1-7 C 541 (M+H) 202-210 (CDCI3) 9.88 (s, 1 H), 8.61 (s, 1 H), 8.60 (s, 1 H), 8.27 (d, J = 8.4 Hz, 2H), 7.9 (s, 1 H), 7.9-7.7 (m, 4H), 7.4 (d, J = 8,6 Hz, 2H), 6.7 (s, 2H), 3.81 (s, 3H), 2.33 (s, 6H)
1-8 B 581 195-199 (CDCI3) 10.2 (s, 1H), 8.7 (s, 1H), 8.6 (s, 1H), 8.25 (d, J = 8.4 Hz, 2H), 8.0 (s, 1 H), 7.82 (m, 4H), 7.4 (d, J= 8.4 Hz, 2H), 7.0 (s, 2H), 3.82 (s, 3H)
1-9 C 591 (M+H) 233-236 (CDCI3) 9.89 (s, 1H), 8.60 (s, 2H), 8.25 (d, J = 8.5 Hz, 2H), 7.95 (s, 1H), 7.88-7.70 (m, 4H), 7.41 (d, J = 9.0 Hz, 2H), 6.70 (s, 2H), 3.81 (s, 3H), 2.31 (s, 6H)
1-10 C 525 (M+H) 230-240 (CDCI3) 9.93 (s, 1 H), 8.69 (s, 1 H), 8.60 (s, 1H), 8.26 (d, J= 8.4 Hz, 2H), 7.93 (d, J= 9.5 Hz, 2H), 7.95 (s, 1H), 7.86-7.75 (m, 4H), 6.69 (s, 2H), 3.81 (s, 3H), 2.31 (s, 6H)
Page 61 of 160
ID Synthesis Method MS mp (°C) Ή NMR (□)’
1-11 C 561 (M+H) 234—238 (CDCI3) 9.62 (s, 1 H), 8.70 (s, 1H), 8.60 (s, 1 H), 8.26 (d, J = 8.4 Hz, 2H), 7.92 (s, 1 H), 7.86-7.75 (m, 4H), 7.41 (d, J= 9.0 Hz, 2H), 7.18 (m, 3H), 2.35 (s, 6H)
1-12 C 577 (M+H) 197-200 (CDCIa) 10.2 (s, 1H), 8.90 (s, 1H), 8.62 (s, 1 H), 8.25 (d, J = 8.4 Hz, 2H), 7.98 (s, 1 H), 7.9-7.7 (m, 4H), 7.4 (m, 3H), 6.8 (m, 2H), 3.82 (s, 3H), 2.37 (s, 3H)
1-13 B 541 (M+H) 180-186 (CDCIs) 9.9 (s, 1 H), 8.6 (s, 1 H), 8.23 (d, J = 8.4 Hz, 2H), 7.9 (s, 1 H), 7.8 (d, J = 8.6 Hz, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.7 (d, J = 7 Hz, 1 H), 7.45-7.35 (m, 4H), 6.91 (d, J = 8 Hz, 2H), 5.73 (m, 1H), 3.80 (s, 3H), 1.65 (d, J = 7.2 Hz, 3H)
1-14 B 559 (M+H) 196-203 (CDCI3) 9.32 (s, 1 H), 8.6 (s, 1 H), 8.22 (d, J = 8.4 Hz, 2H), 7.85-7.7 (m, 5H), 7.6 (d, J = 6 Hz, 1 H), 7.4 (d, J = 8.5 Hz, 2H), 7.25-7.15 (m, 2H), 6.93 (m, 1H), 5.7 (m, 1H), 3.89 (s, 3H), 1.67 (d, J = 6Hz, 3H)
1-15 B 511 (M+H) 201-206 (CDCI3) 9.32 (s, 1 H), 8.61 (s, 1 H), 8.27 (d, J = 8.4 Hz, 2H), 7.9-7.7 (m, 6H), 7.5-7.3 (m, 7H), 5.76 (m, 1 H), 1.67 (d, J = 7 Hz, 3H)
1-16 C 525 (M+1) 218-225 (CDCIs) 9.37 (s, 1 H), 8.63 (s, 1H), 8.60 (s, 1 H), 8.26 (d, J = 8.4 Hz, 2H), 7.89 (s, 1 H), 7.85-7.76 (m, 4H), 7.41 (d, J = 8.4 Hz, 2H), 6.97 (s, 2H), 2.32 (s, 3H), 2.30 (s, 6H)
Page 62 of 160
ID Synthesis Method MS mp (°C) 1H NMR (O)1
1-17 C 525 (M+H) 168-180 (CDCI3) 10.2 (s, 1H), 9.07 (s, 1H), 8.63 (s, 1 H), 8.25 (d, J = 8.4 Hz, 2H), 8.0 (s, 1 H), 7.9-7.7 (m, 4H), 7.65 (d, J = 8 Hz, 1 H), 7.47.25 (m, 5H), 3.25 (heptet, J = 7 Hz, 1H), 1.35 (d, J = 7 Hz, 6H)
1-18 C 539 (M+1) 216-221 (CDCI3) δ 9.29 (s, 1H), 8.87 (s, 1H), 8.59 (s, 1H), 8.31 - 8.19 (m, 2H), 7.90 - 7.84 (m, 2H), 7.85 - 7.79 (m, 2H), 7.73 (dd, J = 7.5, 1.7 Hz, 1H), 7.39 (dd, J = 12.6, 5.1 Hz, 3H), 7.35 - 7.27 (m, 2H), 3.37 - 3.04 (m, 1H), 2.40 (s, 3H), 1.29 (d, J = 7.5 Hz, 6H)
1-19 C 509 (M+1) 223-225 (CDCI3) δ 9.74 (s, 1H), 9.06 (s, 1 H), 8.69 (s, 1 H), 8.31 - 8.20 (m, 2H), 7.98 - 7.84 (m, 3H), 7.80 (m, 4H), 7.65 (d, J = 1.4 Hz, 1 H), 7.43 - 7.28 (m, 3H), 3.19 (heptet, J = 6.9 Hz, 1H), 1.32 (d, J = 6.9 Hz,6H)
I-20 C 538 (M+H) 220 (dec) (CDCI3) δ 9.52 (s, 1H), 9.31 (s, 1H), 8.66 (d, J = 8.2 Hz, 1H), 8.60 (s, 1H), 8.25 (d, J = 8.4 Hz, 2H), 7.87 (s, 1H), 7.86 - 7.80 (m, 2H), 7.77 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 8.3 Hz, 2H), 7.32 (ddd, J = 13.9,z 7.2, 4.3 Hz, 1H), 7.24-7.15 (m, 2H), 6.27 (s, 1H), 2.03 (d, J = 1.3 Hz, 3H), 1.73 (d, J = 1.1 Hz, 3H)
1-21 C 540 (M+H) 207-210; 215-218 (CDCI3) δ 9.48 (s, 1H), 9.14 (s, 1H), 8.60 (s, 1H), 8.26 (d, J = 8.4 Hz, 2H), 7.92 (s, 1H), 7.87 (d, J = 7.7 Hz, 1 H), 7.84 - 7.76 (m, 4H), 7.40 (d, J = 8.3 Hz, 2H), 7.30 (dt, J = 8.2, 3.7 Hz, 1 H), 7.28 - 7.23 (m, 2H), 2.57 (d, J = 7.2 Hz, 2H), 1.93 (dq, J = 13.6, 6.7 Hz, 1 H), 0.98 (d, J = 6.6 Hz, 6H)
Page 63 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
I-22 C 540 (M+H) 210-215 (CDCI3) δ 9.46 (s, 1H), 9.05 (s, 1H), 8.60 (s, 1 H), 8.26 (d, J = 8.4 Hz, 2H), 7.91 (s, 1 H), 7.84 - 7.74 (m, 4H), 7.69 (d, J = 7.4 Hz, 1 H), 7.40 (d, J = 8.3 Hz, 2H), 7.36 - 7.27 (m, 3H), 2.91 (dt, J= 13.9, 6.9 Hz, 1H), 1.75-1.58 (m, 2H), 1.30 (d, J = 6.9 Hz, 3H), 0.92 (t, J = 7.4 Hz, 3H).
I-23 C 560 (M+H) 213-216 (CDCI3) δ 9.41 (s, 1H), 9.01 (s, 1H), 8.74 (d, J = 7.7 Hz, 1H), 8.60 (s, 1H), 8.15 (d, J =8.4 Hz, 2H), 7.86 - 7.78 (m, 2H), 7.69 (s, 1H), 7.57 - 7.44 (m, 6H), 7.42 (d, J = 9.1 Hz, 2H), 7.37 - 7.27 (m, 4H).
I-24 C 524 (M+H) 200-206; 210-211 (CDCh) δ 9.65 (d, J = 17.9 Hz, 1H), 9.20 (s, 1 H), 8.60 (s, 1 H), 8.27 (dd, J = 8.0, 4.5 Hz, 3H), 7.89 (s, 1H), 7.86 - 7.75 (m, 4H), 7.41 (d, J = 8.3 Hz, 2H), 7.30 - 7.27 (m, 1 H), 7.18 (q, J = 7.8 Hz, 2H), 2.00 -1.90 (m, 1 H), 1.09 -1.01 (m,2H), 0.81-0.73 (m, 2H).
I-25 C 550 (M+H) 221-223 (DMSO-de) δ 12.13 (s, 1H), 10.07 (s, 1H), 9.44 (s, 1H), 8.23 (s, 1H), 8.16 (d, J= 8.4 Hz, 2H), 8.13 - 8.06 (m, 2H), 8.01 - 7.98 (m, 3H), 7.63 (d, J - 8.4 Hz, 2H), 7.38 - 7.26 (m, 3H), 7.23 (t, Jhf=74.1 Hz, 1H)
I-26 c 590 (M+H) 230- 231 (CDCI3) δ 9.37 (s, 1H), 8.60 (s, 1H), 8.57 (s, 1 H), 8.27 (d, J = 8.4 Hz, 2H), 7.90 (s, 1 H), 7.81 (dt, J= 8.5, 4.8 Hz, 4H), 7.41 (d, J= 8.3 Hz, 2H), 7.31 (s, 2H), 2.31 (s, 6H)
Page 64 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
I-27 C 556 (M+H) 190-192 (CDCI3) δ 9.39 (s, 1H), 9.15 (s, 1H), 8.61 (s, 1 H), 8.29 (d, J = 8.4 Hz, 2H), 8.16 - 8.05 (m, 2H), 7.95 - 7.85 (m, 3H), 7.85 - 7.76 (m, 4H), 7.41 (d, J = 8.3 Hz, 2H), 4.39 (q, J = 7.1 Hz, 2H), 1.41 (t, J= 7.1 Hz, 3H)
I-28 C 528 (M+H) 219-221 (300 MHz, CDCI3) δ 10.17 (s, 1H), 9.09 (s, 1H), 9.03 (t, J= 5.4 Hz, 1H), 8.60 (s, 1H), 8.23 (t, J = 8.9 Hz, 2H), 7.89 - 7.76 (m, 5H), 7.39 (t, J = 7.2 Hz, 2H), 7.17 - 7.07 (m, 1 H), 7.03 (d, J = 7.8 Hz, 1 H), 6.94 (d, J = 6.9 Hz, 1 H), 4.18 (q, J = 7.1 Hz, 2H), 1.61 (t, J = 7.0 Hz, 3H)
I-29 C 499 (M+1) 195-200 (DMSO-de) δ 9.44 (s, 1H), 8.49 (s, 1H), 8.42 (d, J = 5.2 Hz, 1H), 8.29 - 8.21 (m, 2H), 8.16 (d, J = 8.5 Hz, 2H), 8.10 (d, J = 2.3 Hz, 1 H), 8.08 (d, J = 3.0 Hz, 1H), 8.04 (t, J = 6.5 Hz, 2H), 7.63 (d, J = 8.3 Hz, 3H), 2.29 (s, 3H).
I-30 C 499 (M+1) 114-118 (CDCI3) δ 8.60 (s, 1H), 8.31 (s, 1H), 8.24 (d, J = 8.4 Hz, 2H), 8.16 (d, J = 3.9 Hz, 1 H), 7.95 (d, J = 8.4 Hz, 2H), 7.82 (d, J = 9.0 Hz, 2H), 7.55 (d, J = 6.7 Hz, 1H), 7.41 (s, 2H), 6.99 (dd, J = 7.4, 5.1 Hz, 1H), 2.35 (s, 3H).
1-31 C 513 (M+1) 122-125 (CDCI3) δ 8.60 (s, 1H), 8.32 (s, 1 H), 8.25 (d, J = 8.4 Hz, 2H), 8.19 - 8.16 (m, 1H), 7.97 (d, J = 8.4 Hz, 2H), 7.84 - 7.81 (m, 2H), 7.58 (d, J = 7.5 Hz, 1 H), 7.40 (d, J = 8.3 Hz, 2H), 7.03 (dd, J = 7.5, 5.1 Hz. 1H), 2.67 (s, 2H), 1.35 (t, J = 7.5 Hz, 3H).
NMR spectral data were acquired using a 400 MHz instrument.
Page 65 of 160
Table 3: Structures for Compounds
ID Structure
1C
2C Cl
3C '--scl'Y fPf Cl
4C ζη-χ Λ-N Br\
5C ymv, Rr n
6C OH p<xçtpvs ΤΊ FFf
7C 7-N tV Ρ'Ό'^+ρι Λ Ύ] FF F
8C 17 F
Page 66 of 160
ID Structure
9C χγ /*N
10C -η FFf
11C p<y y-.
12C 0<y v^XX JΝ-γχ s YX FF F
13C 0 oJVnI 0 Va V ”ΑΧ%ιγ
14C N-S ,Χ> ΓΆ CJ1 /νχ
15C o VvVx9
16C VXXçÇ
Page 67 of 160
Page 68 of 160
Page 69 of 160
Page 70 of 160
ID Structure
40C
41C °Ÿ~ _y-x o_-s V/ ZN\ Z=\ m \
420 o— /-N °^SSn\
43C
44C °Z~> _£j° ZN\ /==\ M \ Aû··^
45C ,h>’ 2do F F 1
Page7l of I60
ID Structure
46C oV- F F I
47C /=N HOp
48C HO-γθ ’P’PfS Vv°x F/p k^k^N.NXNÀyJ
49C S/OO ho “/2! Ύ v.
50C vO-X- “T ÎV ïX-A.xp'0'
51C AçF X^^n-n^nX|J
52C O- Λ—\ /^N ΗΟ-γ^θ pOnnS> Ts P fff kXx^N-NXNA,
53C F 0- r-χ /*N HO-γ0 y-i ?onnVi x P FFF PPx^N-nXn'P
Page 72 of 160
Page 73 of 160
ID Structure
61C Ύθ f'O’Vy'i \ V>.
62C CF3CO2H (Y θ FFF
63C cf3co2h h2n λΟλαΛ 7 y» f F F VA^.N.N AN EJ)
64C CFîC°2Î2fO p-onX>
65C cf3co2h hn^ /=»Ν Χ^Ν-γ° pY=/νν*Υ> ΥΎΟχ
66C cf3co2h / \ N 1 n ζτ~χ Λ=Ν ΝΎ Φ^Ν“\χύ,\)
67C CF3 C°2H ΗΝχ f-», /-N \__,Ν'Υ pOnn V. \ V>]
Page 74 of 160
Page 75 of 160
Page 76 of 160
ID Structure
83C
84C °γ-\ n„ ΓΎν'νχ ? fxf ps CI
85C 'm n.xyw ΛN^Q
86C Λ V>VF^
87C n ΓΤνΌ
88C v^X rN ν'Τ'ι fXo-C'NnàO-n'n
89C O F rN ÇNŸ~) F
90C rN
Page 77 of 160
ID Structure
91C 0 /-N SYNO
92C H° £ /=N syNT3 ρΛΛ>Νν^>ν'ν
93C P Cl z=n sy ΫΛ
94C /-N ®YN l) F/oO'Nn^>N'N
95C /-n W)
96C
97C H° k /=n syY3
98C
99C :^Ax.-iS5
Page 78 of I60
ID Structure
100C p p M-M
101C
102C FyF ΓΆ Cl °Α_Λ Mp, M'A MM-n c| AJ
103C FF D -v/ yNv\ mxA- χ;
104C RF __ P 'M>M JA <Xn-n XJ
105C '^ΑΜλ
106C p\-zyNX f* J Μ» M
107C -μ. μ ί
108C AM M° M M-M
109C sO a V MA, LMn-n C1AJ
Page 79 of 160
ID Structure
110C ο^θ- F F /θ syNrS Ap-'·' aj
111c
112C
113C
114C A /-x-n'7. h° i -Υχχ Ά
115C Χο-ΖΎΙ A \Χ»-Γτχ
116C
117C ’Wâ
118C Χ.ΓΧ/ f~C | Τχ.Χ'ό
119C
120C
Page 80 of I60
ID Structure
121C
122C
123C sXA AAn-n
124C
125C r F Λ~~\ m \AyN-N >-p~
126C F. 7 r\ - x>0 O F
127C ΟΛ_/ N-X% syNvA LA^n-n
128C
129C NYn VnyS AA^N-nC|AJ
130C FXF .J-V>rï W’ Fl o<> Tx.AÔ
Page8l of I60
ID Structure
131C Κ/Υ’ΠΙ sH° /
132C :χ·^ΝΛχ..ίΗ
133C
134C
135C
136C s-N r M^n-n
137C \
138C \
139C
140C
141C
Page 82 of 160
ID Structure
142C
143C
144C Υχγ çN 9 Ux^N-N
145C K<y<ïixY
146C
147C
148C
149C
150C
151C Y>X> ÇkY YA^n-n
152C F FY /^N .— o^F
Page 83 of 160
ID Structure
153C F
154C
155C
156C
157C
1580 :χζ^ΥχΥό
1590
1600 Ρ<XVnY r< ο<> ~·\χ»κΐ
1610 Χχχ-Κ çK
1620 I
1630
Page 84 of 160
ID Structure
164C
165C
166C ÇÎA
167C fXF JXnH r-C~ Cl
168C
169C X ryN-ï H YF
170C F
171C Χ-ΖΛ-ν'^Ϊ J-/ f
172C çÇl LA^n-n AAo
173C N\x«»y ύ
Page 85 of 160
ID Structure
174C
175C
176C
177C
178C
179C
180C Q
181C Qv i<A^N-N )=k H-
182C q φχΝ-Νν/
183C
Page 86 of 160
ID Structure
184C 'ΟΟΧΧγ sQ M
185C
186C
187C 'Χ“Ο<Υ1 Q XM-'· )—( Cl \J
188C ρχζ _τγΝΎ ο Λβ Ln « F<7
189C ïxl v'VhTi <r\ N ΤΊ M F VAn-n )=/ FAJ
190C
191C TX-'-y-
192C AXO Q OAn-n 5=Z H-
Page 87 ofl60
ID Structure
193C
194C O M; W
195C Q
196C ~ Yl-A ci~O
197C
198C '^Ax-.R, O
199C ^-OvA. O f lXN-AyAF
200C
201C
Page 88 of 160
ID Structure
202C och3
203C Br
204C rN J0CHî γΛΌ'ΚνΛΌ-ν'ν
205C G ΚΟ*θΥζ)
206C N G h3co
207C G CO2Et
208C
209C
210C
Page 89 of 160
ID Structure
211C Vy-x Q.
212C “YxXy-
213C FyF Λ=Ν ΧΧ.γ, X Ï^N-N U/
214C N ΤΊ H oy χ/χ- Mf F
215C ° Of//'
216C q-oVf M^N-N F
217C FVF zr-\ /®®>Ν /—\
218C
219C Y.X^Sx.i’y χθ
Page 90 of 160
ID Structure
220C
221C /=N S /— F '<Χ>Αχ.'·γο <F
222C
223C
224C Γνγ
225C Tyo
226C
227C Xr°
228C ,-N ÇrX ^A>NnXXN'NcX
229C r y*o p /=N Sy-N PX-F F, Cr^O-”- Ô
230C ÇFk'
Page 91 of 160
ID Structure
231C 0-
232C Çfk
233C F /=N SV-N
234C ίΛΤ° c.
235C
236C
237C
238C
239C
Table 4: Analytical Data for Compounds in Table 3
ID Synthesis Method MS mp (°C) 1H NMR(C)1
Page 92 of 160
ID Synthesis Method MS mp(°C) ’H NMR(D)1
1C D 540 (M+) - (DMSO-t/e) 8.61 (s, 1H), 8.48 (s, 1H), 8.22 (d, J = 8.24 Hz, 2H), 8.17 (s, 1 H), 7.89 (d, J = 8.24 Hz, 2H), 7.80 (d, J = 8.28 Hz, 2H), 7.41 (d, J = 8.28 Hz, 2H), 7.19 (d, J - 8.24 Hz, 2H), 6.71 (d, J = 8.24 Hz, 2H), 2.99 (s, 6H), 2.42 (s, 3H)
2C D 580 (M+) 168-171 (DMSO-d6) 9.42 (s, 1H), 8.18-8.03 (m, 5H), 7.78-7.69 (m, 2H), 7.61 (d, J = 8.26 Hz, 2H), 7.44 (d, J = 8.24 Hz, 2H), 7.18 (m, 1H), 3.09-2.99 (m, 2H), 1.39-1.32 (m, 3H)
3C D 594 180-182 (DMSO-cfe) 9.42 (s, 1H), 8.18-8.04 (m, 5H), 7.78-7.69 (m, 2H), 7.61 (d, J = 8.26 Hz, 2H), 7.48 (d, J = 8.24 Hz, 2H), 7.19 (m, 1 H), 3.06-3.02 (m, 2H), 1.78-1.64 (m, 2H), 1.040.96 (m, 3H)
4C D 629 (M+) (DMSO-de) 8.57 (s, 1H), 8.48 (d, J= 5.5 Hz, 1 H), 8.22 (d, J = 8.2 Hz, 2H), 7.91-7.75 (m, 5H), 7.38 (d, J = 8.7 Hz, 2H), 7.22-7.07 (m, 3H), 6.50-6.19 (m, 2H), 3.85 (d, J = 7.2 Hz, 1 H), 3.75-3.64 (m, 1 H), 2.33 (s, 6H)
50 E 636 (M+) (300 MHz, CDCI3) 8.56 (s, 1H), 8.54 (s, 1H), 8.23 (d, J = 8.3 Hz. 2H), 7.89 (d, J = 8.2 Hz, 3H), 7.79 (d, J = 9.0 Hz, 2H), 7.38 (d, J = 8.7 Hz, 2H), 7.23-7.00 (m, 4H), 6.88-6.74 (m, 2H), 4.44 (s, 2H), 2.33 (s, 6H)
6C D 645 (M+H) 196-198 (methanol-d4) 9.16 (s, 1H), 8.46 (s, 1H), 8.21 (d, J= 8.3 Hz, 2H), 8.03 (m, 6H), 7.52 (d, J = 8.3 Hz, 4H), 7.28 - 6.91 (m, 3H), 4.39 (s, 2H), 2.08 (s, 6H)
Page 93 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
7C E 636 (M+) (300 MHz, CDCI3) 8.56 (m, 2H), 8.23 (d. J = 8.3 Hz, 2H), 7.88 (d, J= 8.3 Hz, 3H), 7.79 (d, J = 9.0 Hz, 2H), 7.55-7.42 (m, 1 H), 7.37 (d, J= 9.0 Hz. 2H), 7.20-7.01 (m, 3H), 6.89- 6.68 (m, 2H), 4.30 (s, 2H), 2.28 (s, 6H)
8C E 684 (M+) (CDCI3) 8.57 (s, 1 H), 8.52 (s, 1 H), 8.24 (d, J = 8.3 Hz, 2H), 7.91-7.84 (m, 3H), 7.80 (d, J = 9.1 Hz, 2H), 7.39 (d, J= 8.6 Hz, 4H), 7.18-7.03 (m, 5H), 4.32 (s, 2H), 2.29 (s, 6H)
9C E 620 (M+) (CDCI3) 8.57 (s, 1 H). 8.47 (s, 1 H), 8.23 (d, J = 8.3 Hz, 2H), 7.87 (d, J= 8.3 Hz, 2H), 7.80 (m, 3H), 7.39 (d, J = 8.4 Hz, 2H), 7.21-7.10 (m, 3H), 3.93 (s, 2H), 2.35 (s, 6H), 0.13 (s, 9H)
10C D 600 (M+) (DMSO-d6) 8.57 (s, 1H), 8.54 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.89 (d, J = 8.3 Hz, 2H), 7.87 (s, 1 H), 7.80 (d, J = 9.0 Hz, 2H), 7.447.32 (m, 4H), 7.31-7.19 (m, 3H), 7.19-7.00 (m, 3H), 4.34 (s, 2H), 2.31 (s, 6H)
11C D 618 (M+) (DMSO-de) 8.57 (s, 1H), 8.55 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.89 (d, J ~ 8.3 Hz, 2H), 7.86 (s, 1H), 7.83-7.73 (m, 2H), 7.48 (td, J = 7.6, 1.7 Hz, 1 H), 7.38 (d, J = 8.5 Hz, 2H), 7.23-6.91 (m, 6H), 4.39 (s, 2H), 2.30 (s, 6H)
12C D 658 (M+) (DMSO-ds) 8.57 (s, 1H), 8.51 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.94 (d, J = 8.3 Hz, 2H), 7.88 (d, J = 8.2 Hz, 2H), 7.86 (s, 1H), 7.79 (d, J = 9.0 Hz, 2H), 7.44 (d, J = 8.3 Hz, 2H), 7.38 (d, J= 8.6 Hz, 2H), 7.20-7.05 (m, 3H), 4.35 (s, 2H), 3.88 (s, 3H), 2.28 (s, 6H)
Page 94 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
13C E 679 (M+) (DMSO-de) 8.59 (s, 1H), 8.51 (s, 1H), 8.23 (d, J= 8.3 Hz, 2H), 7.93-7.76 (m, 7H), 7.53 (d, J = 8.2 Hz, 2H), 7.39 (d, J = 8.7 Hz, 2H), 7.20-7.06 (m, 3H), 4.88 (s, 2H), 4.36 (s, 2H), 2.28 (s, 6H)
14C E 658 (M+) (CDCI3) 8.57 (s, 1 H), 8.52 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.91-7.85 (m, 4H), 7.80 (d, J = 9.1 Hz, 2H), 7.73 (d, J = 6.8 Hz, 1H), 7.52 (dd, J = 8.8, 6.9 Hz, 1 H), 7.39 (d, J = 9.0 Hz, 2H), 7.13-7.01 (m, 3H), 4.88 (s, 2H), 2.27 (s, 6H)
15C E 667 (M+) (CDCI3) 8.57 (s, 1H), 8.25-8.14 (m, 3H), 7.94-7.66 (m, 7H), 7.52-7.35 (m, 6H), 7.16- 7.03 (m, 3H), 4.54 (s, 2H), 2.32 (s, 6H)
16C E 658 (M+) (CDCI3) 8.57 (s, 1H), 8.49 (s, 1H), 8.24 (d, J = 8.4 Hz, 2H), 7.88 (d, J= 8.3 Hz, 2H), 7.83-7.77 (m, 3H), 7.39 (d, J = 8.3 Hz, 2H), 7.19-7.07 (m, 3H), 6.69-6.65 (m, 1H), 6.396.35 (m, 1 H), 4.36 (s, 2H), 2.29 (s, 6H)
17C E 678 (M+) (CDCI3) 8.58 (s, 1H), 8.50 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.94-7.74 (m, 7H), 7.59 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 7.20-7.04 (m, 3H), 4.37 (s, 2H), 3.01 (s, 3H), 2.29 (s, 6H)
18C E 773 (M+) (CDCI3) 8.59 (s, 1H), 8.46 (s, 1H), 8.22 (d, J = 8.4 Hz, 2H), 7.86 (d, J= 8.4 Hz, 2H), 7.83-7.75 (m, 3H), 7.63 (d, J= 8.4 Hz, 2H), 7.44 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 7.17-7.05 (m, 3H), 7.03-6.98 (m, 3H), 6.89 (t, J = 8.6 Hz, 2H), 4.30 (s, 2H), 2.24 (s, 6H)
Page 95 of 160
ID Synthesis Method MS mp (°C) 1H NMR (D)1
19C E 728 (M+) (CDCI3) 8.59 (s, 2H), 8.26 (d, J = 8.3 Hz, 2H), 7.93 (d, J = 8.3 Hz, 2H), 7.89 (s, 1H), 7.82 (d, J = 9.1 Hz, 2H), 7.40 (d, J = 8.3 Hz, 2H), 7.20-7.05 (m, 3H), 6.86 (s, 1H), 4.49 (s, 2H), 3.98 (s, 3H), 2.31 (s, 6H)
20C E 681 (M+) (CDCI3) 8.58 (s, 1H), 8.38 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.86 (d, J= 8.3 Hz, 3H), 7.81 (d, J= 9.1 Hz, 2H), 7.67-7.63 (m, 2H), 7.467.36 (m, 5H), 7.18-7.05 (m, 3H), 4.24 (s, 2H), 2.47 (s, 3H), 2.29 (s, 6H)
21C E 596 (M+) (DMSO-de) 8.58 (s, 1 H), 8.15 (d, J = 8.4 Hz. 2H), 7.80 (d, J = 9.0 Hz, 2H), 7.47-7.35 (m, 4H), 7.21-6.93 (m, 5H), 3.68 (t, J = 5.4 Hz, 2H), 3.35 (s, 3H), 2.65 (t, J= 6.2 Hz, 2H), 2.29 (s, 6H)
22C E 626 (M+) (DMSO-d6) 8.59 (s, 1H), 8.52 (s, 1H), 8.23 (d, J= 8.3 Hz, 2H), 7.95-7.75 (m, 5H), 7.39 (d, J= 8.4 Hz, 2H), 7.21-7.06 (m, 3H), 5.80 (s, 2H), 4.12 (s, 2H), 3.69-3.50 (m, 2H), 2.31 (s,6H), 1.35-1.11 (m, 3H)
23C E 731 (M+) (DMSO-de) 8.58 (s, 1H), 8.50 (s, 1H), 8.22 (d, J= 8.2 Hz, 2H), 7.93-7.70 (m, 5H), 7.457.28 (m, 8H), 7.23-7.03 (m, 3H), 5.79 (s, 2H), 5.38-5.27 (m, 1H), 5.11 (s, 2H), 4.073.98 (m, 2H), 2.30 (s, 6H)
24C E 626 (M+) (DMSO-d6) 8.58 (s, 1H), 8.51 (s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.93-7.73 (m, 5H), 7.39 (d, J = 8.9 Hz, 2H), 7.21-7.07 (m, 3H), 5.76 (s, 2H), 5.05-4.70 (m, 1H), 2.32 (s, 6H), 1.38-1.17 (m, 6H)
Page 96 of 160
ID Synthesis Method MS mp (°C) 1H NMR (O)1
25C E 610 (M+) (DMSO-de) 8.59 (s, 1H), 8.52 (s, 1H), 8.23 (d, J= 8.3 Hz, 2H), 7.91-7.79 (m, 5H), 7.40 (d, J= 8.5 Hz, 2H), 7.18-7.06 (m, 3H), 5.73 (s, 2H), 2.70-2.45 (m, 1H), 2.32 (s, 6H), 1.15 (s, 6H)
26C E 654 (M+) (DMSO-cfe) 8.58 (s, 1 H), 8.21 (d, J = 8.4 Hz, 2H), 7.98 (d, J = 8.4 Hz, 2H), 7.81 (d, J = 6.9 Hz, 2H), 7.69 (s, 1H), 7.40 (d, J = 8.8 Hz, 2H), 6.63 (s, 2H), 5.73 (s, 2H), 3.80 (s, 3H), 2.64-2.53 (m, 1H), 2.58 (s, 3H), 2.28 (s,6H), 1.17 (d, J= 7.0 Hz, 6H)
27C E 640 (M+) (DMSO-d6) 8.58 (s, 1 H). 8.50 (s, 1 H). 8.23 (d. J = 8.2 Hz, 2H), 7.88 (d, J = 8.3 Hz, 2H), 7.81 (d, J = 9.0 Hz, 2H), 7.74 (s, 1 H), 7.39 (d, J = 8.6 Hz, 2H), 6.63 (s, 2H), 5.71 (s. 2H), 3.79 (s, 3H), 2.74-2.43 (m, 1H), 2.27 (s, 6H), 1.16 (d, J =7.0 Hz, 6H)
28C E 761 (M+) (300 MHz, CDCI3) 8.58 (s, 1H), 8.48 (s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.87 (d, J = 8.4 Hz, 2H), 7.80 (d, J = 9.0 Hz, 2H), 7.74 (s, 1H), 7.45-7.28 (m, 7H), 6.63 (s, 2H), 5.78 (s, 2H), 5.29 (m, 1 H), 5.12 (s, 2H), 4.03 (d, J = 5.6 Hz, 2H), 3.79 (s, 3H), 2.27 (s, 6H)
29C E 656 (M+) (300 MHz, CDCI3) 8.58 (s, 1H), 8.49 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.87 (d, J = 8.4 Hz, 2H), 7.81 (d, J = 9.0 Hz, 2H), 7.72 (s, 1 H), 7.40 (d, J = 8.7 Hz, 2H), 6.63 (s, 2H), 5.78 (s, 2H), 4.11 (s, 2H), 3.80 (s, 3H), 3.59 (q, J = 7.0 Hz, 2H), 2.27 (s, 6H), 1.24 (t, J = 7.1 Hz, 3H)
Page 97 of 160
ID Synthesis Method MS mp(°C) 1H NMR(D)1
30C E 697 (M+) (300 MHz, CDCI3) 8.60 (s, 1H), 8.50 (s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.88 (d, J = 8.2 Hz, 2H), 7.82 (s, 1 H), 7.80 (d, J = 9.0 Hz, 2H), 7.38 (d, J= 8.8 Hz, 3H), 7.23-7.02 (m. 3H), 5.78 (s, 2H), 3.96 (s, 2H), 2.31 (s, 6H), 1.44 (s, 9H)
31C E 582 (M+) (300 MHz, CDCI3) 8.58 (s, 1 H), 8.52 (s, 1H), 8.23 (d, J= 8.3 Hz, 2H), 7.88 (m, 3H), 7.80 (d, J = 9.0 Hz, 2H), 7.38 (d, J = 8.6 Hz, 2H), 7.14 (m, 3H), 5.72 (s, 2H), 2.32 (s, 6H), 2.09 (s, 3H)
32C E 697 (M+) (CDCI3) (Mixture of atropisomers) [8.61 (s), 8.58 (s), 8.56 (s), 8.51 (s), 8.37 (d, J = 8.3 Hz), 8.23 (d, J = 8.4 Hz), 8.21-8.14 (m), 8.00 (d, J = 8.4 Hz), 7.89 (d, J = 8.2 Hz), 7.84-7.77 (m), 7.45-7.35 (m); 11 H], 6.94 (s, 2H), [5.87 (s), 5.80 (s); 2H], [4.12 (s), 4.11 (s); 2H], 3.83 (s, 3H), 3.69-3.44 (m, 2H), 1.38-1.10 (m, 3H)
33C E 697 (M+) (CDCI3) 8.57 (s, 1H), 8.51 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.88 (d, J = 8.4 Hz, 2H), 7.83-7.77 (m, 3H), 7.39 (d, J= 8.4 Hz, 2H), 6.94 (s, 2H), 5.76 (s, 2H), 4.96-4.77 (m, 1H), 3.82 (s, 3H), 1.30 (d, J = 6.3 Hz, 6H)
34C E 681 (M+) (CDCI3) 8.57 (s, 1 H), 8.51 (s, 1 H), 8.23 (d, J = 8.3 Hz, 2H), 7.92-7.76 (m, 5H), 7.39 (d, J = 8.4 Hz, 2H), 6.93 (s, 2H), 5.73 (s, 2H), 3.82 (s, 3H), 2.59 (m, 1H), 1.17 (d, J =7.0 Hz, 6H)
Page 98 of 160
ID Synthesis Method MS mp (°C) 1H NMR(Ü)1
35C E 636 (M+) (CDCIg) 8.57 (s, 1 H), 8.50 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.92-7.73 (m, 5H), 7.38 (d, J = 8.3 Hz, 2H), 7.20-6.92 (m, 3H), 5.72 (s, 2H), 2.94-2.63 (m, 1H). 2.31 (s, 6H), 2.021.38 (m, 8H)
36C E 624 (M+) (CDCls) 8.56 (s, 1H), 8.49 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.87 (d, J= 8.3 Hz, 2H), 7.84 (s, 1 H), 7.79 (d, J = 9.0 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 7.19-7.05 (m, 3H), 5.71 (s, 2H), 2.31 (s, 6H), 1.20 (s, 9H)
37C E 691 (M+H) (CDCI3) 8.59 (s, 1H), 8.50 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.93-7.77 (m, 4H), 7.72 (s, 1 H), 7.40 (d, J = 9.0 Hz, 2H), 6.63 (s, 2H), 5.71 (s, 2H), 3.80 (s, 3H), 2.68-2.48 (m, 1H), 2.28 (s, 6H), 1.16 (d, J= 7.0 Hz, 6H)
38C E 724 (M+) (CDCI3) 8.58 (s, 1H), 8.47 (s, 1H), 8.23 (d, J - 8.3 Hz, 2H), 7.87 (d. J = 8.3 Hz, 2H), 7.81 (d, J = 9.1 Hz, 2H), 7.71 (s, 1H), 7.39 (d, J = 9.0 Hz, 2H), 6.64 (s, 2H), 5.76 (dd, J= 37.3, 11.0 Hz, 2H), 4.19 (q, J = 6.9 Hz, 1H), 4.143.97 (m, 1H), 3.80 (s, 3H), 3.79-3.68 (m, 1 H), 2.27 (s, 6H), 1.47 (d, J = 6.9 Hz, 3H)
39C E 694 (M+) (CDCI3) 8.58 (s, 1H), 8.48 (s, 1 H), 8.24 (d, J = 8.3 Hz, 2H), 7.87 (d, J= 8.3 Hz, 2H), 7.83 (s, 1H), 7.81 (d, J = 9.1 Hz, 2H), 7.39 (d, J = 8.3 Hz, 2H), 7.23-6.99 (m, 3H), 5.77 (dd, J = 36.4, 11.0 Hz, 2H), 4.19 (q, J= 6.9 Hz, 1H), 4.14-3.97 (m, 1H), 3.84-3.65 (m, 1H), 2.31 (s, 6H), 1.47 (d, J = 6.9 Hz, 3H)
Page 99 of 160
ID Synthesis Method MS mp (°C) 1H NMR (D)1
40C E 654 (M+) (CDCI3) 8.57 (s, 1H), 8.48 (s, 1H), 8.23 (d, J ~ 8.3 Hz, 2H), 7.87 (d, J = 8.3 Hz, 2H), 7.80 (d, J = 9.0 Hz, 2H), 7.72 (s, 1 H), 7.38 (d, J = 8.4 Hz, 2H), 6.62 (s, 2H), 5.70 (s, 2H), 3.79 (s, 3H), 2.27 (s, 6H), 1.20 (s. 9H)
41C E 670 (M+) (CDCI3) 8.58 (s, 1 H). 8.49 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.87 (d, J = 8.3 Hz. 2H), 7.84 (s, 1 H), 7.80 (d, J = 9.0 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 7.23-6.96 (m, 3H), 5.77 (dd, J = 27.4, 10.9 Hz, 2H), 4.07 (q, J ~ 6.9 Hz, 1 H), 3.78-3.70 (m, 1H), 3.66-3.39 (m, 3H), 3.35 (s, 3H), 2.31 (s,6H), 1.42 (d, J =6.9 Hz, 3H)
42C E 700 (M+) (CDCI3) 8.58 (s, 1H), 8.48 (s, 1 H), 8.23 (d, J = 8.4 Hz, 2H), 7.87 (d, J= 8.3 Hz, 2H), 7.80 (d, J= 9.1 Hz, 2H), 7.71 (s, 1H), 7.39 (d, J = 8.3 Hz, 2H), 6.63 (s, 2H), 5.76 (dd, J= 27.8, 10.9 Hz, 2H), 4.07 (q, J= 6.9 Hz, 1H), 3.79 (s, 3H), 3.79-3.70 (m, 1 H), 3.63-3.45 (m, 3H), 3.35 (s, 3H), 2.27 (s, 6H), 1.42 (d, J = 6.9 Hz, 3H)
43C E 666 (M+) (CDCI3) 8.57 (s, 1H), 8.49 (s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.87 (d, J= 8.3 Hz, 2H), 7.79 (d, J = 9.1 Hz, 2H), 7.74 (s, 1H), 7.38 (d, J = 8.3 Hz, 2H), 6.62 (s, 2H), 5.71 (s, 2H), 3.79 (s, 3H), 2.85-2.65 (m, 1 H), 2.27 (s, 6H), 1,98-1.51 (m, 8H)
Page ÎOO of 160
ID Synthesis Method MS mp(°C) ’H NMR (Π)1
44C E 668 (M+) (CDCI3) 8.59 (s, 1 H), 8.55 (s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.87 (d, J= 8.3 Hz, 2H), 7.84-7.74 (m, 3H), 7.38 (d, J = 8.4 Hz, 2H), 6.63 (s, 2H), 5.85-5.73 (m, 2H), 4.54-4.47 (m, 1H), 4.03 (dd, J= 14.7, 6.9 Hz, 1H), 3.91 (dd, J = 13.8, 7.4 Hz, 1 H), 3.79 (s, 3H), 2.27 (s, 6H), 2.09-1.83 (m, 4H)
45C E 746 (M+H) 132-137 (CDCI3) 8.68 (s, 1 H), 8.49 (s, 1 H), 8.24 (d, J = 8.3 Hz, 2H), 7.93 (d, J = 8.4 Hz, 2H), 7.88 (d, J= 8.3 Hz, 2H), 7.81 (d. J = 8.5 Hz, 2H), 7.73 (s, 1H), 7.35 (s, 5H), 6.64 (s, 2H), 5.78 (s, 2H), 5.24 (s, 1 H), 5.12 (s, 2H), 4.04 (d, J = 5.5 Hz, 2H), 3.80 (s, 3H), 2.28 (s, 6H)
46C E 624 108-113 (CDCI3) 8.68 (s, 1 H), 8.50 (s, 1H), 8.24 (d, J = 8.3 Hz, 2H), 7.98-7.69 (m, 7H), 6.63 (s, 2H), 5.71 (s, 2H), 3.80 (s, 3H), 2.59 (heptet, J = 7.0 Hz, 1 H), 2.29 (d, J = 6.9 Hz, 6H), 1.16 (d, J = 7.0 Hz, 6H)
47C E 149-151 (acetone-cfe) 9.20 (s, 1H), 8.52 (s, 1H), 8.40 - 8.21 (m, 2H), 8.21 - 8.01 (m, 4H), 7.61 (d, J = 8.3 Hz, 2H), 7.32 - 6.94 (m, 3H), 3.83 (S, 2H), 2.34 (s, 6H)
48C E 599 (M+H) 128-137 (acetone-d6) 9.18 (s, 1H), 8.83 (s, 1H), 8.67 - 7.82 (m, 8H), 7.60 (d, J = 8.4 Hz, 2H), 6.78 (s, 2H), 3.99 - 3.72 (m, 3H), 2.41 2.20 (m, 6H)
49C E 619 (M+H) 177-185 (methanoK) 9.23 (s, 1H), 8.62 (s, 1H), 8.29 (m, 2H), 8.17 - 7.98 (m, 4H), 7.60 7.45 (m, 2H), 7.41 - 7.19 (m, 3H), 4.22 (s, 2H), 2.34 (s, 6H)
Page ΙΟΙ of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
50C E 635 (M+H) 193-196 (methanol-d4) 9.23 (s, 1H), 8.57 (s, 1H), 8.28 (m, 3H), 8.09 - 7.98 (m,4H), 7.50 (m, 4H), 4.19 - 4.11 (m, 2H), 3.85 (s, 3H), 2.36 (s, 3H)
51C E 649 (M+H) 176-179 (methanol-d4) 9.23 (s, 1H), 8.60 (s, 1H), 8.30 (m, 2H), 8.14 - 8.00 (m, 4H), 7.52 (m, 2H), 6.81 (s, 2H), 4.22 (s, 2H), 3.84 - 3.81 (m, 3H), 2.33 (s, 6H)
52C E 599 (M+H) 168-178 (methanol-d4) 9.21 (s, 1H), 8.44 (s, 1H), 8.27 (d, J = 8.1 Hz, 2H), 8.09 - 7.98 (m, 4H), 7.52 (d, J = 8.3 Hz, 2H), 7.40 (d, J = 8.7 Hz, 2H), 6.97 (d, J = 8.8 Hz, 2H), 5.40 (s, 1H), 4.37 - 4.13 (m, 2H), 3.79 (s, 3H), 1.79 (m, 3H)
53C E 617 (M+H) 168-170 (methanol-d4) 9.21 (s, 1H), 8.44 (m, 1H), 8.28 (d, J = 8.2 Hz, 2H), 8.11 - 7.99 (m, 4H), 7.52 (d, J - 8.4 Hz, 2H), 7.25 (m, 2H), 7.14 (t, J = 8.5 Hz, 1H), 5.42 (m, 1H), 4.25 (m, 2H), 3.88 (s, 3H), 1.75 (m, 3H)
54C E 569 (M+H) 167-170 (methanol-d4) 9.23 (s, 1H), 8.46 (s, 1H), 8.27 (m, 2H), 8.05 (m, 4H), 7.57 - 7.39 (m, 7H), 5.41 (m. 1H), 4.24 (m, 2H), 1.79 (m, 3H)
55C E 624 (M+H) 90-97 (methanol-d4) 9.12 (s, 1H), 8.46 (s, 1H), 8.14 (m, 2H), 7.99 (m, 3H), 7.78 (s, 1 H), 7.49 (d, J= 8.5 Hz, 2H), 7.12 (m, 3H), 3.69 (s, 2H), 3.22 - 2.80 (m, 2H), 2.25 (s, 6H), 2.03 (s,2H), 1.93-1.66 (m, 1H), 0.92 (m, J = 9.7 Hz, 6H)
ID Synthesis Method MS mp(°C) 1H NMR(D)1
56C E 765 (M+H) 148-151 (methanol-d4) 9.18 (s, 1 H), 8.59 (s, 1H), 8.30 (d, J = 8.1 Hz, 2H), 8.12 (m, 2H), 8.07 - 8.00 (m, 2H), 7.58 - 7.43 (m, 2H), 7.33 (dd, J = 8.6, 6.5 Hz, 1 H), 7.25 (d, J = 7.6 Hz, 2H), 4.02 (m, 2H), 3.97 - 3.75 (m, 2H), 3.21 (d, J= 6.9 Hz, 2H), 2.90 (m, 1H), 2.59 (m, 1 H), 2.35 (s, 6H), 1.84 (m, 2H), 1.78 1.63 (m, 2H), 1.44 (s, 9H), 1.29 (m, 3H)
57C E 737 (M+H) 151-153 (methanol-d4) 9.20 (s, 1H), 8.65 (s, 1H), 8.30 (m, 2H). 8.21 - 7.96 (m, 4H), 7.53 (d, J = 8.4 Hz, 2H), 7.35 (dd, J = 8.5, 6.5 Hz, 1 H), 7.28 (d, J = 7.5 Hz, 2H), 4.44 (s, 2H), 3.91 - 3.40 (m, 9H), 2.38 (s, 6H), 1.50 (s, 9H)
58C E 725 (M+H) 125-127 (methanol-d4) 9.18 (s, 1H), 8.61 (s, 1H), 8.31 (m, 2H), 8.14 (m. 2H), 8.06 (d, J = 9.0 Hz, 2H), 7.53 (d, J= 8.5 Hz, 2H), 7.32 (dt, J = 26.0, 7.0 Hz, 3H), 4.02 (s, 2H), 3.383.34 (m, 2H), 3.22 - 3.03 (m, 2H), 2.37 (s, 6H), 1.74 (m, 2H), 1.45 (s, 9H)
59C E 755 (M+H) 147-149 (methanol-d4) 9.18 (s, 1H), 8.62 (s, 1H), 8.38 - 7.97 (m, 6H), 7.51 (d, J = 8.4 Hz, 2H), 7.32 (dd, J= 8.5, 6.6 Hz, 1H), 7.25 (d, J = 7.6 Hz, 2H), 4.40 (s, 1H), 4.06 (m, 2H), 3.91 - 3.74 (m, 2H), 3.56 - 3.41 (m, 1 H), 2.36 (s, 6H), 1.44 (s, 9H)
60C E 755 (M+H) 136-139 (methanol-d4) 9.16 (s, 1H), 8.58 (s, 1H), 8.28 (d, J = 7.4 Hz, 2H), 8.16-7.76 (m, 4H), 7.52 (p, J = 8.8 Hz, 2H), 6.83 (m, 2H), 4.04 (d, J = 8.5 Hz, 2H), 3.90-3.73 (m, 3H), 3.55- 3.37 (m, 2H), 3.14-2.75 (m, 3H), 2.30 (s, 6H), 1.99-1.80 (m, 2H), 1.43-1.31 (m, 2H)
Page 103 of 160
ID Synthesis Method MS mp(°C) ’H NMR(D)1
61C E 738 (M+H) 70-79 dec (methanol-d4) 9.12 (s, 1H), 8.12 - 8.07 (m, 2H), 8.02 - 7.96 (m, 2H), 7.55 - 7.50 (m, 2H), 7.50 - 7.45 (m, 2H), 7.43 (d, J = 7.7 Hz, 1H), 7.31 (d, J = 7.6 Hz, 2H), 4.03 (s, 2H), 3.25 (dt, J = 15.5, 7.0 Hz, 4H), 2.84 (s, 3H), 2.04 (s, 6H), 1.81 - 1.66 (m, 2H), 1.44 (s, 9H)
62C K 665 (M+H) 110-120 (methanol-d4) 6 9.18 (s, 1H), 8.56 (m, 1H), 8.26 (m, 2H), 8.16 - 7.84 (m, 4H), 7.52 (m, 2H), 7.27 (m. 1H), 7.22 (m, 2H), 4.00 (s, 2H), 3.28 (m, 3H), 3.06 - 2.83 (m, 1 H), 2.75 (t, J = 12.2 Hz, 1H), 2.34 (s, 6H), 2.21 - 1.83 (m, 4H), 1.72 (m, 1H), 1.47 - 1.19 (m, 2H)
63C K 655 (M+H) 98-110 (methanol-d4) 9.18 (s, 1H), 8.63 (s, 1H), 8.28 (m, 2H), 8.13 - 7.97 (m, 4H), 7.51 (d, J = 8.3 Hz, 2H), 7.31 (dd, J= 8.5, 6.5 Hz, 1 H), 7.24 (d. J = 7.6 Hz, 2H), 4.32 - 4.07 (m, 3H), 3.98 - 3.81 (m, 1H), 3.72 (s, 1H), 2.35 (s, 6H)
64C K 655 (M+H) 83-112 (methanol-d4) 9.19 (s, 1H), 8.58 (s, 1H), 8.28 (m, 2H), 8.14 - 7.97 (m, 4H), 7.51 (m, 2H), 6.78 (s, 2H), 4.00 (m, 2H), 3.81 (s, 3H), 3.10 - 2.93 (m, 4H), 2.30 (s, 6H), 1.91 (m, 2H)
65C K 667 (M+H) 128 dec (methanol-d4) 9.20 (s, 1H), 8.65 (s, 1H), 8.27 (m 2H), 8.11 - 7.99 (m, 4H), 7.52 (d, J = 8.3 Hz, 2H), 6.78 (s, 2H), 4.40 (s, 2H), 3.87 (m, 4H), 3.53 (s, 3H), 2.32 (s, 6H), 1.33 (m,4H)
Page I04of 160
ID Synthesis Method MS mp(°C) 1H NMR (D)1
66C K 625 (M+H) 100-105 (methanol-^) 9.20 (s, 1H), 8.56 (s, 1H), 8.27 (m, 2H), 8.12 - 7.99 (m, 3H), 7.53 (d, J = 8.4 Hz, 2H), 7.24 (m, 4H), 3.99 (s, 2H), 3.42 (m, 2H), 3.05 (m, 2H), 2.36 (s, 6H), 1.99-1.88 (m, 2H)
67C K 636 (M+H) 237-240 dec (methanol-cQ 9.20 (s, 1H), 8.74 (s, 1H), 8.33 - 8.25 (m, 2H), 8.12 - 7.98 (m, 4H), 7.53 (d, J = 8.3 Hz, 2H), 7.33 (dd, J = 8.5, 6.4 Hz, 1 H), 7.26 (d, J = 7.5 Hz, 2H), 4.55 (s, 2H), 3.92 (m, 4H), 3.37 (m, 2H), 3.31 (m, 2H), 2.38 (s, 6H)
69C F 581 (M+H) 188-190 (CDCI3) 8.56 (s, 1H), 8.33 (s, 1H), 8.22 (d, J = 8.1 Hz, 2H), 7.90 - 7.70 (m, 4H), 7.39 (d, J = 8.7 Hz, 2H), 6.72 (s, 2H), 4.01 (s, 2H), 3.87-3.73 (s, 3H), 2.18 (s, 6H)
70C F 592 (M+) 134-138 (CDCI3) 8.65 (s, 1H), 8.31 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.83 (m, 4H), 7.50 (d, J = 8.1 Hz, 2H), 7.45 - 7.38 (m, 3H), 4.05 (s, 2H)
71C F 551 (M+H) 104-111 (CDCI3) 8.62 (s, 1H), 8.32 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.88 - 7.74 (m, 4H), 7.40 (d, J = 8.3 Hz, 2H), 7.34 - 7.26 (m, 1 H), 7.20 (d, J = 7.5 Hz, 2H), 4.02 (s, 2H), 2.22 (s, 6H)
72C F 565 (M+H) 118-121 (CDCI3) 8.58 (s, 1H), 8.33 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.81 (m, 4H), 7.40 (d, J = 8.3 Hz. 2H), 7.01 (d, J = 0.4 Hz, 2H), 4.01 (s, 2H), 2.34 (s, 3H), 2.17 (s, 6H)
Page 105 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
73C F 565 (M+H) 145-150 (CDCb) 8.58 (s, 1H), 8.30 (s, 1H), 8.23 (d, J = 8.3 Hz, 1 H), 7.81 (m, 2H), 7.49 (d, J ~ 4,0 Hz, 1 H), 7.40 (d, J = 8.4 Hz, 1 H), 7.34 (s, 1H), 7.18 (d, J= 7.8 Hz, 1H), 4.01 (d, J = 1.4 Hz, 1H), 2.83 (heptet, J = 6.8 Hz, 1H), 1.23 (t, J = 6.6 Hz, 3H).
74C G 682 (M+H) 190-193 (methanol-cM 9.20 (s, 1H), 8.38 (s, 1H), 8.31 - 8.24 (m, 2H), 8.08 - 8.00 (m, 2H), 7.95 - 7.88 (m, 2H), 7.55 - 7.48 (m, 3H), 7.48 - 7.36 (m, 5H), 7.31 (d, J = 7.7 Hz, 2H), 3.60 (q, J= 7.2 Hz, 4H), 2.20 (s, 6H), 1.07 (t, J =7.2 Hz, 6H);
75C G 617 (M+) (CDCI3) 8.56 (s, 1 H), 8.23 (s, 1H), 8.19 (d, J = 8.4 Hz, 2H), 7.84-7.73 (m, 5H), 7.41-7.33 (m, 3H), 7.21 (d, J = 7.2 Hz, 2H), 7.16 (s, 1H), 7.12 (d, J = 3.2 Hz, 1 H), 2.20 (s, 6H).
76C G 711 (M+) (CDCI3) 8.56 (s, 1H), 8.25 (s, 1H), 8.20 (d, J = 8.4 Hz, 2H), 7.80 (dd, J = 8.7, 5.6 Hz, 4H), 7.48-7.34 (m, 8H), 7.26 (d, J = 7.7 Hz, 2H), 7.08 (s, 1H), 2.20 (s, 6H)
77C G 655 (M+H) 261-263 (methanol-d4) 9.14 (s, 1H), 8.21 -8.13(m, 3H), 8.06 - 7.99 (m, 2H), 7.86 - 7.75 (m, 4H), 7.50 (d, J = 8.3 Hz, 2H), 7.28 - 7.18 (m, 3H), 7.14 (d, J= 7.9 Hz, 2H), 6.72 (s, 1H), 0.09--0.09 (m, 6H)
78C G 694 (M+H) (CDCI3) 8.55 (s, 1H), 8.22 (s, 1H), 8.18 (d, J = 8.3 Hz, 2H), 7.79 (dd, J = 8.7, 5.1 Hz, 4H), 7.37 (d, J= 9.0 Hz, 2H), 7.23-6.94 (m, 7H), 6.26 (s, 1H), 2.17 (s, 6H)
Page 106 of 160
ID Synthesis Method MS mp(°C) 1H NMR (D)1
79C G 678 (M+H) (CDCIa) 8.55 (s, 1H), 8.23 (s, 1H), 8.19 (d, J = 8.3 Hz, 2H), 7.79 (d, J = 8.7 Hz, 4H), 7.43 (d, J = 8.3 Hz, 2H), 7.37 (d, J = 8.9 Hz, 2H), 7.23-7.16 (m, 3H), 7.08 (d, J = 7.4 Hz, 2H), 6.35 (s, 1H), 2.18 (s, 6H)
80C G 609 (M+H) 215-219 (methanol-c/4) 9.23 (s, 1H), 8.40 (s, 1H), 8.26 (m, 2H), 8.22 (s, 1H), 8.07 - 8.00 (m, 3H), 7.91 (d, J = 8.4 Hz, 2H), 7.51 (d, J = 8.3 Hz, 2H), 6.90 (s, 1 H), 3.88 (s, 3H), 2.13 (s, 6H)
81C I 551 (M+H) 209-213 (CDCI3) 9.42 (s, 1H), 8.59 (s, 1H), 8.28 (d, J = 8.4 Hz, 2H), 8.01 (d, J= 8.3 Hz, 2H), 7.80 - 7.77 (m, 2H), 7.43 - 7.34 (m, 2H), 7,07 (d, J = 7.5 Hz, 2H), 6.98 (dd, J = 8.2, 6.7 Hz, 1H), 3.90 (s, 2H), 2.17 (s, 6H)
82C I 565 (M+H) 225-232 (CDCI3) 9.46 (s, 1H), 8.60 (s, 1H), 8.29 (d, J = 8.4 Hz, 2H), 8.02 (d, J = 8.4 Hz, 2H), 7.89 - 7.76 (m, 2H), 7.40 (d, J = 8.3 Hz, 2H), 6.88 (s, 2H), 3.90 (s, 2H), 2.28 (s, 3H), 2.13 (s, 6H).
83C I 581 (M+H) 211-215 (CDCI3) 9.44 (s, 1 H), 8.60 (s, 1 H), 8.30 (d, J = 8.4 Hz, 2H), 8.02 (d, J= 8.4 Hz, 2H), 7.82 (d, J = 9.1 Hz, 2H), 7.40 (d, J = 8.3 Hz, 2H), 6.63 (s, 2H). 3.90 (s, 2H), 3.78 (s, 3H), 2.15 (s, 6H)
84C I 591 250 dec (CDCI3) 9.42 (s, 1H), 8.40 (s, 1 H), 8.18 (d, J = 8.24 Hz, 2H), 8.07 (d, J = 8.28 Hz, 2H), 7.89 (d, J = 8.24 Hz, 2H), 7.76 (d, J = 8.28 Hz, 2H), 7.64-7.58 (m, 3H), 4.42 (s, 2H)
Page 107 of 160
ID Synthesis Method MS mp(°C) 1H NMR(D)1
85C I 551 (M+H) 146-149 (CDCIs) δ 9.36 (s, 1H), 8.60 (s. 1H), 8.30 (d, J ~ 8.4 Hz, 2H), 8.01 (d, J = 8.4 Hz, 2H), 7.86 - 7.77 (m, 2H), 7.40 (d, J = 8.3 Hz, 2H), 7.32 (dd, J = 6.9, 2.3 Hz, 1 H), 7.24 7.12 (m, 2H), 6.91 (dd, J = 7.1, 2.0 Hz, 1H), 3.93 (s, 2H), 3.15-2.97 (m, 1H), 1.21 (d, J = 6.9 Hz, 6H)
86C J 566 (M+H) 163-169 (CDCIs) δ 8.81 (bs, 1 H), 8.57 (s, 1H), 8.20 (d, J = 8.3 Hz, 2H), 7.87 - 7.75 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.32 - 7.25 (m, 1 H), 7.10 (2dt, J = 7.4, 1.5 Hz, 2H), 6.83 (d, J = 6.5 Hz, 1H), 3.96 (t, J = 6.1 Hz, 2H), 3.13 (heptet, J = 6.9 Hz, 1H), 2.99 - 2.88 (m, 2H), 2.49 - 2.36 (m, 2H), 1.29 -1.21 (m, 6H).
87C J 550 (M+H) 187-189 (CDCIg) δ 8.81 (s, 1H), 8.66 (s, 1H), 8.21 (d, J = 8.3 Hz, 2H), 7.92 (d, J - 8.4 Hz, 2H), 7.81 (t, J = 10.2 Hz, 4H), 7.30 - 7.26 (m, 2H), 7.17 - 7.04 (m, 1H), 6.83 (d, J = 6.4 Hz, 1H), 3.96 (t, J = 6.1 Hz, 2H), 3.13 (heptet, J = 6.9 Hz, 1H), 2.97 - 2.90 (m, 2H), 2.47 - 2.38 (m, 2H), 1.25 (d, J= 7.5 Hz, 6H).
88C F 579.2 (M+H) 178-182 (CDCI3) δ 8.58 (s, 1H), 8.30 (s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.82 (dd, J = 8.7, 7.2 Hz, 4H), 7.48 (dd, J = 4.1, 1.3 Hz, 2H), 7.40 (d, J =8.3 Hz, 2H), 7.37-7.30 (m, 1H), 7.17 (m, 1H), 4.23 (dq, J= 14.5, 7.2 Hz, 1H), 2.83 (dd, J = 14.6,6.9 Hz, 1H), 1.79 (d, J = 7.2Hz, 3H), 1.22 (ddd, J= 12.1, 6.9,1.9 Hz, 6H).
Page 108 of 160
ID Synthesis Method MS mp(°C) 1H NMR(D)1
89C F 559 (M+H) 205-206 (CDCI3) δ 8.58 (s, 1H), 8.32 (s, 1 H). 8.23 (d, J = 8.4 Hz, 2H), 7.90 - 7.75 (m, 4H), 7.52 7.44 (m, 1H), 7.40 (d, J = 8.3 Hz, 2H), 7.10 (dd, J = 8.6, 7.4 Hz, 2H), 4.04 (s, 2H).
90C F 566 (M+H) 148-151 (CDCI3) δ 8.58 (s, 1 H). 8.31 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.82 (t, J = 8.5 Hz, 4H), 7.46 - 7.31 (m, 3H), 7.25 - 7.18 (m, 2H), 4.02 (s, 2H), 2.53 (q, J = 7.6 Hz, 2H), 2.21 (s, 3H), 1.26-1.16 (m, 3H).
91C F 554 (M+H) 227-235 (CDCI3) δ 8.58 (s, 1H), 8.36 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.88 - 7.76 (m, 4H), 7.49 7.35 (m, 3H), 7.01 (dd, J = 8.5, 2.5 Hz, 1 H), 6.96 (dd, J= 7.8,1.0 Hz, 1H), 6.91 (t, J = 2.2 Hz, 1H), 3.98 (s, 2H), 3.85 (s, 3H).
92C F 554 (M+H) 104-108 (CDCI3) δ 8.58 (s, 1H), 8.32 (s, 1H), 8.22 (d, J = 8.4 Hz, 2H), 7.86 - 7.77 (m, 4H), 7.50 7.43 (m, 1H), 7.40 (d, J = 8.3 Hz, 2H), 7.32 - 7.27 (m, 1H), 7.14 - 7.04 (m, 2H), 4.01 (d, J =17.2 Hz, 1H), 3.94 (d, J= 17.3 Hz, 1H), 3.84 (s, 3H).
93C F 572 (M+H) 183-186 (CDCI3) δ 8.58 (s, 1H), 8.31 (s, 1H), 8.27 - 8.18 (m, 2H), 7.88 - 7.77 (m, 4H), 7.43 - 7.37 (m, 3H), 7.34 (t, J= 7.8 Hz, 1H), 7.30 - 7.26 (m, 1H), 4.07 (d, J =17.4 Hz, 1H), 4.00 (d, J= 17.4 Hz, 1H), 2.29 (s, 3H).
94C F 552 (M+H) 134-136 (CDCI3) δ 8.58 (s, 1H), 8.31 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.86 - 7.78 (m, 4H), 7.49 7.32 (m, 5H), 7.24 - 7.18 (m, 1 H), 4.06 3.94 (m, 2H), 2.56 (q, J = 7.6 Hz, 2H), 1.26 -1,18 (m, 3H).
Page 109 of 160
ID Synthesis Method MS mp (°C) 1H NMR (D)1
95C F 576.1 (M+H) 195-201 (CDCI3) δ 8.59 (d, J= 4.8 Hz, 1H), 8.26 (m, 3H), 7.89 - 7.74 (m, 4H), 7.52 - 7.31 (m, 4H), 7.24-7.13 (m, 1H), 4.05 (d, J =0.9 Hz, 2H).
96C F 600 (M+H) 182-185 (300 MHz, CDCI3) δ 8.58 (s, 1H), 8.33 (d, J = 7.9 Hz, 1H), 8.24 (s, 1H), 8.21 (s, 1H), 7.86 - 7.76 (m, 4H), 7.53 (t, J = 5.9 Hz, 3H), 7.44 - 7.29 (m, 8H), 3.80 - 3,73 (m, 1 H), 3.59-3.51 (m, 1H).
97C F 567 (M+H) 234-236 (CDCI3) δ 8.57 (s, 1H), 8.37 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.89 - 7.73 (m, 4H), 7.45 7.29 (m, 3H), 6.79 (dd, J = 8.2, 2.2 Hz, 1 H), 6.70 (d, 1 H), 6.57 (s, 1H), 3.96 (s, 2H), 2.98 (s, 6H)
98C F 612 (M+H) 225-226 (CDCI3) δ 8.55 (s, 1H), 8.29 (s, 1H), 8.21 (d, J = 8.4 Hz, 2H), 7.86 - 7.71 (m, 4H), 7.42 7.23 (m, 3H), 6.63 (d, J = 8.5 Hz, 2H), 4.07 (q, J = 7.0 Hz, 4H), 3.94 (s, 2H), 1.31 (t, J = 7.0 Hz, 6H)
99C F 679 (ΜΗ) 230-231 (CDCI3) δ 8.58 (s, 1 H), 8.32 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.89 - 7.77 (m, 4H), 7.70 (d, J = 8.1 Hz, 2H), 7.40 (d, J = 8.3 Hz, 2H), 7.29-7.20 (m, 1H), 4.04 (s. 2H)
100C F 602 (M+H) 118-120 (CDCI3) δ 8.58 (s, 1H), 8.30 (s, 1 H), 8.22 (d, J = 8.4 Hz, 2H), 7.93 - 7.70 (m, 4H), 7.39 (d, J = 9.0 Hz, 2H), 7.28 (t, 1 H), 7.19 (d, J = 7.7 Hz, 2H), 4.01 (s, 2H), 2.21 (s, 6H).
Page l ΙΟ of 160
ID Synthesis Method MS mp (°C) 1H NMR(Ü)1
101C F 583 (M+H) 106-107 (CDCh) δ 8.60 (s, 1 H), 8.32 (s, 1H), 8.23 (d, J ~ 8.4 Hz, 2H), 7.89 - 7.74 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 6.56 (s, 1H), 4.01 (s, 2H), 3.94 (s, 3H), 2.32 (s, 3H), 2.16 (s, 3H)
102C F 589 (ΜΗ) 123-126 (CDCI3) δ 8.27 (s, 1H), 7.95 - 7.71 (m, 5H), 7.60 (d, J = 1.3 Hz, 1 H), 7.53 - 7.43 (m, 4H), 7.45 - 7.32 (m, 3H), 4.04 (s, 2H)
103C F 551 (M+H) 194-196 (CDCI3) δ 8.28 (s, 1H), 7.93 (dd, J= 5.4, 4.1 Hz, 3H), 7.78 (m, 4H), 7.36 - 7.23 (m, 3H), 7.19 (d, J = 7.6 Hz, 2H), 6.81 (d, J = 2.5 Hz, 1 H), 4.00 (s, 2H), 2.21 (s, 6H)
104C F 551 (M+H) 100-102 (CDCI3) δ 8.27 (s, 1 H), 8.16 (s, 1 H), 8.03 (s, 1 H), 7.80 - 7.71 (m, 4H), 7.57 (d, J = 8.3 Hz, 2H), 7.30 (dd, J = 28.7, 5.8 Hz, 3H), 7.19 (d, J = 7.6 Hz, 2H), 4.01 (s, 2H), 2.21 (s,6H)
105C F 586 (M+H) 209-211 (CDCI3) δ 8.58 (s, 1 H), 8.31 (s, 1H), 8.23 (d, J = 7.8 Hz. 2H), 7.82 (m, 4H), 7.39 (d, J = 8.0 Hz, 2H), 7.19 (s, 2H), 4.01 (s, 2H), 2.19 (s, 6H)
106C F 558 (M+H) 180-182 (CDCh) δ 8.58 (s, 1 H), 8.30 (s, 1H), 8.22 (d, J = 8.2 Hz, 2H), 7.81 (m, 4H), 7.58 (dd, J = 6.0, 3.3 Hz, 1 H), 7.43 (ddd, J = 23.4, 11.3, 5.5 Hz, 5H), 4.02 (dd, J= 29.9,17.4 Hz, 2H)
107C F 596 (M+H) 227-232 (CDCI3) δ 8.58 (s, 1H), 8.32 (s, 1H), 8.22 (dd, J = 10.0, 8.6 Hz, 4H), 7.82 (m, 4H), 7.49 (d, J = 8.5 Hz, 2H), 7.40 (d, J = 8.6 Hz, 2H), 4.42 (q, J = 7.1 Hz, 2H), 4.00 (s, 2H), 1.41 (t, J = 7.1 Hz, 3H)
Page 111 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
108C F 580 (M+H) 167-171 (CDCI3) δ 8.58 (s, 1 H), 8.28 (d, J = 15.0 Hz, 1 H), 8.23 (d, J = 8.3 Hz, 2H), 7.87 - 7.76 (m, 4H), 7.53 - 7.30 (m, 5H), 7.18 (ddd, J = 7.8, 4.2, 1.2 Hz, 1H), 4.03 - 3.98 (m, 2H), 2.53 (dd, J = 14.1,7.0 Hz, 1H), 1.77-1.56 (m, 2H), 1.26 - 1.16 (m, 3H), 0.78 (td, J = 7.4, 2.3 Hz, 3H).
109C F 652 (M+H) 105-111 (CDCI3) δ 8.25 (s, 1H), 7.73 (d, J= 7.4 Hz, 4H), 7.55 - 7.43 (m, 2H), 7.43 - 7.36 (m, 1 H), 7.10 (t, J = 11.6 Hz, 4H), 4.90 - 4.79 (m, 1 H). 4.04 (s, 2H), 3.76 (s, 3H), 3.73 3.62 (m, 1 H), 3.52-3.35 (m, 1H)
110C F 611 (M+H) Oil (CDCI3) δ 8.25 (s, 1H), 7.82 - 7.64 (m, 4H), 7.30 (t, 1H), 7.22 - 6.99 (m, 6H), 4.83 (dd, J = 12.8, 6.5 Hz, 1H), 4.00 (s, 2H), 3.89 - 3.59 (m, 4H), 3.44 (dd, J = 17.2, 6.5 Hz, 1H), 2.20 (s, 6H).
me F 580 (M+H) 209-210 (CDCI3) δ 8.58 (s, 1H), 8.30 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.86 - 7.77 (m, 4H), 7.39 (t, J = 7.8 Hz, 3H), 7.34 - 7.27 (m, 1H), 7.20 (d, J = 7.4 Hz, 1H), 4.03 (s, 2H), 2.86 - 2.71 (m, 1H), 2.21 (s, 3H), 1.21 (2d, J = 6.7 Hz, 6H).
112C F 564 (M+H) 154-158 (CDCI3) δ 8.58 (s, 1H), 8.32 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.87 - 7.75 (m, 4H), 7.43 7.33 (m, 4H), 7.26 - 7.19 (m, 2H), 4.02 (s, 2H), 1.86 - 1.77 (m, 1 H), 0.90 - 0.83 (m, 2H), 0.77 - 0.68 (m, 1H), 0.67 - 0.59 (m, 1H).
Page 112 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
113C F 538 (M+H) 111-116; 210-212 (Acetone-D6) δ 9.20 (s, 1H), 8.28 (d, J = 8.2 Hz, 3H), 8.13 (d, J = 9.0 Hz, 2H), 7.94 (d, J = 8.2 Hz, 2H), 7.60 (d, J = 8.8 Hz, 2H), 7.39 (t, J= 17.1 Hz, 4H), 4.15 (q, J = 17.3 Hz, 2H), 2.23 (s, 3H)
114C F 568 (M+H) 203-205 (CDCI3) δ 8.58 (s, 1H), 8.33 (s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.88 - 7.67 (m, 4H), 7.38 (d, J= 8.4 Hz, 2H), 7.14 (d, J = 8.3 Hz, 1H), 6.87 (d, J= 8.9 Hz, 2H), 3.98 (s, 2H), 3.83 (s, 3H), 2.20 (s, 3H)
115C F 554 (M+H) 261-264 (CDCI3) δ 8.58 (s, 1H), 8.35 (s, 1H), 8.23 (d, J = 8.2 Hz, 2H), 7.82 (m, 4H), 7.40 (d, J 8.6 Hz, 2H), 7.30 (d, 2H), 7.03 (d, J = 8.8 Hz, 2H), 3.97 (s, 2H), 3.86 (s, 3H)
116C F 568 (M+H) 92-97 (CDCI3) δ 8,58 (s, 1H), 8.31 (s, 1 H), 8.22 (d, J = 8.3 Hz, 2H), 7.88 - 7.72 (m, 4H), 7.48 7.32 (m, 3H), 7.31 -7.20 (m, 1H), 7.13 — 6.97 (m, 2H), 4.09 (q, J = 7.0 Hz, 2H), 3.95 (t, J = 11.7 Hz, 2H), 1.33 (t, J = 7.0 Hz, 3H).
117C F 539 (M+H) 127-132 (CDCI3) δ 8.59 (s, 1H), 8.54 (dd, J = 4.8, 1.3 Hz, 1 H), 8.28 (s, 1 H), 8.22 (d, J = 8.4 Hz, 2H), 7.84 - 7.77 (m, 4H), 7.77 - 7.72 (m, 1H), 7.38 (dd, J= 7.7, 5.0 Hz, 3H), 4.02 (d, J= 1.2 Hz, 2H), 2.30 (s, 3H)
118C F 539 (M+H) 215 (dec) (CDCI3) δ 8.67 (s, 1H), 8.59 (s, 1H), 8.24 (d, J = 8.4 Hz, 2H), 7.99 (d, J = 8.4 Hz, 1H), 7.84 (dd, J = 8.3, 3.8 Hz, 4H), 7.80 (s, 1H), 7.42 - 7.39 (m, 3H), 4.03 (d, J = 1.3 Hz, 2H), 2.26 (s, 3H).
Page 113 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
119C F 580 (M+H) 124-138 (CDCI3) δ 8.58 (s, 1H), 8.29 (s, 1H), 8.23 (d, J ~ 8.4 Hz, 2H), 7.88 - 7.77 (m, 4H), 7.48 7.34 (m, 5H), 7.23 - 7.18 (m, 1H), 4.06 3.93 (m, 2H), 2.40 (qd, J = 14.2, 7.3 Hz, 2H), 1.94-1.81 (m, 1H), 0.89 (d, J=6.6 Hz, 6H).
120C F 549.7 (M+H) 153-159 (CDCI3) δ 8.67 (s, 1H), 8.30 (s, 1 H), 8.24 (d, J = 8.3 Hz, 2H), 7.92 (d, J = 8.5 Hz, 2H), 7.82 (m, 3H), 4.01 (d, J = 1.5 Hz, 2H), 3.80 - 3.64 (m, 2H), 2.91 - 2.76 (m, 2H), 1.30 1.14 (m, 6H)
121C F 578 (M+H) 143-147; 148-151 (CDCI3) δ 8.57 (d, J = 7.4 Hz, 1 H), 8.30 (s, 1 H), 8.23 (d, J = 8.4 Hz, 2H), 7.87 - 7.78 (m, 4H), 7.49 - 7.33 (m, 5H), 7.29 - 7.26 (m, 1 H), 6.03 (s, 1 H), 3.95 (s, 2H), 1.84 (d, J = 1.3 Hz, 3H), 1.71 (d, J= 1.2 Hz, 3H).
122C F 579.3 (M+1) 169-171 (CDCI3) δ 8.58 (s, 1H), 8.24 - 8.18 (m, 2H), 7.99- 7.94 (m, 2H), 7.84 - 7.78 (m, 2H), 7.47 (dd, J = 5.0, 1.1 Hz, 2H),7.40 (d, J = 8.3 Hz, 2H), 7.34 (ddd, J = 7.9, 5.1,3.7 Hz, 1 H). 7.18 (d, J = 7.6 Hz, 1 H), 4.00 (d, J = 1.5 Hz, 2H), 3.72 (dd, J= 7.0, 5.1Hz, 2H), 2.94 - 2.80 (m, 1 H), 2.22 (s, 3H), 1.23 (m, 9H).
123C F 553 (M+H) 130-135 (CDCI3) δ 8.62 (s, 1 H), 8.54 (d, J = 3.2 Hz, 1 H), 8.28 - 8.19 (m, 3H), 7.82 (d, J = 8.8 Hz, 5H), 7.43 - 7.37 (m, 3H), 4.02 (s, 2H), 2.63 (d, J = 7.6 Hz, 2H), 1.22 (s, 3H)
Page 114 of 160
ID Synthesîs Method MS mp (°C) 1H NMR (D)1
124C F 608 (M+H) 140-145 (CDCI3) δ 8.58 (s, 1H), 8.29 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.89 - 7.75 (m, 4H), 7.58 7.51 (m, 1 H), 7.49 - 7.36 (m, 5H), 4.04 (d, J = 17.4 Hz, 1 H), 3.97 (d, J = 17.4 Hz, 1 H).
125C F 580 (M+H) 130-140 (CDCI3) δ 8.58 (s, 1H), 8.31 (s, 1H), 8.22 (d, J = 8.4 Hz, 2H), 7.86 - 7.78 (m, 4H), 7.65 (dd, J = 8.1,1.4 Hz, 1H), 7.49-7.42 (m, 1 H), 7.40 (d, J = 8.3 Hz, 2H), 7.35 (dt, J = 7.6, 1.5 Hz, 1 H), 7.05 (dd, J = 7.8, 1.5 Hz, 1H), 3.95 (s, 2H), 1.38 (s, 9H).
126C F 590 (M+H) 175-177 (CDCI3) δ 8.58 (s, 1H), 8.29 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.87 - 7.77 (m, 4H), 7.52 (ddd, J = 8.1,6.0, 3.4 Hz, 1 H), 7.44 - 7.34 (m, 5H), 6.46 (t, JHF = 73.5 Hz, 1H), 4.05 3.95 (m, 2H).
127C F 578 (M+H) 112-115 (CDCIg) δ 8.58 (s, 1H), 8.32 (s, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.87 - 7.75 (m, 4H), 7.43 7.32 (m, 4H). 7.26 - 7.24 (m, 2H), 4.23 (q, J = 7.3 Hz, 1H), 1.85- 1.78 (m, 4H), 0.900.78 (m, 2H), 0.78 - 0.69 (m, 1H), 0.65 0.55 (m, 1H).
128C F 580 (M+H) 164-171 (CDCI3) δ 8.58 (s, 1H), 8.29 (d, J = 7.8 Hz, 1H), 8.22 (d, J = 8.3 Hz, 2H), 7.88 - 7.74 (m, 4H), 7.48 - 7.30 (m, 5H), 7.20 (t, J = 11.1 Hz, 1H), 4.26-4.14 (m, 1H), 2.502.46 (m, 2H), 1.79 (d, J = 7.3 Hz, 3H), 1.69 - 1.56 (m, 2H), 0.93 (t, J = 7.3 Hz, 3H).
129C F 606 (M+H) 140-142 (CDCI3) δ 8.58 (s, 1 H), 8.30 (s, 1H), 8.22 (d, J = 8.4 Hz, 2H), 7.87 - 7.76 (m, 4H), 7.53 7.47 (m, 2H), 7.44 - 7.35 (m, 3H), 4.27 (q, J = 7.3 Hz, 1 H), 1.82 (d, J = 7.3 Hz, 3H).
Page 115 of 160
ID Synthesis Method MS mp (°C) 1H NMR (D)1
130C F 590 (M+H) 93-97; 191-194 (CDCI3) δ 8.58 (s, 1H), 8.31 (s, 1H), 8.22 (d, J = 8.4 Hz, 2H), 7.88 - 7.76 (m, 4H), 7.48 7.34 (m, 4H), 7.20 (tt, J = 12.4, 6.1 Hz, 1H), 4.35-4.18 (m, 1H), 1.81 (2d, J=7.3 Hz, 3H).
131C F 572 (ΜΗ) 93-98; 185-186 (CDCI3) δ 8.58 (s, 1 H), 8.32 (s, 1 H), 8.26 - 8.20 (m, 2H), 7.86 - 7.78 (m, 4H), 7.53 - 7.42 (m, 1H), 7.40 (d, J = 8.3 Hz, 2H), 7.09 (t, J = 8.1 Hz, 2H), 4.26 (q, J = 7.3 Hz, 1 H), 1.80 (d, J = 7.3 Hz, 3H).
132C J 552 (M+H) 193-196 (CDCI3) δ 8.56 (s, 1 H), 8.22 (s, 1H), 8.17 (d, J = 8.4 Hz, 2H), 7.80 (ddd, J = 9.5, 6.9, 4.9 Hz, 4H), 7.43 - 7.33 (m, 4H), 7.31 - 7.21 (m, 2H), 4.05 (td, J = 9.4, 7.1 Hz, 1 H), 3.97 3.87 (m, 1 H), 3.42 - 3.33 (m, 1 H), 3.33 3.24 (m, 1H), 3.12 (heptet, J = 6.8 Hz, 1H), 1.27 (d, J = 6.8 Hz, 3H), 1.22 (d, J - 6.9 Hz, 3H).
133C J 538 (M+H) 167-169 (CDCb) δ 8.55 (d, J = 7.1 Hz, 1 H), 8.23 (s, 1 H), 8.17 (d, J = 8.4 Hz, 2H), 7.80 (dt, J = 11.4, 6.2 Hz, 4H), 7.43 - 7.23 (m, 6H), 4.00 (s, 2H), 3.32 (s, 2H), 2.67 (q, J = 7.6 Hz, 2H), 1.25 (dd, J = 9.6, 5.5 Hz, 3H).
134C J 536 (M+H) 217-220; 230-232 (CDCI3) δ 8.65 (s, 1 H), 8.22 (s, 1 H), 8.18 (d, J = 8.4 Hz, 2H), 7.94 - 7.88 (m, 2H), 7.817.78 (m, 4H), 7.41 (dd, J = 7.8, 1.5 Hz, 1 H), 7.39 - 7.33 (m, 1 H), 7.30 - 7.24 (m, 1 H), 7.23 (dd, J = 7.8, 1.5 Hz, 1 H), 4.09 - 4.02 (m, 1 H), 3.98 - 3.88 (m, 1 H), 3.43 - 3.24 (m, 2H), 3.12 (heptet, J = 6.9 Hz, 1H), 1.27 (d, J = 6.8 Hz, 3H), 1.22 (d, J= 6.9 Hz, 3H).
Page 116 of160
ID Synthesis Method MS mp (°C) 1H NMR (O)1
135C J 566 (M+H) 167-169 (CDCI3) δ 8.56 (s, 1H), 8.19 (dd, J= 12.7, 9.0 Hz, 3H), 7.84 - 7.74 (m, 4H), 7.37 (dd, J = 14.9, 6.1 Hz, 4H), 7.26 (s, 1H), 7.21 (d, J = 7.6 Hz, 1H), 4.17 - 3.85 (m, 2H), 3.42 3.22 (m, 2H), 2.82 (d, J = 23.6 Hz, 1 H), 1.80 -1.55 (m, 2H), 1.23 (2d, J = 6.9 Hz, 3H), 0.82 (2t, J =7.4 Hz, 3H).
136C J 552 (M+H) 143-147 (CDCI3) ô 8.56 (s, 1H), 8.22 (s, 1H), 8.17 (d, J = 8.4 Hz, 2H), 7.84 - 7.74 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 7.5 Hz, 1 H), 7.19 (d, J = 6.4 Hz, 1H), 7.15 (d, J = 7.3 Hz, 1 H), 3.92 (qt, J = 10.1.7.3 Hz, 2H), 3.43 3.28 (m, 2H), 2.72 - 2.51 (m, 2H), 2.27 (s, 3H), 1.25 (t, J= 7.6 Hz, 3H).
137C J 554 (M+H) 183-186 (CDCI3) δ 8.56 (d, J = 5.3 Hz, 1 H), 8.26 (s, 1H), 8.17 (d, J = 8.4 Hz, 2H), 7.84-7.74 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.18 (d, J = 8.5 Hz, 1H), 6.81 (dt, J= 8.4, 2.9 Hz, 2H), 3.96 (t, J = 6.6 Hz, 2H), 3.81 (s, 3H), 3.30 (t, J = 6.9 Hz, 2H), 2.28 (s, 3H).
138C J 568 (M+H) 231-233 (CDCI3) δ 8.56 (d, J = 5.4 Hz, 1H), 8.25 (s, 1H), 8.17 (d, J= 8.4 Hz, 2H), 7.84-7.72 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 6.67 (s, 2H), 3.92 - 3.85 (m, 2H), 3.79 (s, 3H), 3.34 (t, J = 7.1 Hz, 2H), 2.25 (s, 6H).
139C J 552 (M+H) 195-197 (CDCI3) δ 8.56 (s, 1H), 8.24 (s, 1 H), 8.17 (d, J = 8.3 Hz, 2H), 7.83 - 7.73 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 6.95 (s, 2H), 3.90 (t, J = 7.1 Hz, 2H), 3.35 (t, J = 7.1 Hz, 2H), 2.30 (s, 3H), 2.23 (s, 6H).
Page 117 of 160
ID Synthesis Method MS mp (°C) 1H NMR (Π)1
140C J 540 (M+H) 181-184 (CDCI3) δ 8.56 (s, 1 H). 8.24 (s, 1H), 8.17 (d, J = 8.3 Hz, 2H), 7.84 - 7.75 (m, 4H), 7.43 7.36 (m, 3H), 7.30 (ddd, J = 12.6, 6.9, 3.1 Hz, 1 H), 7.06 - 6.97 (m, 2H), 4.04 (t, J = 7.0 Hz. 2H), 3.86 (s, 3H), 3.29 (t, J = 7.0 Hz, 2H).
141C J 524 (M+H) 173-176 (CDCI3) δ 8.56 (s, 1H), 8.25 (s, 1H), 8.18 (d, J = 8.4 Hz, 2H), 7.83 - 7.75 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H). 7.34 - 7.23 (m, 4H), 4.01 (t, J = 6.9 Hz, 2H), 3.32 (t, J = 6.9 Hz, 2H), 2.31 (s, 3H).
142C J 538 (M+H) 210-213 (CDCI3) δ 8.56 (s, 1H), 8.23 (s, 1H), 8.17 (d, J = 8.4 Hz, 2H), 7.84 - 7.74 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.22 - 7.10 (m, 3H), 3.92 (t, J = 7.1 Hz, 2H), 3.36 (t. J = 7.1 Hz, 2H), 2.28 (s, 6H).
143C J 562 (M+H) 221-224 (CDCI3) δ 8.56 (s, 1H), 8.23 (s. 1H), 8.18 (d, J = 8.4 Hz, 2H), 7.83 - 7.74 (m, 4H), 7.38 (d, J = 8.3 Hz, 2H), 7.30 (dt, J = 7.4, 4.8 Hz, 2H), 7.15 - 7.09 (m, 1H), 4.05 (ddd, J = 9.4, 7.3, 5.2 Hz, 1 H), 4.00 - 3.89 (m, 1 H), 3.46 3.30 (m, 2H).
144C J 586 (M+H) 117-123; 134-138 (300 MHz, CDCI3) δ 8.56 (d, J = 4.3 Hz. 1H), 8.34 (s, 1 H), 8.21 (s, 1H), 8.18 (s, 1H), 7.81 (dd, J = 8.9, 2.3 Hz, 4H), 7.52 (d. J = 6.7 Hz, 1H), 7.50 - 7.31 (m, 10H), 3.53 3.49 (m, 2H), 2.95 - 2.90 (d, J = 6.8 Hz, 2H).
Page 118 of 160
ID Synthesis Method MS mp(°C) 1H NMR(n)1
145C J 550 (M+H) 207-209 (CDCI3) δ 8.56 (s, 1H), 8.26 (s, 1H), 8.18 (d, J = 8.3 Hz, 2H), 7.84 - 7.74 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.32 - 7.21 (m, 3H), 7.01 (dd, J =8.9, 2.5 Hz, 1H), 4.12-4.04 (s, 2H), 3.34 (t, J = 6.9 Hz, 2H), 2.09 -1.98 (m, 1 H), 0.95 (dd, J = 8.5, 1.7 Hz, 2H), 0.72 (bs, 2H).
146C J 554 (M+H) 141-144 (CDCI3) δ 8.56 (d, J = 5.2 Hz, 1H), 8.24 (s, 1 H), 8.17 (d, J = 8.3 Hz, 2H), 7.80 (dt, J = 8.2, 4.6 Hz, 4H), 7.45 - 7.36 (m, 3H), 7.30 7.24 (m, 1H), 7.05 - 6.95 (m, 2H), 4.13 4.02 (m, 4H), 3.28 (t, J = 7.0 Hz, 2H), 1.44 1.35 (m, 3H).
147C J 540 (M+H) 168-170 (CDCI3) δ 8.57 (s, 1H), 8.37 (s, 1H), 8.21 (d, J = 8.3 Hz, 2H), 7.87 - 7.76 (m, 4H), 7.40 (d, J = 8.4 Hz, 2H), 7.29 (dd, J = 14.2, 6.0 Hz, 1 H), 7.24 (d, J = 2.3 Hz, 1 H), 7.09 7.02 (m, 1 H), 6.72 (dd, J = 8.0, 2.1 Hz, 1 H), 4.20 (t, J = 6.9 Hz, 2H), 3.83 (d, J = 8.7 Hz, 3H), 3.24 (t, J = 6.9 Hz, 2H).
148C J 546 (M+H) 213-216 (CDCI3) δ 8.56 (s, 1H), 8.24 (s, 1H), 8.18 (d, J = 8.3 Hz, 2H), 7.80 (dt, J = 4.0, 2.5 Hz, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.30 (ddd, J = 8.5, 7.4, 4.2 Hz, 1H), 7.05 - 6.97 (m, 2H), 4.02 (t, J = 6.9 Hz, 2H), 3.36 (t, J = 6.9 Hz, 2H).
149C J 612 (M+H) 200-203 (CDCI3) δ 8.56 (s, 1 H), 8.18 (d, J = 2.6 Hz, 2H), 8.16 (s, 1 H), 7.80 (dt, J = 8.3, 4.7 Hz. 4H), 7.71 (t, J = 8.6 Hz, 2H), 7,47 (t, J = 7.7 Hz, 1 H), 7.39 (d, J = 8.3 Hz, 2H), 4.18 4.07 (m, 1 H), 3.93 - 3.84 (m, 1 H), 3.46 (td, J = 10.7, 7.3 Hz, 1 H), 3.35 - 3.25 (m, 1 H).
Pagell9ofl60
ID Synthesis Method MS mp (°C) ’H NMR(D)1
150C J 566 (M+H) 169-172 (CDCI3) 5 8.56 (s, 1 H), 8.22 (s, 1H), 8.17 (d, J = 8.4 Hz, 2H), 7.80 (dt, J = 11.5, 6.2 Hz, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.31 - 7.27 (m, 3H), 7.26 - 7.24 (m, 1H), 4.10 - 3.89 (m, 2H), 3.38 - 3.32 (m, 2H), 2.48 (s, 2H), 2.01 1.84 (m, 1H), 0.91 (d, J = 6.2 Hz, 6H).
151C J 564 (M+H) 149-153 (CDCI3) δ 8.57 (s, 1H), 8.25 (s, 1H), 8.18 (d. J = 8.3 Hz, 2H), 7.99 (s, 1 H), 7.81 (dt, J = 8.3, 4.5 Hz, 4H), 7.39 (dd, J = 6.1, 3.5 Hz, 3H), 7.33 - 7.27 (m, 2H), 6.21 (s, 1H), 3.92 (t, J = 6.9 Hz, 2H), 3.26 (t, J = 6.8 Hz, 2H), 1.89 (d, J= 1.1 Hz, 3H), 1.79 (d, J= 1.1 Hz, 3H).
152C J 576 (M+H) 161-163 (CDCI3) δ 8.57 (s, 1H), 8.23 - 8.16 (m, 3H), 7.83 - 7.77 (m, 4H), 7.48 (dd, J = 7.5, 2.0 Hz, 1 H), 7.39 (d, J = 8.3 Hz, 2H), 7.33 (dt, J = 7.2, 2.1 Hz, 2H), 7.28 (dd, J = 9.8, 1.9 Hz, 1 H), 6.52 (t, JHF = 74.1 Hz, 1 H), 4.06 (t, J = 6.9 Hz, 2H), 3.33 (t, J = 6.9 Hz, 2H).
153C J 594 (M+H) 195-197 (CDCI3) δ 8.57 (s, 1H), 8.25 (s, 1H), 8.19 (d, J = 8.4 Hz, 2H), 7.81 (dt, J = 4.1, 2.6 Hz, 4H), 7.58 - 7.52 (m, 1H), 7.42 - 7.33 (m, 5H), 4.05 (t, J = 6.9 Hz, 2H), 3.31 (t, J = 6.9 Hz, 2H).
154C J 538 (M+H) 164-167 CDCI3) δ 8.56 (s, 1H), 8.23 (d, J= 9.8 Hz, 1H), 8.17 (d, J= 8.3 Hz, 2H), 7.84-7.74 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.35 7.27 (m, 3H), 7.19 (s, 1H), 3.54 - 3.31 (m, 1 H), 3.07 - 2.93 (m, 1 H), 2.31 (d, J = 9.0 Hz, 3H), 1.62 - 1.56 (m, 1H), 1.31 -1.19 (m, 3H).
Page 120 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
155C J 566 (M+H) 201-204 Two Isomers (CDCI3) 6 8.56 (s, 2H), 8.18 (dd, J = 10.8, 7.4 Hz, 6H), 7.84 - 7.73 (m, 8H), 7.45 - 7.30 (m, 8H), 7.30 - 7.23 (m, 2H), 7.20 (d, J = 6.7 Hz. 1H), 7.12 (dd, J = 7.8, 1.2 Hz, 1H), 4.43-4.33 (m, 1H), 4.16 (dd, J = 12.6, 6.3 Hz, 1 H), 3.48 (dt, J = 13.3, 6.7 Hz, 1H), 3.37 (dd, J = 10.8, 6.2 Hz, 1 H). 3.24 (dt, J = 13.7, 6.9 Hz, 1 H), 3.08-2.92 (m, 3H), 1.33-1.16 (m, 18H).
156C J 566 (M+H) 105-110 (CDCI3) δ 8.56 (s, 1H), 8.20 (d, J = 3,4 Hz, 1H), 8.16 (d, J = 8.4 Hz, 2H), 7.84 - 7.73 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.25 7.09 (m, 3H), 4.39 - 4.23 (m, 1 H), 3.53 3.35 (m, 1 H), 3,04 - 3.00 (m, 1 H), 2.78 2.49 (m, 2H), 2.28 (2s, 3H), 1.34 - 1.08 (m, 6H).
157C J 592 (M+H) 175-176 (CDCIa) δ 8.56 (d, J= 0.6 Hz, 1H), 8,21 (s, 1 H), 8.17 (d. J = 8.2 Hz, 2H), 7.82 - 7.77 (m, 4H), 7.49 - 7.35 (m, 4H), 7.30 - 7.28 (m, 1 H), 4.64 - 4.57 (m, 1 H), 3.44 (dd, J = 10.2, 6.3 Hz, 1H), 3.16 - 3.01 (m, 1H), 1.27 (d, J = 6.3 Hz, 3H).
158C J 572 (M+H) 99-102 Two Isomers (CDCI3) δ 8.56 (s, 2H), 8.20 (s, 2H), 8.19 - 8.12 (m, 4H), 7.84 - 7.73 (m, 8H), 7.39 (d, J = 8.3 Hz, 4H), 7.36 - 7.29 (m, 2H), 7.25 - 7.17 (m, 4H), 4.78 - 4.55 (m, 1 H), 4.35 (dt, J = 9.4, 6.3 Hz, 1 H), 3.48 (dd, J = 10.7, 6.5 Hz, 1 H), 3.38 (dd, J = 10.7, 6.2 Hz, 1H), 3.11 (dd, J= 10.7, 9.4 Hz, 1H), 3.01 (dd, J= 10.7, 8.3 Hz, 1H), 2.35 (s, 3H), 2.30 (s, 3H), 1.26 (d. J = 6.3 Hz, 3H), 1.21 (d, J = 6.4 Hz, 3H)
ID Synthesis Method MS mp(°C) 1H NMR(D)1
159C J 607 (M+H) 85 (dec) (CDCI3) δ 8.56 (s, 1H), 8.18 (dd, J= 11.9, 5.3 Hz, 3H), 7.79 (dd, J = 8.7, 6.5 Hz, 4H), 7.47 (dd, J = 7.8, 2.3 Hz. 1H), 7.42 - 7.32 (m, 5H), 4.48 - 4.29 (m, 1 H), 3.45 (dd, J = 10.7, 6.4 Hz, 1H), 2.98 (dd, J = 10.7, 7.1 Hz, 1H), 1.26 (d, J = 6.3 Hz, 3H)
160C J 626 (M+H) 93 (dec) Two Isomers (CDCI3) δ 8.56 (s, 2H), 8.19 8.12 (m, 6H), 7.84 - 7.73 (m, 10H). 7.71 (d, J = 8.2 Hz, 2H), 7.47 (t, J = 8.0 Hz, 2H), 7.39 (d, J = 8.3 Hz, 4H), 4.76 - 4.64 (m, 1 H), 4.48 (dd, J = 14.6, 6.3 Hz, 1H), 3.43 (dd, J= 10.6, 6.2 Hz, 1H), 3.29 (dd, J = 10.5, 5.5 Hz, 1H), 3.16-3.00 (m, 2H), 1.27 (d, J =6.4 Hz, 3H), 1.17 (d, J = 6.4 Hz, 3H)
161C J 566 (M+H) 105 (dec) (CDCI3) Ô 8.56 (s, 1H), 8.22 (s, 1H), 8.16 (d, J = 8.4 Hz, 2H), 7.83 - 7.70 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 6.94 (d, J = 9.3 Hz, 2H), 4.43 - 4.22 (m, 1 H), 3.42 (dd, J = 10.8, 6.5 Hz, 1 H), 3.00 (dd, J = 10.8, 8.5 Hz, 1 H), 2.30 (S, 3H), 2.25 (s, 3H), 2.21 (s, 3H), 1.20 (d, J = 6.3 Hz, 3H)
162C J 568 (M+H) 100 (dec) (CDCI3) δ 8.56 (s, 1H), 8.24 (s, 1H), 8.17 (d, J = 8.4 Hz, 2H), 7.83 - 7.73 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.18 - 7.09 (m, 1 H), 6.86 - 6.76 (m, 2H), 4.33 - 4.19 (m, 1H), 3.82 (s, 3H), 3.47 - 3.38 (m, 1 H), 3.00 - 2.99 (m, 1H), 2.29-2.27 (m, 3H), 1.33- 1.15 (m, 3H)
ID Synthesis Method MS mp (°C) 1H NMR (O)1
163C J 580 (M+H) 92-102 (CDCI3) δ 8.56 (s, 2H), 8.18 (dd, J = 10.7, 5.3 Hz, 6H), 7.84 - 7.74 (m, 8H), 7.42 - 7.30 (m, 8H), 7.23 - 7.10 (m, 2H), 4.37 (dd, J = 19.5,13.6 Hz, 1H), 4.16 (dd, J= 13.1, 6.6 Hz, 1 H), 3.56 - 3.42 (m, 1 H), 3.34 (dd, J = 10.8, 6.0 Hz, 1H). 3.08 - 2.87 (m, 3H), 2.70 (dd, J= 16.0, 7.0 Hz, 1H), 1.71 -1.56 (m, 4H), 1.34-1.25 (m, 6H), 1.24-1.14 (m, 6H), 0.93-0.73 (m, 6H)
164C J 589 (M+H) 80 (dec) (CDCI3) δ 8.56 (s, 1H), 8.22 - 8.14 (m, 3H), 7.84 - 7.76 (m, 4H), 7.42 - 7.27 (m, 6H), 6.51 (t, JHF= 74.3 Hz, 1H), 4.52 - 4.31 (m, 1H), 3.44 (dd, J= 10.8, 6.5 Hz, 1H), 2.99 (dd, J = 10.8, 7.6 Hz, 1 H), 1.25 (d, J = 6.3 Hz, 3H)
165C J 580 (M+H) 143 (dec) Two Isomers (CDCI3) δ 8.56 (s, 2H), 8.22 (s, 1H), 8.20 (s, 1H), 8.16 (d, J = 8.3 Hz, 4H), 7.84 - 7.74 (m, 8H), 7.58 (ddd, J = 9.7, 8.0,1.7 Hz, 2H), 7.39 (d, J = 8.4 Hz, 4H), 7.36 - 7.27 (m, 4H), 7.15 (dd, J - 7.7, 1.6 Hz, 1 H), 7.09 (dd, J = 7.6, 1.7 Hz, 1 H), 4.38 - 4.22 (m, 2H), 3.61 (dd, J = 10.8, 7.0 Hz, 1 H), 3.24 (dd, J = 10.7, 5.6 Hz, 1 H), 3.07 2.94 (m, 1H), 2.91 (dd, J = 10.8,1.5 Hz, 1H), 1.47-1.38 (m, 24H)
166C J 552 (M+H) 93 (dec) (CDCI3) δ 8.56 (s, 1H), 8.21 (s, 1 H), 8.16 (d, J = 8.4 Hz, 2H), 7.84 - 7.73 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.32 - 7.28 (m, 3H), 7.20 (s, 1H), 4.20-4.06 (m, 1H), 3.41 (s, 1H), 3.05 (dd, J= 10.8, 8.2 Hz, 1H), 2.31 32.30 (m, 3H), 1.66 (s, 2H), 0.90 - 0.88 (m, 3H)
Page 123 of 160
ID Synthesis Method MS mp (°C) 1H NMR (O)1
167C J 586 (M+H) 105 (dec) Two Isomers (CDCI3) δ 8.56 (s, 2H), 8.20 (s, 2H), 8.16 (d, J = 8.3 Hz, 4H), 7.83 - 7.74 (m, 8H), 7.43 - 7.28 (m, 6H), 7.21 (dd, J = 5.4, 3.3 Hz, 4H), 4.49 - 4.36 (m, 1H), 4.17 4.05 (m, 1 H), 3.49 (dd. J = 10.7, 6.6 Hz, 1H), 3.40 (dd, J- 10.7, 6.3 Hz, 1H), 3.10 (dd, J = 10.7, 9.4 Hz, 1 H), 3.04 (dd, J ~ 10.8, 8.2 Hz, 1H), 2.34 (s, 3H), 2.30 (s, 3H), 1.73-1.48 (m, 4H), 0.91 (m,6H)
168C J 560 (M+H) 199-200 (CDCI3) δ 8.56 (s, 1H), 8.18 (m„ 2H), 7.79 (m, 4H), 7.47 (dd, J = 7.8, 2.3 Hz, 1H), 7.42 - 7.32 (m, 5H), 4.48 - 4.29 (m, 1H), 3.45 (dd, J= 10.7, 6.4 Hz, 1H), 2.98 (dd, J = 10.7, 7.1 Hz, 1H), 1.26 (d, J = 6.3 Hz, 3H)
169C G 623 (M+H) Oil (CDCI3) δ 10.45 (s, 1H), 8.59 (s, 1H), 8.25 (d, J = 8.3 Hz, 2H), 7.88 (d, J = 8.3 Hz, 2H), 7.81 (d, J = 8.9 Hz, 2H), 7.61 (t, J = 7.5 Hz, 2H), 7.40 (d, J = 8.7 Hz, 2H), 7.11 (t, J = 8.0 Hz, 1H), 5.71 (d, J =1.1 Hz, 1H), 2.35 (s, 3H) 19F NMR (376 MHz, CDCI3) δ -58.02, -62.31
170C G 606 (M+H) 157-159 (CDCI3) δ 8.56 (s, 1 H), 8,19 - 8.14 (m, 3H), 7.79 (m, 4H), 7.56 - 7.46 (m, 2H), 7.46 7.43 (m, 2H). 7.39 (d, J= 8.3 Hz, 2H), 5.88 (d, J = 1.3 Hz, 1 H), 1.86 (d, J = 1.2 Hz, 3H)
171C G 558 (M+H) 236-237 (CDCI3) δ 8.56 (s, 1H), 8.19 (d, J= 5.9 Hz, 2H), 8.16 (s, 1H), 7.83 - 7.76 (m, 4H), 7.45 (tt, J = 8.4, 6.1 Hz, 1H), 7.39 (d, J =8.3 Hz, 2H), 7.10 (dd, J = 8.5, 7.3 Hz, 2H), 5.90 (d, J = 1.3 Hz, 1H), 1.92 (s, 3H)
[D Synthesis Method MS mp (°C) 'H NMR(D)1
172C G 580 (M+H) 103-108 (CDCIa) δ 8.56 (d, J = 3.7 Hz, 1 H), 8.21 (s, 1 H), 8.16 (d, J = 8.4 Hz, 2H), 7.84 - 7.72 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 6.72 (s, 2H), 5.89 (d, J = 1.3 Hz, 1 H), 3.82 (s, 3H), 2.14 (s, 6H), 1.75 (d, J=1.2 Hz, 3H).
173C G 536 (M+H) 87 (dec) (CDCI3) δ 8.56 (s, 1H), 8.19-8.15 (m, 3H), 7.82 - 7.75 (m, 4H), 7.43 - 7.30 (m, 5H), 7.24 (d, J = 7.3 Hz, 1 H), 5.88 (s,1 H), 2.21 (s, 3H), 1.80 (d, J= 1.2 Hz, 3H)
174C G 570 (M+H) 95 (dec) (CDCI3) δ 8.56 (s, 1H), 8.20 - 8.12 (m, 3H), 7.83 - 7.74 (m, 4H), 7.43 - 7.36 (m, 3H), 7.32 (t, J = 7.7 Hz, 1H), 7.29-7.27 (m, 1H), 5.92 (d, J = 1.3 Hz, 1 H), 2.26 (s, 3H), 1.81 (d, J= 1.2 Hz, 3H)
175C G 550 (M+H) 132-136 (CDCI3) δ 8.56 (d, J = 5.0 Hz, 1 H), 8.21 - 8.13 (m, 3H), 7.83 - 7.74 (m, 4H), 7.39 (d, J = 8.2 Hz, 2H), 7.29 - 7.23 (m, 1H), 7.19 (d, J = 7.7 Hz, 2H), 5.92 (d, J = 1.3 Hz, 1 H), 2.18 (s, 6H), 1.75 (d, J= 1.2 Hz, 3H).
176C G 564 (M+H) 123-138 (CDCI3) Ô 8.56 (s, 1H), 8.19 - 8.14 (m, 3H), 7.83 - 7.75 (m, 4H), 7.49 - 7.43 (m, 2H), 7.39 (d, J = 8.3 Hz, 2H), 7.33 (ddd, J = 7.8, 5.9, 3.0 Hz, 1 H), 7.19 - 7.17 (m, 1H), 5.88 (d, J = 1.3 Hz, 1 H), 2.96 - 2.76 (m, 1 H), 1.81 (d, J = 1.2 Hz, 3H), 1.24 (t, J = 6.4 Hz, 3H), 1.22-1.16 (m, 3H).
Page 125 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
177C J 566 (M+H) 185-187 (CDCI3) δ 8.55 (s, 1 H). 8.14 (d, J = 8.4 Hz, 2H), 8.05 (s, 1H), 7.84 - 7,77 (m, 2H), 7.74 (d, J = 8.3 Hz, 2H), 7.42 - 7.35 (m, 3H), 7.32 (dd, J = 10.6, 4.3 Hz, 1 H), 7.28 - 7.24 (m, 1H), 7.18 (dd, J= 7.8, 1.4 Hz, 1H), 3.80 -3.69(m, 1H), 3.59-3.48(m, 1H), 3.11 (dd, J = 13.2, 6.8 Hz, 3H), 2.41 - 2.27 (m, 2H), 1.22 (t, J =5.6 Hz, 6H).
178C J 580 (M+H) 186-190 (CDCI3) δ 8.55 (d, J = 3.6 Hz, 1H), 8.14 (d, J = 8.4 Hz, 2H), 8.06 (s, 1H), 7.84 - 7.77 (m, 2H), 7.74 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 9.0 Hz, 3H), 7.32 (td, J = 7.5, 1.4 Hz, 1 H), 7.26 (s, 1H), 7.17 (t, J = 7.1 Hz, 1H), 3.69- 3.26 (m, 1H), 3,55-3.37 (m, 1H), 3.182.98 (m, 2H), 2.93 - 2.80 (m, 1 H), 2.47 (d, J = 35.9 Hz, 1H), 1.31 -1.12 (m, 9H).
179C J 550 (M+H) 212-213 (CDCI3) δ 8.64 (s, 1 H), 8.15 (d, J = 8.4 Hz, 2H), 8.06 (s, 1H), 7.91 (d, J= 8.5 Hz, 2H), 7.79 (d, J = 8.6 Hz, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.38 (dd, J = 7.8, 1.6 Hz, 1 H), 7.33 (td, J = 7.5, 1.4 Hz, 1 H), 7.29 - 7.23 (m, 1 H), 7.18 (dd, J = 7.8, 1.4 Hz, 1H), 3.78-3.72 (m, 1H), 3.59 - 3.48 (m, 1H), 3.18 - 3.04 (m, 3H), 2.40 - 2.30 (m, 2H), 1.26 - 1.20 (m, 6H).
180C J 566 (M+H) 127-133 (300 MHz, CDCI3) δ 8.55 (s, 1H), 8.13 (d, J = 8.3 Hz, 2H), 8.05 (s, 1 H), 7.76 (dd, J = 17.0, 8.7 Hz, 4H), 7.37 (t, J= 8.4 Hz, 2H), 7.18 (dd, J = 12.7, 9.6 Hz, 3H), 3.54 - 3.49 (m, 2H), 3.12 - 3.08 (m, 2H), 2.70 - 2.55 (m, 2H), 2.39 - 2.31 (m, 2H), 2.28 (s, 3H), 1.25 (t, J = 7.6 Hz, 3H).
Page 126 of 160
ID Synthesis Method MS mp (°C) 1H NMR(d)1
181C J 582 (M+H) 170-174 (CDCI3) δ 8.55 (s, 1 H), 8.14 (d, J= 8.3 Hz, 2H), 8.08 (s, 1 H), 7.84 - 7.76 (m, 2H), 7.74 (d, J = 8.3 Hz, 2H), 7.38 (d, J = 8.3 Hz, 2H). 6.65 (s, 2H), 3.79 (s, 3H), 3.52 - 3.45 (m, 2H), 3.10 - 3.07 (m, 2H), 2.38 - 2.31 (d, J = 5.7 Hz, 2H), 2.25 (s, 6H).
182C J 552 (M+H) 148-155; 166-168 (300 MHz, CDCI3) δ 8.55 (d, J = 1.0 Hz, 1 H), 8.14 (d, J = 8.4 Hz, 2H), 8.05 (s, 1 H), 7.83 - 7.76 (m, 2H), 7.74 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 9.0 Hz, 2H), 7.14 - 7.09 (m, 3H), 3.51 (dd, J= 9.1, 3.5 Hz, 2H), 3.15 - 3.03 (m, 2H), 2.36 (s, 2H), 2.28 (s, 6H).
183C J 580 (M+H) 159-162 (CDCI3) δ 8.55 (d, J= 3.7 Hz, 1H), 8.14 (d, J = 8.4 Hz, 2H), 8.03 (d, J = 19.3 Hz, 1 H), 7.84 - 7.77 (m, 2H), 7,74 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 3.8 Hz, 2H), 7.25 (d, J = 6.6 Hz, 1H), 7.19 (t, J = 8.0 Hz, 1H), 3.76 (ddd, J = 24.2, 12.0, 5.9 Hz, 1H), 3.58-3.46 (m, 1H), 3.11 (dd, J= 15.3, 6.1 Hz, 2H), 2.82 (dd, J = 14.6, 7.2 Hz, 1H), 2.41 -2.29 (m, 2H), 1.711.55 (m. 2H), 1.20 (d, J = 6.8 Hz, 3H), 0.87 - 0.76 (m, 3H).
184C J 566 (M+H) 194-198 (CDCI3) δ 8.55 (s, 1H), 8.14 (d, J = 8.4 Hz, 2H). 8.07 (s, 1H), 7.83 - 7.76 (m, 2H), 7.74 (d, J = 8.4 Hz, 2H), 7.40 (t, J = 10.1 Hz, 2H), 6.93 (s, 2H), 3.53 - 3.47 (m, 2H), 3.12 3.05 (m, 2H), 2.34 (dt, J = 11.7, 5.8 Hz, 2H), 2.30 (s, 3H), 2.23 (s, 6H).
Page I27of 160
ID Synthesis Method MS mp (°C) ήΗ NMR(C)1
185C J 552 (M+H) 157-160 (CDCI3) δ 8.55 (s, 1H), 8.14 (d, J= 8.4 Hz, 2H), 8.06 (s, 1H), 7.83 - 7.77 (m, 2H), 7.74 (d, J = 8.3 Hz, 2H), 7.38 (d, J = 8.3 Hz, 2H), 7.36 - 7.27 (m, 3H), 7.23 - 7.19 (m, 1 H), 3.74 (m, 1H), 3.50 (m, 1H), 3.10 (d, J = 5.9 Hz, 2H), 2.64 (q, J = 7.6 Hz, 2H), 2.40 2.29 (m, 2H), 1.28-1.21 (m, 3H).
1860 J 564 (M+H) 173-177 (CDCI3) δ 8.55 (s, 1 H), 8.14 (d, J = 8.4 Hz, 2H), 8.09 (s, 1H), 7.83 - 7.77 (m, 2H), 7.81 7.77 (m, 2H), 7.38 (d, J = 8.3 Hz, 2H), 7.24 - 7.22 (m, 3H), 7.05 - 6.95 (m, 1H), 3.77 3.63 (m, 2H). 3.14 - 3.07 (m, 2H), 2.45 2.29 (m, 2H), 2.09 -1.92 (m, 1 H), 0.97 0.82 (m, 3H), 0.53 (bs, 1H).
187C J 593 (M+H) 180-182 (300 MHz, CDCI3) δ 8.55 (s, 1H), 8.14 (d, J = 8.4 Hz, 2H), 8.05 (d, J = 4.9 Hz, 1 H), 7.77 (dd, J = 11.4, 8.6 Hz, 4H), 7.39 (t, J = 8.1 Hz, 4H), 7.21 (dd, J= 13.2, 5.6 Hz, 1H), 3.65 - 3.58 (m, 2H), 3.09 (t, J = 5.5 Hz, 2H), 2.45-2.35 (m, 2H).
188C J 576 (M+H) 209-212 (CDCI3) δ 8.56 (s, 1H), 8.15 (d. J = 8.4 Hz, 2H), 8.07 (s, 1H), 7.79 (ddd, J = 15.8, 7.8, 5,8 Hz, 4H), 7.38 (d, J = 8.3 Hz, 2H), 7.31 - 7.21 (m, 2H), 7.10 (ddd, J = 9.7, 7.8, 2.0 Hz, 1 H), 3.64 (t, J = 5.4 Hz, 2H), 3.11 (t, J = 6.0 Hz, 2H), 2.46 - 2.33 (m, 2H).
189C J 560 (M+H) 217-219 (CDCI3) δ 8.56 (s, 1 H), 8.15 (d, J = 8.4 Hz, 2H), 8.08 (s, 1H), 7.83 - 7.74 (m, 4H), 7.38 (d, J = 8.3 Hz, 2H), 7.31 - 7.21 (m, 1H), 7,03 - 6.94 (m, 2H), 3.72 - 3.62 (m, 2H), 3.15 - 3.07 (m, 2H), 2.40 - 2.34 (m, 2H).
Page I28of 160
ID Synthesis Method MS mp(°C) 1H NMR(D)1
190C J 626 (M+H) 190-193 (CDCIs) δ 8.55 (s, 1H), 8.14 (d, J= 8.3 Hz, 2H), 8.00 (s, 1 H), 7.83 - 7.73 (m, 4H), 7.71 (d, J =8.1 Hz, 1H), 7.67 (d, J =7.7 Hz, 1H), 7.40 (dd, J = 15.8, 8.2 Hz, 3H). 3.79 - 3.69 (m, 1H), 3.55 - 3.49 (m, 1H), 3.16 - 3.04 (m, 2H), 2.47 - 2.31 (m, 2H).
191C J 554 (M+H) 150-155 (CDCI3) δ 8.54 (d, J = 4.3 Hz, 1 H), 8.13 (d, J = 8.3 Hz, 2H), 8.05 (d, J = 6.3 Hz, 1 H), 7.77 (dd, J ~ 15.4, 8.7 Hz, 4H), 7.38 (d, J = 8.3 Hz, 2H), 7.29 (dd, J = 8.0, 4.8 Hz, 2H), 7.04 - 6.93 (m, 2H), 3.85 (s, 3H), 3.65 - 3.61 (m, 2H), 3.10 - 3.06 (m, 2H), 2.36 - 2.28 (s, 2H).
192C J 568 (M+H) 164-167; 168-173 (CDCI3) δ 8.55 (s, 1 H), 8.14 (d, J - 8.4 Hz, 2H), 8.09 (s, 1H), 7.82 - 7.77 (m, 2H), 7.74 (d, J = 6.7 Hz, 2H), 7.38 (d, J = 8.3 Hz, 2H), 7.13 (d, J = 8.3 Hz, 1H), 6.79 (dd, J = 11.9, 3.3 Hz, 2H), 3.81 (s, 3H), 3.74 - 3.66 (m, 1 H), 3.57 - 3.48 (m, 1 H), 3.12 - 3.04 (m, 2H), 2.36 - 2.30 (m, 2H), 2.25 (s, 3H).
193C J 580 (M+H) 155-158 (CDCI3) δ 8.55 (s, 1H), 8.14 (d, J = 8.4 Hz, 2H), 8.04 (s, 1H), 7.83 - 7.77 (m, 2H), 7.74 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.3 Hz, 2H), 7.31 - 7.24 (m, 3H), 7.23 - 7.20 (m, 1H), 3.82 - 3.71 (m, 1H), 3.56 - 3.47 (m, 1 H), 3,17 - 3.02 (m, 2H), 2.46 (t, J = 6.7 Hz, 2H), 2.39 - 2.27 (m, 2H), 1.99 (heptet, J = 6.8 Hz, 1H), 0.95 - 0.92 (m, 6H).
194C J 600 (M+H) 102-108 (CDCI3) δ 8.56 (s, 1H), 8.17 (m 3H), 7.80 (m, 4H), 7.52 - 7.47 (m, 2H), 7.47 - 7.31 (m, 9H), 3.42 - 3.05 (m, 2H), 2.86 (bs, 2H), 2.04 -1.71 (m, 2H).
Page 129of 160
ID Synthesis Method MS mp(°C) 1H NMR(D)1
195C J 538 (M+H) 159-162 (CDCh) δ 8.55 (s, 1H), 8.14 (d, J = 8.3 Hz, 2H), 8.08 (s, 1H), 7.84 - 7.77 (m, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.5 Hz, 2H), 7.31 - 7.19 (m, 4H), 3.81 - 3.47 (m, 2H), 3.20 - 3.00 (m, 2H), 2.35 (dt, J = 11.7, 5.8 Hz, 2H), 2.28 (s, 3H).
196C J 572 (M+H) 140-143 (CDCh) δ 8.55 (s, 1H), 8.14 (d, J = 8.1 Hz, 2H), 8.05 (s, 1 H), 7.80 (d, J = 8.9 Hz, 2H), 7.75 (d, J = 8.2 Hz, 2H), 7,38 (d, J = 8.8 Hz, 2H), 7.33 (dd, J = 6.1, 3.4 Hz, 1 H), 7.21 - 7.15 (m, 2H), 3.72 - 3.66 (m, 1H), 3.55 - 3.41 (m, 1H), 3.16-3.05 (m, 2H), 2.48- 2.34 (m, 2H), 2.32 (s, 3H).
197C J 578 (M+H) 151-155 (CDCI3) δ 8.55 (s, 1H), 8.14 (d, J = 8.2 Hz, 2H), 8.06 (s, 1 H). 7.80 (d, J = 8.9 Hz, 2H), 7.75 (d, J = 8.2 Hz, 2H), 7.38 (d, J = 8.8 Hz, 2H), 7.29 (dd, J= 10.7, 4.6 Hz, 4H), 6.20 (s, 1H), 3.59 - 3.48 (m, 2H), 3.10 - 3.01 (m, 2H), 2.34-2.20 (m, 2H), 1.90 (s, 3H), 1.78 (s, 3H).
198C J 539 (M+H) 186-189 (CDCh) δ 8.56 (s, 1 H), 8.36 (dd, J = 4.8, 1.3 Hz, 1 H), 8.15 (d, J = 8.3 Hz, 2H), 8.09 (s, 1H), 7.78 (m, 4H), 7.54 (dd, J = 7.5, 0.9 Hz, 1 H), 7.37 (d, J = 8.5 Hz, 2H), 7.13 (dd, J = 7.4, 4.8 Hz, 1H), 3.87 (t, J = 5.7 Hz, 2H), 3.12 - 3.03 (m, 2H), 2.40 - 2.32 (m, 2H), 2.24 (s, 3H).
199C J 608 (M+H) 207-208 (CDCh) Ô 8.55 (s, 1H), 8.15 (d, J = 8.4 Hz, 2H), 8.05 (s, 1H), 7.83 - 7.78 (m, 2H), 7.76 (d, J ~ 8.4 Hz, 2H), 7.43 - 7.36 (m, 3H), 7.34 (t, J = 4.7 Hz, 3H), 3.71 - 3.64 (m, 2H), 3.12 - 3.06 (m, 2H), 2.39 - 2.30 (m, 2H).
Page 130 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
200C J 590 (M+H) 170-172 (CDCI3) δ 8.56 (s, 1 H), 8.15 (d, J = 8.4 Hz, 2H), 8.03 (s, 1H), 7.83 - 7.77 (m, 2H), 7.76 (d, J = 8.3 Hz, 2H), 7.42 - 7.27 (m, 6H), 6.74 - 6.29 (m, 1 H), 3.70 - 3.64 (m, 2H), 3.13 - 3.06 (m, 2H), 2.40 - 2.31 (m, 2H).
201C J 626 (M+H) 190-193 (CDCh) δ 8.55 (s, 1H), 8.14 (d, J = 8.3 Hz, 2H), 8.00 (s, 1H), 7.83 - 7.73 (m, 4H), 7.71 (d, J = 8.1 Hz, 1H), 7.67 (d, J =7.7 Hz, 1H), 7.40 (dd, J = 15.8, 8.2 Hz, 3H), 3.79 - 3.69 (m, 1H), 3.55 - 3.49 (m, 1H), 3.16 - 3.04 (m, 2H), 2.47 - 2.31 (m, 2H).
202C J 554 (M+H) 231-234 (CDCh) δ 8.56 (s, 1H), 8.19 - 8.08 (m, 3H), 7.84 - 7.72 (m, 4H), 7.39 (d, J = 8.4 Hz, 2H), 7.25 - 7.20 (m, 2H), 6.96 - 6.88 (m, 2H), 3.83 (s, 3H), 3.76 - 3.68 (m, 2H), 3.13 - 3.03 (m, 2H), 2.39 - 2.27 (m, 2H).
203C J 631 (M+H) 200-201 (CDCh) δ 8.56 (s, 1H), 8.15 (d, J= 8.2 Hz, 2H), 8.06 (s, 1H), 7.83 - 7.77 (m, 2H), 7.75 (d. J = 8.2 Hz, 2H), 7.39 (d, J = 8.5 Hz, 2H), 7.28 - 7.25 (m, 2H), 3.51 - 3.42 (m, 2H), 3.14 - 3.05 (m, 2H), 2.35 (s, 2H), 2.25 (s, 6H).
204C J 568 (M+H) 193-196 (CDCh) δ 8.55 (s, 1H), 8.14 (d, J= 8.4 Hz, 2H), 8.09 (s, 1H), 7.84-7.77 (m, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.38 (d, J = 8.3 Hz, 2H), 7.08 (t, J = 4.0 Hz, 2H), 6.88 (d, J = 8.6 Hz, 1 H), 3.82 (s, 3H), 3.66 - 3.58 (m, 2H), 3.11 3.03 (m, 2H), 2.36 - 2.27 (m, 5H).
Page I3l of 160
ID Synthesis Method MS mp (°C) 1H NMR (D)1
205C J 539 (M+H) Oil (CDCIa) δ 8.55 (s, 1 H), 8.45 (dd, J = 4.8, 1.6 Hz, 1H), 8.18 - 8.12 (m, 2H), 8.06 (s, 1H), 7.82 - 7.72 (m, 4H), 7.53 (dd, J = 7.9, 1.6 Hz, 1 H), 7.40 - 7.33 (m, 2H), 7.24 - 7.18 (m, 1H), 3.63 (br s, 2H), 3.18 - 3.03 (m, 2H), 2.51 (s 3H), 2.35 (dt, J = 11.7, 5.7 Hz, 2H)
206C J 554 (M+H) 177-178 (CDCI3) δ 8.56 (s, 1 H). 8.16 (d, J= 8.9 Hz, 3H), 7.84 - 7.73 (m, 4H), 7.39 (d, J = 8.8 Hz, 2H), 7.30 (t, J = 8.1 Hz, 1H), 6.95-6.85 (m, 2H), 6.78 (dt, J= 11.1, 5.5 Hz, 1H), 3.81 (s, 3H), 3.79 - 3.73 (m, 2H), 3.12 - 3.04 (m, 2H), 2.38 - 2.28 (m, 2H).
207C J 596 (M+H) 171-173 (CDCI3) δ 8.57 (s, 1H), 8.23 - 8.13 (m, 3H), 8.06 (d, J = 8.5 Hz, 2H), 7.80 (dd, J = 8.5, 4.5 Hz, 4H). 7.39 (d, J = 8.5 Hz, 4H), 4.38 (q, J = 7.2 Hz, 2H), 3.82 (t, J = 6.0 Hz, 2H), 3.14 - 3.03 (m, 2H), 2.37 (s, 2H), 1.40 (t, J = 7.1 Hz, 3H).
208C J 568 (M+H) 171-173 (CDCh) δ 8.55 (s, 1 H). 8.14 (d, J= 8.3 Hz, 2H), 8.07 (s, 1 H), 7.84 - 7.77 (m, 2H), 7.75 (d, J = 8.3 Hz, 2H), 7.38 (d, J = 8.3 Hz, 2H), 7.32 - 7.23 (m, 2H), 6.99 (ddd, J = 8.3, 5.5, 1.4 Hz, 2H), 4.08 (q, J = 7.0 Hz, 2H), 3.69 3.57 (m, 2H), 3.16 - 3.02 (m, 2H), 2.32 (dt, J = 11.7, 5.9 Hz, 2H), 1.39 (t, J = 7.0 Hz, 3H).
Page 132 of 160
ID Synthesis Method MS mp(°C) 1H NMR (Cl)1
209C J 550 (M+H) 212-213 (CDCI3) δ 8.64 (s, 1 H), 8.15 (d, J= 8.4 Hz, 2H), 8.06 (s, 1H), 7.91 (d, J = 8.5 Hz, 2H), 7.79 (d, J = 8.6 Hz, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.38 (dd, J =7.8, 1.6 Hz, 1H), 7.33 (td, J = 7.5, 1.4 Hz, 1H), 7.29-7.23 (m, 1H), 7.18 (dd, J =7.8, 1.4 Hz, 1H), 3.78-3.72 (m, 1H), 3.59 - 3.48 (m, 1H), 3.18 - 3.04 (m, 3H), 2.40 - 2.30 (m, 2H), 1.26 - 1.20 (m, 6H).
210C J 580 (M+H) 136-139 (CDCI3) δ 8.55 (s, 1H), 8.14 (d, J = 8.4 Hz, 2H), 8.07 (s, 1H), 7.83 - 7.77 (m, 2H), 7.75 (d, J =8.4 Hz, 2H), 7.55-7.49 (m, 1H), 7.38 (d, J = 8.3 Hz, 2H), 7.32 - 7.26 (m, 2H), 7.19-7.13 (m, 1H), 3.72 (ddd, J = 12.9, 9.3, 3.8 Hz, 1H), 3.60-3.51 (m, 1H), 3.15 (ddd, J = 13.3, 9.4, 4.0 Hz, 1H), 3.10 3.01 (m, 1H), 2.51 - 2.36 (m, 1H), 2.36 2.22 (m, 1H), 1.43 (s, 9H).
211C J 566 (M+H) 100-106 (CDCI3) δ 8.55 (s, 1H), 8.15 (d, J = 8.4 Hz, 2H), 8.10 (s, 1H), 7.79 (dt, J= 10.4, 5.8 Hz, 4H), 7.38 (d, J = 8.3 Hz, 2H), 7.11 (s, 3H), 3.85 - 3.78 (m, 2H), 3.20 - 3.12 (m, 2H), 2.30 (s, 6H), 2.13 - 2.07 (m, 2H), 1.87 - 1.82 (m, 2H).
212C J 580 (M+H) 186-188 (CDCI3) δ 8,55 (s, 1H), 8.19 - 8.10 (m, 3H), 7.79 (dt, J = 10.7, 5.9 Hz, 4H), 7.38 (dd, J = 8.5, 2.6 Hz, 3H), 7.30 (td. J = 7.5, 1.4 Hz, 1H), 7.23 (td, J= 7.5, 1.7 Hz, 1H), 7.13 (dd, j = 7.8, 1.4 Hz. 1 H), 3.94 (bs, 2H), 3.24 - 3.02 (m, 3H), 2.13 - 2.05 (m, 2H), 1.84 - 1.73 (m, 2H), 1.24 (t. J = 10.5 Hz, 6H).
Page 133 of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
213C J 580 (M+H) 123-127 (CDCI3) δ 8.55 (s, 1H), 8.13 (d, J = 8.4 Hz, 2H), 8.03 (d, J = 4.4 Hz, 1 H), 7.83 - 7.76 (m. 2H), 7.74 (d, J = 8.0 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 7.24 - 7.15 (m, 2H), 7.12 (dd, J = 11.9, 4.6 Hz, 1 H), 3.82 - 3.71 (m, 1 H), 3.30- 3.18 (m, 1H), 3.07-2.94 (m, 1H), 2.72 - 2.40 (m, 3H), 2.30 - 2.16 (m, 4H), 1.30- 1.12 (m, 6H).
214C J 622 (M+H) 160-162 (CDCI3) δ 8.55 (s, 1 H), 8.15 (d, J = 8.4 Hz, 2H), 8.06 (s, 1H), 7.83 - 7.72 (m, 4H), 7.38 (m, 3H), 7.34 (dd, J = 2.9, 1.5 Hz, 3H), 3.58 (ddd, J= 12.3, 3.9, 1.4 Hz, 1 H), 3.39 (dd, J = 12.2, 9.2 Hz, 1 H), 3.04 (ddd, J - 12.2, 3.9, 1.4 Hz, 1 H), 2.84 (dd, J = 12.2, 9.5 Hz, 1H), 2.61 -2.42 (m, 1H), 1.18 (d, J= 6.7 Hz, 3H)
215C J 640 (M+H) 116 (dec) (CDCI3) δ 8.55 (s, 1H), 8.14 (dd, J = 8.3, 1.5 Hz. 2H), 8.00 (d, J = 4.0 Hz, 1 H), 7.84 7.72 (m, 4H), 7.72 - 7.63 (m, 2H), 7.45 7.32 (m, 3H), 3.60 - 3.44 (m, 1 H), 3.37 3.27 (m, 1H), 3.03 - 2.92 (m, 1 H), 2.92 2.82 (m, 1H), 2.69-2.54 (m, 1 H), 1.191.12 (m, 3H)
216C J 622 (M+H) 132-135 (CDCI3) δ 8.55 (s, 1H), 8.14 (d, J = 8.4 Hz, 2H), 8.02 (s, 1 H), 7.82 - 7.71 (m, 4H), 7.44 7.30 (m, 6H), 3.87 (d, J = 6.3 Hz, 1 H), 3.23 (td, J = 11.9, 3.8 Hz, 1 H), 3.07 - 2.94 (m, 1 H), 2.54 - 2.43 (m, 1 H), 2.19 (ddd, J = 13.9, 9.0, 5.0 Hz, 1 H), 1.31 (d, J = 6.6 Hz, 3H)
Page I34of 160
ID Synthesis Method MS mp (°C) 1H NMR(D)1
217C J 640 (M+H) 93 (dec) Two isomers (CDCI3) δ 8.55 (s, 2H), 8.14 (dd, J = 8.4, 2.7 Hz, 4H), 7.98 (d, J = 4.2 Hz, 2H), 7.83 - 7.72 (m. 8H), 7.67 (dt, J = 12.9, 7.4 Hz, 4H), 7.40 (dd, J = 15.3, 8.1 Hz, 6H), 4.17 (s, 1 H), 3.96 (td, J= 6.6, 3.1 Hz, 1 H), 3.24 - 3.12 (m, 2H), 3.12 - 3.01 (m, 2H), 2.41 (dddd, J= 10.8, 10.0, 8.9, 4.2 Hz, 2H), 2.30 - 2.15 (m, 2H), 1.24 (d, J = 6.7 Hz, 3H), 1.04 (d, J = 6.7 Hz, 3H)
218C J 580 (M+H) 95 (dec) (CDCI3) δ 8.55 (s, 1H), 8.18 - 8.10 (m, 2H), 8.05 (s, 1H), 7.83 - 7.76 (m, 2H), 7.73 (d, J = 8.4 Hz, 2H), 7.41 - 7.37 (m, 2H), 6.93 (d, J = 9.4 Hz, 2H), 3.76 (dd, J = 10.8, 4.6 Hz, 1H), 3.29-3.16 (m, 1H), 2.99 (ddd, J = 12.2, 5.9, 3.9 Hz, 1H), 2.54-2.37 (m, 1H), 2.31 (s, 3H), 2.22 (d, J = 6.4 Hz, 7H), 1.19 (d, J = 6.7 Hz, 3H)
219C J 592 (M+H) 100 (dec) (CDCI3) δ 8.55 (s, 1H), 8.14 - 8.06 (m, 3H), 7.91 - 7.65 (m, 4H), 7.44 - 7.37 (m, 2H), 7.16 - 7.09 (m, 1H), 6.93 - 6.77 (m, 2H), 4.06 - 3.64 (m, 4H), 3.31 - 3.16 (m, 1H), 3.02 - 2.92 (m, 1 H), 2.51 - 2.40 (m, 1 H), 2.25 - 2.17 (m, 4H), 1.41 -1.14 (m, 3H)
Pagel35ofl60
ID Synthesis Method MS mp (°C) 1H NMR(C)1
220C J 593 (M+H) 95 (dec) Two isomers: (CDCI3) δ 8.55 (s, 1H), 8.16 8.09 (m, 2H), 8.01 (m, 1H), 7.86 - 7.76 (m, 2H), 7.76 - 7.70 (m, 2H), 7.64 - 7.28 (m, 4H), 7.24 - 7.14 (m, 2H), 4.08 - 3.65 (m, 1H), 3.37 - 3.15 (m, 1H), 3.09 - 2.92 (m, 1H), 2.80 (td, J= 14.2, 6.8 Hz, 1H), 2.45 m, 1 H), 2.35 - 2.09 (m, 1 H), 1.76 - 1.58 (m, 1H), 1.48- 1.35 (m, 2H), 1.27- 1.19 (m, 2H), 1.19 - 1.13 (m, 2H), 1.06 - 0.92 (m, 1H), 0.92-0.72 (m, 3H)
221C J 603 (M+H) 113 (dec) (400 MHz, CDCI3) δ 8.56 (s, 1H), 8.20 8.10 (m, 2H), 8.00 (s, 1 H), 7.83 - 7.77 (m, 2H), 7.75 (d, J = 8.4 Hz, 2H), 7.42 - 7.28 (m, 6H), 6.72 - 6.25 (m, 1 H), 3.90 (d, J = 6.4 Hz, 1H), 3.24 (td, J= 12.0, 3.6 Hz, 1H), 3.05 - 2.93 (m, 1 H), 2.49 (tt, J = 11.7, 4.0 Hz. 1H), 2.21 (td, J= 8.7, 4.4 Hz, 1H), 1.29 (d, J = 6.6 Hz, 3H)
222C J 594 (M+H) 124 (dec) (CDCI3) δ 8.55 (s, 1 H), 8.14 (dd, J= 8.4, 2.1 Hz, 2H), 8.05 (d, J = 2.8 Hz, 1 H), 7.87 7.72 (m, 4H), 7.61 - 7.49 (m, 1H), 7.38 (d, J = 8.3 Hz, 2H), 7.33 - 7.21 (m, 2H), 7.15 7.05 (m, 1H), 3.79 - 3.68 (m, 1H), 3.51 3.29 (m, 1H), 3.12-2.93 (m, 1H), 2.662.52 (m, 1H), 2.18-2.12(m, 1H), 1.43 (m, 12H)
223C L 566 (M+H) 75-87 (CDCI3) δ 8.58 (s, 1 H), 8.21 (d, J = 8.4 Hz, 2H), 8.16 (s, 1H), 7.85 - 7.77 (m, 4H), 7.40 (d, J = 8.3 Hz, 2H), 7.23 (dd, J = 8.4, 6.6 Hz, 1H), 7.15 (d, J = 7.5 Hz, 2H), 3.24 3.14 (m, 4H),2.18(s, 6H).
Page 136 of 160
ID Synthesis Method MS mp(°C) 'H NMR (D)1
224C L 580 (M+H) 118 (dec) (CDCI3) δ 8.57 (s, 1 H), 8.21 (d, J = 8.4 Hz, 2H), 8.16 (s, 1 H), 7.85 - 7.75 (m, 4H), 7.46 7.36 (m, 4H), 7.33 - 7.26 (m, 1H), 7.10 (d, J = 7.6 Hz, 1H), 3.26 - 3.14 (m, 4H), 2.81 (sept, J - 6.9 Hz, 1 H), 1.21 (t, J = 7.2 Hz, 6H).
225C L 580 (M+H) 111 (dec) (CDCI3) δ 8.57 (s, 1H), 8.21 (d, J= 8.4 Hz, 2H), 8.15 (s, 1H), 7.86 - 7.76 (m, 4H), 7.39 (d, J = 8.3 Hz, 2H), 7.29 (t, J = 7.6 Hz, 1 H), 7.21 - 7.15 (m, 2H), 3.27 - 3.10 (m, 4H), 2.50 (q, J= 7.5 Hz, 2H), 2.18 (s, 3H), 1.20 (t, J = 7.6 Hz, 3H).
226C L 573 (M+H) 196-200 (CDCI3) δ 8.57 (s, 1H), 8.24 - 8.16 (m, 3H), 7.85 - 7.76 (m, 4H), 7.43 - 7.34 (m, 3H), 7.03 (dd, J = 8.5, 7.4 Hz, 2H), 3.21 (s, 4H)
227C L 586 (M+H) Oil (CDCI3) δ 8.57 (s, 1 H), 8.21 (d, J = 8.3 Hz, 2H), 8.15 (s, 1H), 7.81 (t. J= 9.1 Hz, 4H), 7.43 - 7.31 (m, 3H), 7.28 - 7.21 (m, 2H), 3.36 - 3.07 (m, 4H), 2.24 (s, 3H); 19F NMR (376 MHz, CDCI3) δ -58.02
228C L 640 (M+H) 99 (dec) (CDCI3) δ 8.57 (s, 1H), 8.21 (d, J = 8.3 Hz, 2H), 8.11 (s, 1H), 7.81 (dd, J= 11.5, 4.7 Hz, 4H), 7.72 (dd, J = 17.3, 8.0 Hz, 2H), 7.51 (dd, J = 10.0, 5.4 Hz, 1H), 7.39 (d, J = 8.3 Hz, 2H), 3.36 - 3.03 (m, 4H)
229C L 622 (M+H) 95 (dec) (CDCI3) δ 8.57 (s, 1H), 8.21 (d, J = 8.4 Hz, 2H), 8.13 (s, 1 H), 7.80 (dt, J = 5.5, 4.9 Hz, 4H), 7.44 - 7.34 (m, 6H), 3.29 - 3.10 (m, 4H)
Page I37of 160
ID Synthesis Method MS mp(°C) 1H NMR (O)1
230C L 594 (M+H) 94 (dec) (CDCh) δ 8.57 (s, 1H), 8.21 (d, J= 8.3 Hz, 2H), 8.14 (d, J = 15.4 Hz, 1 H). 7.83-7.76 (m, 4H), 7.43 - 7.37 (m, 4H), 7.32 - 7.26 (m, 1H), 7.16 - 7.09 (m, 1 H), 3.24 - 3.12 (m, 4H), 2.61 - 2.44 (m, 1 H), 1.75 - 1.50 (m, 2H), 1.17 (dd, J = 6.9, 3.3 Hz, 3H), 0.87 0.73 (m, 3H)
231C L 582 (M+H) 105 (dec) (CDCI3) δ 8.58 (s, 1H), 8.22 (s, 1H), 8.19 (d, J = 5.0 Hz, 2H), 7.81 (dd, J = 8.7, 5.5 Hz, 4H), 7.40 (d, J = 8.3 Hz, 2H), 7.05 (d, J = 8.3 Hz, 1 H), 6.90 - 6.76 (m, 2H), 3.83 (s, 3H), 3.22 - 3.11 (m, 4H), 2.16 (s, 3H)
232C L 593 (M+H) 120 (dec) (CDCI3) δ 8.57 (s, 1 H), 8.21 (d, J = 8.4 Hz, 2H), 8.16 (s, 1H), 7.81 (dd, J = 8.7, 5.3 Hz, 4H), 7.58 (dd, J = 8.1, 1.5 Hz, 1H), 7.38 (dd, J = 13.2, 5.1 Hz, 3H), 7.33 - 7.27 (m, 1 H), 7.02 - 6.96 (m, 1 H), 3.37 - 3.01 (m, 4H), 1.36 (s, 9H)
233C L 604 (M+H) 92 (dec) (CDCi3) δ 8.58 (s, 1H), 8.21 (d, J = 8.4 Hz, 2H), 8.14 (s, 1H), 7.86 - 7.72 (m, 4H), 7.48 - 7.28 (m, 6H). 6.40 (t, JHF = 74.3 Hz, 1H), 3.25-3.11 (m, 4H)
NMR spectral data were acquired using a 400 MHz instrument except where noted.
Table 4A: Analytical Data for Optically Active Compounds in Table 3
ID Séparation Method MS Chiral Purity (%) 1H NMR(D)1
Page I38of 160
ID Séparation Method MS Chiral Purity (%) 1H NMR(D)1
234C A 571 (M+H) 98.73 (CDCI3) δ 8.58 (s, 1H), 8.31 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.87 - 7.78 (m, 4H), 7.41 (t, J = 6.3 Hz, 3H), 7.37 - 7.31 (m, 1 H), 7.28 (d, J = 7.0 Hz, 1 H), 4.09 - 3.98 (m, 2H), 2.29 (s, 3H)
235C A 571 (M+H) 95.75 (CDCI3) δ 8.58 (s, 1H), 8.31 (s, 1H), 8.23 (d, J = 8.3 Hz, 2H), 7.87 - 7.78 (m, 4H), 7.41 (dd, J = 7.0, 5.6 Hz, 3H), 7.34 (t, J = 7.8 Hz, 1H), 7.28 (d, J - 6.0 Hz, 1H), 4.09 - 3.98 (m, 2H), 2.29 (s, 3H)
236C A 565 (M+H) 96.32 (CDCI3) δ 8.58 (s, 1H), 8.31 (s, 1 H). 8.23 (d, J = 8.4 Hz, 2H), 7.81 (dd, J = 11.7, 5.1 Hz, 4H), 7.40 (d, J = 8.4 Hz, 2H), 7.35 (t, J = 7.7 Hz, 1 H), 7.24 - 7.18 (m, 2H), 4.02 (s, 2H), 2.53 (q, J = 7.5 Hz, 2H), 2.21 (s, 3H), 1.21 (t, J =7.6 Hz, 3H)
237C A 565 (M+H) 92.33 (CDCI3) δ 8.58 (s, 1H), 8.31 (s, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.81 (dd, J = 11.7, 5.1 Hz, 4H), 7.40 (d, J = 8.3 Hz, 2H), 7.35 (dd, J = 10.4, 4.9 Hz, 1 H), 7.24 - 7.20 (m, 2H), 4.02 (s, 2H), 2.59 - 2.45 (m, 2H), 2.21 (s, 3H). 1.21 (t, J = 7.6 Hz, 3H)
238C B 579 (M+H) 95.41 (CDCI3) δ 8.58 (s, 1 H), 8.29 (d, J= 3.9 Hz, 1H), 8.23 (d, J = 8.4 Hz, 2H), 7.82 (t, J = 8.8 Hz, 4H), 7.40 (d, J = 8.3 Hz, 3H), 7.31 (d, J = 6.9 Hz, 1H), 7.19 (dd, J= 7.6, 5.2 Hz, 1H), 4.03 (s, 2H), 2.83 - 2.73 (m, 1 H), 2.21 (s, 3H), 1.25-1.18 (m, 6H)
Page I39of 160
ID Séparation Method MS Chiral Purity (%) 1H NMR (D)1
239C B 579 (M+H) 92.68 (CDCIg) δ 8.58 (s, 1H), 8.30 (s, 1 H), 8.22 (t, J = 8.7 Hz, 2H), 7.82 (t, J = 8.7 Hz, 4H), 7.40 (d, J = 8.2 Hz, 3H), 7.31 (d, J = 8.0 Hz, 1H), 7.20 (d, J = 7.3 Hz, 1H), 4.03 (s, 2H), 2.83 - 2.73 (m, 1H), 2.21 (s, 3H), 1.25- 1.18 (m, 6H)
NMR spectra data were acquired using a 400 IV Hz instrument except where noted.
Table 5: Biological Results
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW 50 □g/cmz % Mortality GPA 200 PPm
1C A A D
2C A A D
3C A A D
4C A A B
5C A A B
6C A A D
7C A D D
8C A A B
9C A A D
10C A A D
11C A A D
Page 140 of 160
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW50 □g/cm2 % Mortality GPA 200 ppm
12C A A B
13C A A B
14C A A B
15C A A A
16C A A D
17C A A B
18C A A B
19C A A B
20C A A D
21C C C D
22C A A B
23C A A D
24C A A B
25C A A D
26C C C D
27C A A B
28C A A B
29C A A B
30C A A B
31C A A B
Page I4l of 160
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW50 □g/cm2 % Mortality GPA200 PPm
32C C C B
33C A A B
34C C C B
35C A A B
36C A A D
37C A A D
38C A A D
39C C C D
40C A A B
41C A A D
42C A A D
43C A A B
44C A A D
45C A A C
46C A A D
47C A A B
48C A A C
49C A A B
SOC A A C
51C A A D
Page 142 of 160
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW50 □g/cm2 % Mortality GPA 200 ppm
52C D B B
53C D B B
54C A A D
55C A A D
56C A A C
57C A A B
58C A A B
59C A A B
60C A A D
61C A A C
62C A A B
63C A A D
64C A A D
65C A A B
66C A A B
67C A A D
68C A A B
69C A A C
70C A A D
71C A A D
Page I43 oflôO
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW50 □g/cm2 % Mortality GPA 200 ppm
72C A A B
73C A A B
74C A A D
75C A A B
76C A A B
77C A A B
78C A A B
79C A A B
80C A A D
81C A A D
82C A A C
83C A A C
84C A A D
85C A A B
86C A A D
87C C C B
88C A A B
89C A A D
90C A A B
91C D D C
Page 144 of 160
Compoun d Number % Mortality CEW 50 Og/cm2 % Mortality BAW50 □g/cm2 % Mortality GPA 200 ppm
92C A A B
93C A A D
94C A A D
95C A A B
96C A A B
97C A A C
98C C A C
99C A A C
100C A A c
101C A A c
102C A A c
103C A A c
104C A A c
105C A A c
106C A A c
107C D D c
108C A A D
109C A A C
110C A A C
me A A B
Page I45of I60
Compoun d Number % Mortality CEW 50 □g/cmz % Mortality BAW50 □g/cm2 % Mortality GPA 200 ppm
1120 A A B
1130 A A C
1140 A A C
1150 D B C
1160 A A C
1170 A A D
1180 A A D
1190 A A D
1200 A A C
1210 A A B
122C A A C
123C A A C
124C A A C
125C A A C
126C A A C
127C A A C
128C A A C
129C A A C
1300 A A C
1310 A A D
Page 146 of 160
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW 50 □g/cmz % Mortality GPA 200 ppm
1320 A A B
133C A A B
134C A A C
135C A A D
1360 A A D
137C A A D
138C A A B
1390 A A B
1400 A A B
141C A A D
1420 A A D
1430 A A C
1440 A A C
1450 A A B
1460 A A B
1470 A A B
1480 A A C
1490 A A D
1500 A A D
1510 A A B
r?
Page 147 of 160
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW50 □g/cm2 % Mortality GPA 200 Ppm
152C A A C
153C A d C
154C A A B
155C A A D
156C A A B
157C A A B
158C A A B
159C A A C
160C A A C
1610 A A C
162C A A C
163C A A C
164C A A C
165C A A C
166C A A C
167C A A C
1680 A A D
169C A A C
1700 A A C
171C A A C
Page 148 of 160
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW50 □g/cm2 % Mortality GPA 200 ppm
172C A A D
173C A A D
174C A A B
175C A A D
176C A A C
177C A A D
178C A A D
179C A A D
180C A A B
181C A A B
182C A A B
183C A A D
184C A A D
185C A A D
186C A A B
187C A A D
188C A A B
189C A A B
1900 A A B
191C A A D
Page 149 of I60
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW50 □g/cm2 % Mortality GPA 200 ppm
192C A A B
193C A A B
194C A A B
195C A A B
196C A A D
197C A A D
198C A A D
199C A A C
200C A A C
201C A A B
202C A A B
203C A A B
204C A A B
205C A A B
206C A A D
207C d D C
208C A A D
209C A A D
21 OC A A C
211C A A D
Compoun d Number % Mortality CEW 50 □g/crn2 % Mortality BAW 50 □g/cm2 % Mortality GPA 200 ppm
212C A A D
213C A A B
214C A A C
215C A A C
216C A A C
217C A A C
218C A A C
219C A A C
220C A A C
221C A A C
222C A A C
223C A A C
224C A A B
225C A A C
226C A A C
227C A A C
228C A A C
229C A A C
230C A A C
231C A A C
Page I5l of I60
Compoun d Number % Mortality CEW 50 □g/cm2 % Mortality BAW50 □g/cm2 % Mortality GPA 200 PPm
232C A A C
233C A A C
234C A A C
235C A A C
236C A A C
237C A A C
238C A A C
239C A A C

Claims (8)

  1. WE CLAIM
    1.
    A a molécule according to Formulas One or Two
    Aq
    Formula 1
    Formula 2 wherein:
    (a) Aq is (1) furanyl, phenyl, pyridazinyl, pyridyl, pyrimidinyl, thienyl, or (2) substituted furanyl, substituted phenyl, substituted pyridazinyl, substituted (1) (2) pyridyl, substituted pyrimidinyl, or substituted thienyl, wherein said substituted furanyl, substituted phenyl, substituted pyridazinyl, substituted pyridyl, substituted pyrimidinyl, and substituted thienyl, hâve one or more substituents independently selected from H, F, Cl, Br, I, CN, NO2, CrC6 alkyl, Ci-C6 haloalkyl, C3-C6 cycloalkyl, C3-Ce halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, CiC6 alkoxy, CrCe haloalkoxy, Cz-Cs alkenyl, C2-C6 alkynyl, S(=O)n(Ci-CB alkyl), S(=O)n(C1-C6 haloalkyl), OSO^-Cg alkyl), OSO2(CrC6 haloalkyl), C(=O)NRxRy, (CrCe alkyl)NRxRy, C(=O)(CrCe alkyl), C(=O)O(CrCB alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-Ce alkenyl), C(=O)O(C2-Ce alkenyl), (CrC6 alkyl)O(CrCB alkyl), (CrCB alkyl)S(CrC6 alkyl), C(=O)(CrC6 alkyl)C(=O)O(Cr Ce alkyl), phenyl, phenoxy, substituted phenyl, and substituted phenoxy, wherein such substituted phenyl and substituted phenoxy hâve one or more substituents independently selected from H, F, Cl, Br, I, CN, N02, CrC6 alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, Cr C6 alkoxy, CrCe haloalkoxy, C2-C6 alkenyl, C2-CB alkynyl, S(=O)n(CrCe alkyl), S(=O)n(CrCe haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)NRxRy, (CrC6 alkyl)NRxRy, C(=O)(CrC6 alkyl), C(=O)O(CrCB alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-Ce cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-CB alkenyl), C(=O)O(C2-C6 alkenyl), (CrCe alkyl)O(CrCB alkyl), (CrCB alkyl)S(CrCB alkyl), C(=O)(CrC6 alkyl)C(=O)O(Cr C0 alkyl) phenyl, and phenoxy;
    (b) Het is a 5 or 6 membered, saturated or unsaturated, heterocyclic ring, containing one or more heteroatoms independently selected from nitrogen, sulfur, or oxygen, and where
    Aq and Ar2 are not ortho to each other (but may be meta or para, such as, for a five membered ring they are 1,3 and for a 6 membered ring they are either 1,3 or 1,4), and where said heterocyclic ring may also be substituted with one or more substituents independently selected from H, F, Cl, Br, I, CN, NO2, oxo, C^Cg alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-C6
    Page 153 of 160 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, Ci-C6 alkoxy, CrCe haloalkoxy, C2-CB alkenyl, C2-C6 alkynyl, S(=O)n(CrCB alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrCe haloalkyl), C(=O)NRxRy, (CrC6 alkyl)NRxRy, C(=O)(CrC6 alkyl), C(=O)O(CrC6 alkyl), C(=O)(CrCe haloalkyl), C(=O)O{CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrCB alkyl), (CrCe alkyl)S(CrC6 alkyl), C(=O)(CrC6 alkyl)C(=O)O(CrCB alkyl), phenyl, phenoxy, substituted phenyl and substituted phenoxy, wherein such substituted phenyl and substituted phenoxy hâve one or more substituents îndependently selected from H, F, Cl, Br, I, CN, NO2> CrCe alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-CB halocycloalkyl, C3-Ce cycloalkoxy, C3-C6 halocycloalkoxy, CrCe alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)NRxRy, (CrCe alkyl)NRxRy, C(=O)(Cr C6 alkyl), C(=O)O(CrCe alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrCe alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=0)(CrC6 alkyl)C(=O)O(CrCB alkyl), phenyl, and phenoxy;
    (c) Arz is (1) furanyl, phenyl, pyridazinyl, pyridyl, pyrimidinyl, thienyl, or (2) substituted furanyl, substituted phenyl, substituted pyridazinyl, substituted pyridyl, substituted pyrimidinyl, or substituted thienyl, wherein said substituted furanyl, substituted phenyl, substituted pyridazinyl, substituted pyridyl, substituted pyrimidinyl, and substituted thienyl, hâve one or more substituents îndependently selected from H, F, Cl, Br, I, CN, NO2, CrCB alkyl, CrCB haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-CB cycloalkoxy, C3-C6 halocycloalkoxy, Cr CB alkoxy, CrCB haloalkoxy, C2-CB alkenyl, C2-CB alkynyl, S(=O)n(CrCB alkyl), S(-O)n(CrCB haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)NRxRy, (CrC6 alkyl)NRxRy, C(=O)(CrCB alkyl), C(=O)O(CrCB alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(CrCB haloalkyl), C(=O)(C3-CB cycloalkyl), C(=O)O(C3-CB cycloalkyl), C(=O)(CZ-CB alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (CrCB alkyl)S(CrC6 alkyl), C(=O)(CrCe alkyl)C(=O)O(Cr C6 alkyl), phenyl, phenoxy, substituted phenyl and substituted phenoxy, wherein such substituted phenyl and substituted phenoxy hâve one or more substituents îndependently selected from H, F, Cl, Br, I, CN, NO2, CrCB alkyl, CrCB haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-CB halocycloalkoxy, Cr
    C6 alkoxy, CrCB haloalkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)NRxRy, (CrC6 alkyl)NRKRy,
    C(=0)(CrCB alkyl), C(=O)O(CrC6 alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl),
    C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(CrC6 haloalkyl), C(=O)(C2-CB
    Page 154 of 160 alkenyl), C(=O)O(C2-C6 alkenyl), (C^Ce alkylJOtC^Ce alkyl), (CrCg alkyl)S(CrC6 alkyl),
    0(=Ο)(0ι-0θ alkyl)C(=O)O(Ci-C6 alkyl), phenyl, and phenoxy;
    (d) R1 is selected from H, CN, F, Cl, Br, I, Ci-C6 alkyl, C3-C6 cycloalkyl, C3-C6 cycloalkoxy, Ci-C6 alkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(CrCe alkyl), OSO2(CrC6 alkyl), C(=O)NRxRy, (CrC6 alkyl)NRxRy, C(=O)(CrC6 alkyl), C(=O)O(CrCe alkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (Ci-C6 alkyl)O(CrC6 alkyl), (CrC6 alkylJSfCrCe alkyl), C(=O)(CrC6 alkyl)C(=O)O(CrC6 alkyl), phenyl, or phenoxy, wherein each alkyl, cycloalkyl, cycloalkoxy, alkoxy, alkenyl, alkynyl, phenyl, and phenoxy, are optionally substituted with one or more substituents independently selected from F, Cl, Br, I, CN, N02, oxo, Ci-C6 alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-Ce halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, Ci-C6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(C1-C6 haloalkyl), C(=O)NRxRy, (CrCe alkyl)NRxRy, 0(=0)(0,-06 alkyl), 0(=0)0(0,-06 alkyl), C(=0)(C,-C6 haloalkyl), C(=O)O(CrC6 haloalkyl), 0(=0)(03-06 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), 0(=0)0(C2-C6 alkenyl), (CrC6 alkyl)O(CrCe alkyl), (0,-06 alkyl)S(C,-C6 alkyl), 0(=0)(0,-06 alkyl)C(=0)0(C,-C6 alkyl), phenyl, and phenoxy;
    (e) R2 is H, 0,-06 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C(=O)H, C(=0)(CrC6 alkyl), C(=O)O(CrC6 alkyl), C(=O)(C3-C6 cycloalkyl), Ο(=Ο)Ο(Ο3-Ο6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (0,-06 alkyl)O(CrC6 alkyl), (CrC6 alkyl)S(C,-C6 alkyl), 0(=0)(0,-06 alkyl)C(=O)O(C1-C6 alkyl), phenyl, Ci-C6 alkylphenyl, C,-Ce alkyl-O-phenyl, C(=O)Het-1, Het-1, 0,-06 alkylHet-1, or Ci-C6 alkyl-O-Het-1, wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and Het-1 are optionally substituted with one or more substituents independently selected from F, Cl, Br, I, CN, N02, NRxRy, 0,-Ce alkyl, CrCe haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, CrC6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C3-C6 cycloalkenyl, C2-C6 alkynyl, 3(=0),,(0,-06 alkyl), S(=O)n(C,-C6 haloalkyl), OSO^CrCe alkyl), OSO2(C,-C6 haloalkyl), C(=O)H, C(=O)NRxRy, (0,-Ce alkyl)NRxRy, C(=O)(C,-Ce alkyl), 0(=0)0(0,-06 alkyl), C(=O)(C,C6 haloalkyl), C(=O)O(C,-Ce haloalkyl), C(=O)(C3-C6 cycloalkyl), 0(=0)0(03-0Θ cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-Ce alkenyl), (C,-C6 alkyl)O(C,-C6 alkyl), (C,-C6 alkyl)S(C,-C6 alkyl), 0(=0)(0,-06 alkyl)C(=0)0(C,-C6 alkyl), phenyl, phenoxy, and Het-1;
    (f) R3 is 0,-06 alkyl, C3-C6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C(=O)H, C(=O)(C,-C6 alkyl), C(=O)O(C,-C6 alkyl), 0(=Ο)(03-0β cycloalkyl), 0(=0)0(03-06 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl). (C,-C6 alkyl)O(C,-C6 alkyl), (C,-C6 alkyl)S(C,-C6 alkyl), C(=0)(Ci-C6 alkyl)C(=0)0(C,-C6 alkyl), phenyl, Ο,-Οβ alkylphenyl, Ο,-Οβ alkyl-O-phenyl,
    Page 155 of 160
    C(=O)Het-1, Het-1, C,-C6 alkylHet-1, C,-C6 alkyl-O-C(=O)C,-Ce alkyl-O-C,-C6 alkyl, CrC6 alkylΟ-Ο(=Ο)Ο,-Ο6 alkyl-O-Ci-Ce alkyl-O- CrCe alkyl, C1-C6alkyl-O-C{=O)Ci-C6 alkyl-O-Ci-C6 haloalkyl, C,-C6alkyl-O-C(=O)Ci-C6 alkyl-N(Rx)C(=O)-O-phenyl, C,-C6 alkyl-O-C(=O)C,-Ce alkylN(RX)C(=O)-O-C,-C6 alkylphenyl, Ci-C6alkylC(=O)N(Rx)Ci-C6 alkyl, C,-C6alkylC(=O)N(Rx)Ci-C6 alkylHet-10(=0)-0-0,-C6 alkyl, Ci-C6alkylC(=O)N(Rx)C,-C6 alkylHet-1, C,-C6alkylC(=0)Het-1, Ci-C6alkylC(=O)N(Rx)Ci-C6 alkyl(N(Rx)(Ry))(C(=O)OH), Ci-C6alkylC(=O)N(Rx)C,-C6 alkylN(Rx)(Ry), C,-CG alkylC(=O)N(Rx)C,-C6 alkylN(Rx)C(=O)-O-Ci-C6 alkyl, 0,-06 alkylC(=O)N(Rx)Ci-Ce alkyl(N(Rx)C(=O)-O-Ci-Ce alkyl)(C(=O)OH), C,-C6alkylC(=O)Het-1C(=O)O-C,-C6 alkyl, CrCealkyl-O-C^OJ-O-Ct-Ce alkyl, C,-C6alkyl-O-C(=O)Ci-C6 alkyl, C,-C6alkyl-OC(=O)C3-C6 cycloalkyl, C,-C6alkyl-0-C(=0)Het-1( CrC6alkyl-O-C(=O)C,-Ce alkyl-N(Rx)C(=O)O-C,-C6 alkyl, Ο,-Οβ alkyl-NRxRy, or Ci-C6 alkyl-O-Het-1, wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and Het-1 are optionally substituted with one or more substituents independently selected from F, Cl, Br, I, CN, N02, NRxRy, 0,-06 alkyl, C,-C6 haloalkyl, C3-C6 cycloalkyl, C3-Ce halocycloalkyl, C3-C6 cycloalkoxy, Ο3-Οβ halocycloalkoxy, C,-C6 alkoxy, Ο,-Οβ haloalkoxy, Ο2-Οβ alkenyl, C3-C6 cycloalkenyl, Ο2-Ο6 alkynyl, S(=O)n(C,-C6 alkyl), S(=O)n(C,-C6 haloalkyl), OSO2(Ci-C6 alkyl), OSO2(C,-Ce haloalkyl), C(=O)H, C(=O)OH, C(=0)NRxRy, (0,-06 alkyl)NRxRy, 0(=0)(0,-06 alkyl), C(=O)O(CrC6 alkyl), C(=O)(C1-Ce haloalkyl), C(=0)0(C1-C6 haloalkyl), 0(=0)(03-06 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (0,-06 alkyl)O(C,-C6 alkyl), (C,-C6 alkyl)S(C,-Ce alkyl), C(=0)(Ci-C6 alkyl)C(=O)O(C1-C6 alkyl), phenyl, phenoxy, Si(C,-C6 alkyl)3, S(=O)nNRxRy, and Het-1;
    (g) R4 is H, C,-C6 alkyl, Ο3-Ο6 cycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, C(=O)H, Ο(=Ο)(Ο1-ΟΘ alkyl), C(=O)O(Ci-C6 alkyl), 0(=0)(03-06 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-Ce alkenyl), C(=O)O(C2-C6 alkenyl), (Ο,-Οβ alkylJOtCrCe alkyl), (C,-C6 alkyl)S(CrC6 alkyl), 0(=0)(0Ί-06 alkyl)C(=0)0(Ci-C6 alkyl), phenyl, Ο,-Οβ alkylphenyl, CrCe alkyl-O-phenyl, C(=0)Het-1, Het-1, Ο,-Οβ alkylHet-1, ογΟγΟ6 alkyl-O-Het-1, wherein each alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, and Het-1 are optionally substituted with one or more substituents independently selected from F, Cl, Br, I, CN, N021 NRxRy, Ο,-Οβ alkyl, 0,-06 haloalkyl, C3-C6 cycloalkyl, Ο3-Οθ halocycloalkyl, C3-C6 cycloalkoxy, C3-Ce halocycloalkoxy, ΟγΟ6 alkoxy, Ο,-Οβ haloalkoxy, Ο2-Ο6 alkenyl, C3-Ce cycloalkenyl, C2-C6 alkynyl, S(=O)n(C,-C6 alkyl), 3(=0)η(0,-06 haloalkyl), OSO2(C,-Ce alkyl), OSO2(C,-C6 haloalkyl), C(=O)H, C(=O)NRxRy, (C,-Ce alkyl)NRxRy, C(=O)(C,-C6 alkyl), C(=O)O(C,-Ce alkyl), C(=O)(Cr C6 haloalkyl), C(=O)O(Ci-C6 haloalkyl), C(=O)(C3-C6 cycloalkyl), Ο(=Ο)Ο(Ο3-Ο6 cycloalkyl), C(=O)(C2-Ce alkenyl), C(=O)O(C2-C6 alkenyl), (0,-06 alkyl)O(C,-C6 alkyl), (0,-06 alkyl)S(C,-C6 alkyl), 0(=Ο)(0,-06 alkyl)C(=O)O(Ci-C6 alkyl), phenyl, phenoxy, and Het-1;
    (h) R5 is a 2 to 4 membered saturated or unsaturated hydrocarbyl linkage where
    Page 156 of 160 said linkage may also be substituted with F, Cl, Br, I, CN, NO21 oxo, NRxRy, CrC6 alkyl, Ci-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-Ce halocycloalkoxy, Cr C6 alkoxy, CrC6 haloalkoxy, C2-C6 alkenyl, C3-C6 cycloalkenyl, C2-C6 alkynyl, S(=O)n(Ci-C6 alkyl), S(=O)n(CrC6 haloalkyl), OSOz(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)OH, C(=O)NRxRy, (CrC6 alkyl)NRxRy, C(=O)(CrC6 alkyl), C(=O)O(CrC6 alkyl), 0(=0)(0,-06 haloalkyl), C(=O)O(C,-C6 haloalkyl), C(=0)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-CS alkenyl), (C,-Ce alkyl)O(C,-C6 alkyl), (C,-Ce alkyl)S(C,-C6 alkyl), C(=O)(C,-C6 alkyl)C(=O)O(C,-C6 alkyl), phenyl, phenoxy, and Het-1, wherein each alkyl, cycloalkyl, cycloalkoxy, alkoxy, alkenyl, alkynyl, phenyl, phenoxy, and Het-1, are optionally substituted with one or more substituents independently selected from F, Cl, Br, I, CN, N02, oxo, NRxRy, C,-CB alkyl, C,-C6 haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-Ce halocycloalkoxy, CrC6 alkoxy, CrCe haloalkoxy, C2-C6 alkenyl, C3-Ce cycloalkenyl, C2-C6 alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(Ci-C6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)OH, C(=O)NRKRy, (CrCe alkyl)NRxRy, C(=O)(CrC6 alkyl), C(=O)O(CrCe alkyl), C(=0)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=0)(CrC6 alkyl)C(=O)O(C,C6 alkyl), phenyl, halophenyl, phenoxy, and Het-1;
    (i) n= 0, 1,or2;
    G) Rx and Ry are independently selected from H, CrC6 alkyl, CrCe haloalkyl, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, C2-C6 alkenyl, C2-C6 alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(CrC6 haloalkyl), C(=O)H, C(=O)(CrC0 alkyl), C(=O)O(Cr C6 alkyl), C(=0)(CrC6 haloalkyl), C(=0)0(CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-C6 cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(C,-C6 alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=0)(CrC6 alkyl)C(=O)O(CrC6 alkyl), and phenyl, wherein each alkyl, cycloalkyl, cycloalkoxy, alkoxy, alkenyl, alkynyl, phenyl, phenoxy, and Het-1, are optionally substituted with one or more substituents independently selected from F, Cl, Br, I, CN, N02, oxo, CrCe alkyl, CrC6 haloalkyl, C3-C6 cycloalkyl, C3-Ce halocycloalkyl, C3-Ce cycloalkoxy, C3-Ce halocycloalkoxy, CrC6 alkoxy, CrCe haloalkoxy, C2-Ce alkenyl, C3-C6 cycloalkenyl, C2-C6 alkynyl, S(=0)n(CrC6 alkyl), S(=O)n(CrC6 haloalkyl), OSO2(CrC6 alkyl), OSO2(Ci-C6 haloalkyl), C(=O)H, C(=O)OH, C(=O)(CrC6 alkyl), C(=0)0(Cr Ce alkyl), C(=0)(CrC6 haloalkyl), C(=O)O(CrC6 haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-Ce cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (CrC6 alkyl)O(CrC6 alkyl), (CrC6 alkyl)S(CrC6 alkyl), C(=0)(CrC6 alkyl)C(=O)O(CrC6 alkyl), phenyl, halophenyl, phenoxy, and Het-1, or Rx and Rytogether can optionally form a 5- to 7-membered saturated or
    Page 157 of 160 unsaturated cyclic group which may contain one or more heteroatoms selected from nitrogen, sulfur, and oxygen, and where said cyclic group can contain >C=O or >C=S, and where said cyclic group may be substituted with F, Cl, Br, I, CN, CrC6 alkyl, CrCg haloalkyl, C3-Cg cycloalkyl, C3-C6 halocycloalkyl, C3-C6 cycloalkoxy, C3-C6 halocycloalkoxy, CrC6 alkoxy, Ci-C6 haloalkoxy, C2-C6 alkenyl, C3-Ce cycloalkenyl, C2-Ce alkynyl, S(=O)n(CrC6 alkyl), S(=O)n(CrC8 haloalkyl), OSOzfCrCg alkyl), OSO2(CrC6 haloalkyl), C(“O)(CrCe alkyl), 0(=0)0(0,-(¾ alkyl), C(=O)(CrC6 haloalkyl), C(=O)O(CrCe haloalkyl), C(=O)(C3-C6 cycloalkyl), C(=O)O(C3-Ce cycloalkyl), C(=O)(C2-C6 alkenyl), C(=O)O(C2-C6 alkenyl), (C^Cg alkyl)O(CrCB alkyl), (C,-Cg alkyl)S(Ci-C6 alkyl), C(=O)(CrC6 alkyl)C(=O)O(Ci-C6 alkyl), phenyl, substituted phenyl, phenoxy, and Het-1 ; and (k) Het-1 is a 5- or 6-membered, saturated or unsaturated, heterocyclic ring, containing one or more heteroatoms independently selected from nitrogen, sulfur or oxygen.
  2. 2. A molécule according to claim 1 wherein Ar4 is a substituted phenyl wherein said substituted phenyl has one or more substituents independently selected from C^Cg haloalkyl and CrCg haloalkoxy.
  3. 5. A molécule according to claim 1 wherein Het is a 1,2,4-triazolyl
  4. 6. A molécule according to claim 1 wherein R3 is CrCg alkyl, C2-C6 alkenyl, C2-C6 alkynyl, CrC6 alkylphenyl, CrC6 alkylHet-1, C1-C6alkyl-O-C(=O)C1-Ce alkyl-O-CrC6 alkyl, CrCgalkyl-OC(=O)Ci-Ce alkyl-O-CrCe alkyl-O- alkyl, Ο,-Ο6 alkyl-O-C(=O)CrC6 alkyl-O-CrCg haloalkyl, Ci-C6alkyl-O-C(=O)CrC6 alkyl-N(Rx)C(=O)-O-phenyl, CrCgalkyl-O-C^OiCrCg alkylN(RX)C(=O)-O-Ci-C6 alkylphenyl, CrCgalkylC^OJNiRxJCrCg alkyl, CrCgalkylC^OJNiRJCrCg alkylHet-1C(=O)-O-Ci-Ce alkyl, CrCgalkylC^OHRxJCrCe alkylHet-1, CrC5alkylC(=O)Het-1, CrCg alkylC(=O)N(Rx)C1-Ce alkyl(N(Rx)(Ry))(C(=O)OH), Ο,-Ο6 alkylC^OHR^CrCe alkylN(Rx)(Ry), CrC6 alkylC(=O)N(Rx)CrC6 alkylN(Rx)C(=O)-O-CrC6 alkyl, CrC6 alkylC(=O)N(Rx)C1-C6 alkyl(N(Rx)C(=O)-O-CrCe alkyl)(C(=O)OH), CrCgalkylC^OJHet-IC^O)O-C1-C6 alkyl, Ci-CBalkyl-O-C(—O)-O-C4-Cg alkyl, C-i-Cgalkyl-O-C(=O)Ci-Cg alkyl, Ci-Cgalkyl-OC(=O)C3-Cg cycloalkyl, C1-C6alkyl-O-C(=O)Het-1, or CrCgalkyl-O-C^OJCrCg alkylN(RX)C(=O)-O-Ci-C6 alkyl wherein each alkyl, alkenyl, alkynyl, phenyl, and Het-1 are optionally substituted with one or more substituents independently selected from F, Cl, Br, CrC6 alkyl, Ο,-Ο6
    Page 158 of 160 haloalkyl, Ci-C6 haloalkoxy, S(=O)n(C1-C6 alkyl), C(=O)OH, 0(=0)0(0,-06 alkyl), phenyl, SîfC,C6 alkyl)3, and S(=O)nNRxRy.
  5. 7. A molécule according to claim 1 wherein R4 is phenyl, Ci-C6 alkylphenyl, or CrC6 alkylO-phenyl, wherein each alkyl and phenyl are optionally substituted with one or more substituents independently selected from F, Cl, NRxRy, 0,-06 alkyl, or Ci-C6 alkoxy.
  6. 8. A molécule according to claim 1 wherein
    Ar, is a substituted phenyl wherein said substituted phenyl, has one or more Ci-Ce haloalkoxy;
    Het is a triazolyl;
    Ar2 is a phenyl;
    R1 is H;
    R2 is H;
    R3 is Ci-C0 alkylHet-1 wherein said alkyl and Het-1 are optionally substituted with one or more substituents independently selected from F, Cl, Br, Ci-C6 alkyl, Ci-Cs haloalkyl, C,-C6 haloalkoxy, 3(=0),,(0,-0(5 alkyl), C(=O)OH, C(=O)O(Ci-Ce alkyl), phenyl, Si(CrC6 alkyl)3, and S(=0)nNRxRy;
    R4 is phenyl, wherein said phenyl is optionally substituted with one or more substituents independently selected from F, Cl, NRxRy, C,-Ce alkyl, or C,-C6 alkoxy; and n= 0, 1, or 2;
    Rx and Ry are independently selected from H and phenyl, wherein said phenyl, may be optionally substituted with one or more substituents independently selected from F and Cl; and
    Het-1 is wherein Het-1 is a 5- or 6-membered, saturated or unsaturated, heterocyclic ring, containing one or more heteroatoms independently selected from nitrogen, sulfur or oxygen.
  7. 9. A molécule according to claim 1 wherein Het-1 is selected from benzothiadizolyl, furanyl, oxazolyl, and thienylpyrazolyl.
  8. 10. A composition comprising a molécule according to claim 1 and at least one other compound selected from the Insecticide Group, Acaricide Group, Nematicide Group, Fungicide Group, Herbicide Group, Al Group, or Synergist Group.
OA1201300315 2011-02-07 2012-02-06 Pesticidal compositions and processes related thereto. OA16500A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/440,003 2011-02-07

Publications (1)

Publication Number Publication Date
OA16500A true OA16500A (en) 2015-10-21

Family

ID=

Similar Documents

Publication Publication Date Title
US9018136B2 (en) Pesticidal compositions and processes related thereto
US8916183B2 (en) Pesticidal compositions and processes related thereto
US9018388B2 (en) Pesticidal compositions and processes related thereto
US9107410B2 (en) Pesticidal compositions and processes related thereto
EP2611299A1 (en) Pesticidal compositions
US20160135464A1 (en) Pesticidal compositions and processes related thereto
OA16500A (en) Pesticidal compositions and processes related thereto.
OA19159A (en) Pesticidal Compositions and Processes Related Thereto
OA17013A (en) Pesticidal compositions and processes related thereto.
OA17014A (en) Pesticidal compositions and processes related thereto.
NZ613659B2 (en) Pesticidal compositions and processes related thereto